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ABSTRACT
Methotrexate (MTX) is prescribed widely, both in the treatment of malignancy and
autoimmune d isease. M TX h as d etrimental e ffects o n a n umber o f o rgan sy stems
including bone, and children who receive MTX therapy in the treatment of childhood
malignancies often show growth retardation throughout the course of the treatment.
On a longer time scale, this may result in a predisposition to osteoporosis. The
mechanism of action of MTX on bone at the cellular level is not clear, but may
involve interaction with the function of a number of bone cells and their precursors.
Mechanical forces influence human bone cell (HBC) metabolism and
function. It has been shown that 0.33 Hz cyclical mechanical stimulation results in
membrane hyperpolarisation of HBC. Membrane hyperpolarisation follows
activation of a mechanotransduction pathway which involves the asPi integrin,
tyrosine kinase activity, the actin cytoskeleton and interleukin-ip (IL-ip) secretion.
IL-ip binds to IL-1 receptors and stimulates a signal cascade involving phospholipase
C (PLC) and protein kinase C (PKC), leading to the activation of small conductance
Ca2+ activated K+ (SK) channels.
Experiments have been performed to further elucidate the
mechanotransduction pathways activated following 0.33 Hz cyclical mechanical
stimulation. It has been demonstrated that type 1 collagen mRNA levels are
increased following 0.33 Hz cyclical mechanical stimulation, whereas bone
morphogenetic protein-4 (BMP-4) mRNA levels are decreased following 0.33 Hz
cyclical mechanical stimulation.
The effect of MTX on HBC responses to 0.33Hz cyclical mechanical
stimulation was investigated. MTX dose-dependently inhibits the hyperpolarisation
response following mechanical stimulation. MTX appears to block mechanically
induced IL1-P release, rather than interfering with downstream IL1-P responses.
Methylene blue cell adhesion assays have provided evidence to indicate that MTX
may have effects on integrin receptors (in particular the p,-integrin subunit), although
at present, the exact mechanisms involved are unknown. MTX does not affect
mechanically induced changes in type 1 collagen and BMP-4 mRNA levels, which
would indicate that the mechanotransduction pathways by which type 1 collagen and
BMP-4 gene expression are regulated are not reliant on IL1-P function.
MTX is known to affect purine biosynthesis resulting in an overproduction of
adenosine. Studies have been performed to investigate the effects of adenosine on
HBC responses to 0.33 Hz cyclical mechanical stimulation. It has been demonstrated
that adenosine inhibits HBC hyperpolarisation following 0.33 Hz cyclical mechanical
stimulation, and that the inhibitory effects ofMTX on HBC responses to mechanical
stimulation can be prevented by adenosine deaminase (ADA). These results suggest
that adenosine signalling may be involved in MTX mediated inhibition of HBC
responses to cyclical mechanical stimulation, although the specific subset(s) of




The following section will give an introduction and background to the work detailed
in this thesis. A substantial part of this work has involved investigating the responses
of human bone cells (HBC) to regimes of cyclical mechanical stimulation (in the
presence and absence ofmethotrexate (MTX)), and therefore, particular attention is
given to the structure and biology ofbone and also to bone mechanotransduction.
Major findings in the mechanotransduction field are discussed, and the relative roles
of different types of bone cells and the extracellularmatrix in recognition and
conversion ofmechanical signals to biochemical events are described. The structure
and mechanism of action ofMTX is also discussed, as are its effects on bone, with
particular attention to its effects on osteoblasts.
This study is the first time that the effects ofMTX on HBC responses to mechanical
stimulation have been investigated.
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1.1 Bone Structure and Biology.
Bone is a specialised connective tissue that provides many essential functions of the
body. These functions include (1) the protection of vital organs, such as the brain, spinal
cord and heart, (2) providing a rigid framework to support the body, (3) providing sites
for muscle attachment to allow mobility, (4) generation of red and white blood cells for
immunoprotection and oxygenation of other tissues and (5) retaining reserve stores of
calcium, phosphate and magnesium (Yaszemski et al, 1996).
1.1.1 Gross Structure.
The skeleton provides the framework of the body and is divided into (a) the axial
skeleton, which includes the vertebrae, skull, ribs, sternum and hyoid bone and (b) the
appendicular skeleton, which includes the bones of the upper and lower limbs and the
pelvis (Van Wynsberghe et al, 1995).
The long bones of the body (e.g. humerous, tibia and femur) provide probably the easiest
descriptive model for the gross anatomy of a typical bone (Van Wynsberghe et al, 1995).
Most adult long bones have a tubular shaft called the diaphysis, which is essentially a
hollow cylinder of compact (dense) bone tissue. In the centre of the cylinder is the
medullary cavity, which is filled with marrow and trabecular (spongy, cancellous) bone
tissue (Buckwalter et al, 1996, Buckwalter et al, 1997). At each end of the bone is a
roughly spherical epiphysis of trabecular bone tissue. The epiphysis is usually wider
than the shaft of the bone. The flat bones and irregular bones of the trunk and limbs
have many epiphyses, whereas the long bones and the fingers and toes have only two
epiphyses.
Separating the diaphysis from the epiphyses at either end of the bone is the metaphysis.
It comprises the epiphyseal (growth) plate and the adjacent bony trabeculae of spongy
bone tissue on the diaphyseal side of the long bone. The epiphyseal plate is a thick plate
of hyaline cartilage that provides the framework for the synthesis of the cancellous bone
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tissue within the metaphysis. The epiphyseal plates are the only place where long bones
continue to grow in length after birth (Van Wynsberghe et al, 1995).
An outer bone sheath called the periosteum, covers both the cortical and the cancellous
bone. The periosteum is a fibrous membrane that has the potential to form bone during
growth periods and in fracture healing and is often attached to the underlying bone by
collagenous fibres called Sharpey's fibres. The periosteum contains nerves, lymphatic
vessels, and many capillaries, which provide nutrients to the bone and is composed of
two distinct layers. The outer layer is fibrous and is used to connect bones at the joint,
whereas the inner layer is more vascularised and contains cells that are capable of
becoming osteoblasts. The periosteum is continuous, except over articular surfaces,
which are covered by cartilage. As well as playing an important role in endochondral
bone formation, the periosteum provides a large proportion of the blood supply to the







(marrow / trabecular bone)
Epiphyseal (growth) plate
Periosteum
Figure 1.1 - Gross anatomy of a typical long bone.
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1.1.2 Macroscopic Physiology.
1.1.2.1 Compact Bone Tissue.
Compact bone tissue is very hard and dense and appears to the naked eye to be solid
although it is not. The basic unit of compact bone is the Haversian system (osteon). The
Haversian system is a hollow, laminated cylinder of collagen and calcium phosphate.
The cylinders are made of concentric layers (lamellae) of bone. These lamellae are
arranged like wider and wider drinking straws; each one nestled inside the next wider
one (Van Wynsberghe et al, 1995; Buckwalter et al, 1996). This structure provides the
great strength needed to resist typical, everyday compressive and bending forces on long
bones (Figure 1.2).
In the centre of osteons are central canals (Haversian canals). The Haversian canals are
longitudinal channels that contain blood vessels, nerves and lymphatic vessels (Figure
1.2). Central canals usually have branches called perforating canals (Volkmans canals)
which run at right angles to the central canals and therefore extend the system of nerves
and vessels outward to the periosteum, and inward to the endosteum (inner lining) of the
bone marrow cavity (Sikavitsas et al, 2001).
Lamellae contain lacunae, which contain osteocytes. Canaliculi radiate from each
lacuna, and contain the cell processes of the osteocytes. Nutrients and waste products
can pass to and from the blood vessels in the central canals (1) by normal processes of
intracellular transport within each osteocyte, (2) over gap junctions from one osteocyte
to another, or (3) possibly via tissue fluid in the tiny spaces between the osteocytes and















Figure 1.2 - Compact bone tissue, (a) an enlargement of a single osteon with lacunae,
canaliculi and a central (Haversian) canal visible. Photograph taken from Athansou, 1999.
(b) An enlarged osteocyte, housed within a lacuna.
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1.1.2.2 Trabecular (cancellous, spongy) Bone Tissue.
Trabecular bone tissue is in the form of an open interlaced pattern that withstands
maximum stress and supports shifts in weight distribution. The mesh like structure is
designed for strength in a similar manner to steel rods within a concrete structure.
Prominent in the interior structure of cancellous bone tissue are trabeculae, tiny spikes of
bone tissue surrounded by bone matrix that has calcified, or become hardened by the
deposition of calcium salts. Trabeculae are relatively thin and do not usually contain
Haversian systems. They are nourished by surrounding vessels within haematopoietic or
fatty marrow. Bone trabeculae are lined by a continuous layer of flattened bone lining
cells or osteoblasts and are separated by haematopoietic or fatty marrow. The trabeculae
form along the lines of greatest pressure or stress. This arrangement provides the
greatest strength with the least weight. Trabecular bone tissue is found within most












Bone is a specialised connective tissue in which bone cells lie within a connective
matrix that has organic and inorganic components (Fujisawa et al, 1998). The organic
component, which comprises approximately 35% of the bone matrix, is composed
predominantly of type 1 collagen fibres (95%), although trace amounts of other collagen
types, such as collagen III, V, XI and XIII, have also been found (Robey et al, 1993;
Athanasou, 1999). The collagen fibres in the matrix are responsible for giving bone its
tensile strength and flexibility and although the hardness of bone comes from the organic
salts, its structure depends equally on the collagen framework (Van Wynesberghe et al,
1995).
All collagens share the same basic structure, which is a long and thin diameter rod-like
protein (Gross et al, 1974; Ottani et al, 2002). Type 1 collagen is 300nm long, 1.5nm in
diameter and consists of 3 coiled subunits composed of two ai (I) chains and one 0C2 (I)
chain (Sandberg et al, 1987). Each chain consists of 1050 amino acids wound around
each other in a right-handed triple helix. Lateral interactions of triple helices of
collagens result in the formation of collagen fibrils roughly 50nm in diameter. The
packing of collagen is such that adjacent molecules are displaced approximately lA of
their length (67nm). This staggered array produces a striated effect that can be seen
under the electron microscope.
Collagenous fibres are whitish in colour and are found in all kinds of connective tissue.
They are composed of bundles of parallel collagen fibrils. Collagenous fibres are sturdy,
flexible, insoluble and virtually unstretchable. The arrangement of collagenous fibres
varies from loose and pliable as in the loosely woven connective tissue that supports
most of the vital organs, to tightly packed and stretch-resistant as in tendon and bone.
In bone, osteoblasts are responsible for the synthesis and deposition of type 1 collagen.
The type 1 collagen formed by osteoblasts is typically deposited in parallel bundles or
concentric layers.
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The remainder of the organic bone matrix is composed of non-collagenous proteins
(NCP) ofbone (Heinegard et al, 1989; Young et al, 1992). NCP's can be classified
according to their structure into three main groups:
1. Proteoglycans are macromolecules, which consist of a central core protein and
covalently attached polysaccharide chains. On the basis of side chains, three subgroups
of proteoglycans can be found in bone: a.) chondroitin sulfate side chains are found in
biglycan, decorin and in a protein which resembles versican (Krusius et al, 1987), b.)
Heparan sulphate side chains are found in association to membrane proteoglycans, e.g.
receptors for transforming growth factor-P (TGF-P). c.) keratan-sulfate side chains are
associated with leucine rich proteins and include osteoglycin and osteoadherin.
2. Osteocalcin and vitronectin are examples of g-carboxylated (gla)-proteins,
(Ruoslahti, 1988; Hauschka, 1986). Osteocalcin is a valuable biochemical indicator of
osteoblastic activity and metabolic turnover in bone (Neradilova et al, 1990).
3. Osteonectin is an example of a glycoprotein found in bone matrix. Others include
thrombospondin, fibronectin (Hauschka, 1986), tetranectin and osteopontin (Gehron
Robey, 1989; McKee et al, 1996).
In addition to these three groups, several other NCP's can be found in variable amounts.
These include growth factors known to be involved in bone formation, and include bone
morphogenetic proteins (BMP's), which are members of TGF superfamily (Ripamonti et
al, 1992) and are important in bone maturation. Bone NCP's can also be classified
according to whether they possess an RGD (arg-gly-asp) sequence or not. This is
especially important in cell-matrix interactions, where RGD-sequences are known to
play a role in attachment of cells to the ECM. RGD-sequences are found in bone
sialoprotein (osteopontin), thrombospondins, vitronectin, osteoglycin and osteoadherin.
1.1.3.2 Inorganic Components.
Bone is a major store ofminerals, containing 99% ofbody calcium and 88% ofbody
phosphate. Inorganic bone matrix (65%) is composed of crystalline salts, mainly
calcium and phosphate, in the form of calcium hydroxyapatite [(Ca)io(P04)6(OH)2].
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Hydroxyapatite crystals are spindle or platelet-shaped, measuring up to 200 nm in
length. This offers a large surface area available for mineral exchange, about 10 m2 per
lg of bone. Other components include calcium carbonate, calcium fluoride, and
magnesium fluoride (Athanasou, 1999).
1.1.4 Bone Cells.
Bone contains five different cell types, which are capable of changing their roles as the
needs of the body changes in the growing and adult skeletons.
1. Osteogenic (osteoprogenitor) cells are small, spindle-shaped, mesenchymal stem
cells. They are found mostly in the deepest layer of the periosteum and in the
endosteum. These cells have a high mitotic potential and can be transformed into bone
forming cells (osteoblasts) during growth, remodelling and healing (Van Wynsberghe et
al, 1995).
2. Osteoblasts are located on the surface of bone tissue and are usually found in
growing portions of bone, including the periosteum. Osteoblasts are derived from
mesenchymal stem cells of the bone marrow stroma and possess a single nucleus. They
have a shape that varies from flat to plump, reflecting their level of cellular activity.
When active, they have a plump, polygonal appearance and when inactive, have a
flattened morphology. Osteoblasts are responsible for the synthesis and secretion of an
unmineralized ground substance called osteoid, which consists of collagen and NCP's.
Mature osteoblasts are also rich in alkaline phosphatase, an organic phosphate-splitting
enzyme (Robey, 1989). Hormones, growth factors, physical activity and other stimuli
act mainly through osteoblasts to bring about their effects on bone. Osteoblasts are
known to express receptors for estrogen, testosterone, parathyroid hormone (PTH)
(Buckwalter et al, 1996), transforming growth factor-P (TGF-P), tumour necrosis
factor-a (TNF-a), interleukin-1 (IL-1), interleukin-6 (IL-6), and interleukin-11 (IL-11).
Osteoblasts also express receptors for vitamin D3, prostaglandin E2 (PGE2) and
prostaglandin I2 (PGI2). Osteoblasts also act as a pump to move calcium and phosphate
into and out ofbone tissue, thereby respectively calcifying or decalcifying it (Van
Wynsberghe et al, 1995, Buckwalter et al, 1996, Athanasou et al, 1999).
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3. Osteocytes are the most numerous cells of fully developed bone. Osteocytes are
derived from osteoblasts which have secreted bone matrix around themselves. Each
osteocyte has a cell body that occupies a lacuna within the bone matrix and long slender
cell processes that extend through the matrix via canaliculi. These processes
interconnect to form gap junctions between neighbouring osteocytes. They, along with
osteoclasts, play an active role in homeostasis by helping to release calcium from bone
interstitial fluid into the blood, thereby regulating calcium concentration in the body
fluids. Osteocytes also keep the matrix in a stable and healthy state by secreting
enzymes and maintaining the mineral content of the matrix (Van Wynsberghe et al,
1995).
4. Osteoclasts are multinuclear giant cells with a size up to 100 pM. They are derived
from hematopoietic stem cells that also give rise to monocytes and macrophages.
Osteoblasts are found on the surface of the bone resorbing bone from sites where it is
either deteriorating or no longer needed, and are normally found where bone is resorbed
during its normal growth. Osteoclasts appear to be activated by "signals" from
osteoblasts. For example, osteoblasts have receptors for PTH whereas osteoclasts do
not, and PTH-induced osteoclastic bone resorption does not occur in the absence of
osteoblasts.
5. Bone-Lining Cells are found on the surface ofmost bones. They are thought to be
derived from osteoblasts that are no longer active and that have flattened out on the bone
surface. Such cells may have several functions. They may serve as osteogenic cells that
can divide and differentiate into osteoblasts, or may serve as an ion barrier around bone
tissue (Van Wynsberghe et al, 1995).
1.1.5 Bone Formation and Development.
1.1.5.1 Bone Formation.
Bones develop through a process called ossification (osteogenesis). The primitive
skeleton of the human embryo is composed of either hyaline cartilage or fibrous
membrane and bones can develop by two ways: intramembranous or endochondral
ossification. Intramembranous ossification occurs when bone develops directly from
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mesenchymal tissue. Bones that develop by intramembranous ossification include the
frontal and parietal bones and the bones of the face (Van Wynsberghe et al, 1995).
The process of endochondral bone ossification begins when mesenchymal stem cells
(MSCs), progenitor cells which can differentiate into bone or cartilage-forming cells
start to differentiate into chondrocytes and secrete a cartilaginous matrix. The cells then
pass through various lineage states and eventually lose the capability to proliferate
(Caplan et al, 1994; Caplan et al, 1997). At this time a periosteal layer appears around
the cartilage model (the periosteal layer is comprised ofMSC's which are predisposed to
form bone rather than cartilage). Shortly after this time, the chondrocytes enlarge and
produce alkaline phosphatase, which triggers a chemical reaction in the matrix that
causes ossification. The calcified matrix blocks the diffusion of nutrients to the
chondrocytes, which die and are eventually resorbed, leaving irregular cavities in the
ossifying matrix. Once the bone is formed, these cavities contain the bone marrow.
Pluripotent cells lining the cavities begin to differentiate into osteoblasts and osteocytes.
The osteoblasts deposit osteoid on the mineralized cartilage cores forming a thin layer of
spongy bone tissue (Buckwalter et al, 1996).
1.1.5.2 Determinants of Peak Bone Mass.
There are many factors which have a bearing on the magnitude of peak bone mass, and
these will be described in the following sections;
1. It is known that there is a genetic component, which accounts for >70% of peak
bone mass. Strong genetic influences affect body size and bone geometry (Marcus,
1996), which can be demonstrated in the variation in skeletal size and density between
various ethnic groups - with Caucasians having higher bone masses on average than
Asians (Pollitzer et al, 1989).
2. Mechanical stresses and strains are known to be important, both by way of
gravitational stress related to the weight of the individual and also to physical exercise.
For example, in individuals who greatly increase the size of their muscles, bone mass
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may also increase at the same time. If the bones do not increase in mass they may
fracture because they are unable to cope with the increased pull of the stronger muscles.
3. Dietary calcium intake plays a substantial role in determining peak bone mass. The
skeleton is responsible for 99% of body calcium stores (in addition to 88% of phosphate
stores and 54% ofmagnesium stores) and constitutes a reservoir ofmineral that can
support plasma calcium levels in times of need. Without calcium, some enzymes would
be unable to function, the permeability of cell membranes would be affected, muscles
(including the heart) could not contract, nerve function would be impaired and blood
could not clot. Clinical trials have shown that calcium intake is likely to be particularly
important to bone mass during the first three decades of life (Recker et al, 1992), and
that calcium supplementation of adolescent boys and girls, leads to increased bone
acquisition (Johnston et al, 1992). In contrast, through the third to fifth decades, growth
has stopped and calcium nutritional state does not appear to be a major influence on
maintenance of bone mass during this period (Elders et al, 1991; Riis et al, 1987).
General nutrition, in addition to calcium intake, is also important and girls with anorexia
nervosa have been reported to have as much as 25% reduction in the trabecular bone
density (Mazess et al, 1990).
4. Growth Hormones also play an important role in the acquisition and maintenance
of bone mass. Patients with deficient growth hormone (GH) secretory function show
low bone mass and it has been demonstrated that GH replacement of such patients
promotes significant increases in bone mineral density.
5. There is a great deal of evidence to suggest a role for reproductive hormones in the
acquisition and maintenance of bone mass. Hypogonadal boys and girls show deficits in
both cortical and trabecular bone mineral and loss of endogenous sex steroids during
adult life regualrly leads to loss of bone mineral. 17P-estradiol is of particular
importance for bone acquisition and mutations in the estradiol receptor in the male can
lead to bone mineral densities which are several standard deviations below predicted
values (Smith et al, 1994). In women, loss of estrogen has dual effects. Decreased
efficiency of intestinal and renal calcium handling increases the level of calcium
necessary to maintain neutral calcium balance (Heany et al, 1977). In addition, estrogen
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directly affects bone cell function. In animal models, strong evidence indicates that
estrogen directly regulates osteoblast production of IL-6, a potent regulator of osteoclast
recruitment (Girasole et al, 1992). The precise details of estrogen regulation of
skeletally active cytokines in humans are not clear but such interactions are thought to
underlie the accelerated bone loss of early estrogen deficiency. Estrogen deficiency
permits osteoclasts to resorb bone with greater efficiency, which may eventually lead to




Terms Used in Mechanical Studies (Armstrong et al, 1992; Woo et al, 1992).
Strain is a measure of force per unit length of a body. It is a ratio of deformation /
initial length.
Tensile strain is an increase in length per unit length ofmaterial along a given line,
while compressive strain is the decrease in length per unit length.
Shear strain is the change in angle in the deformed state between two lines that were
vertical in the undeformed state.
1.2.1 Introduction to Mechanotransduction.
Mechanotransduction is the process by which cells within a living tissue perceive
physical stimuli and respond with biochemical signals. Mechanotransduction is integral
to the successful function of organ systems (Ingber, 1991; Ingber, 1997; Davies et al,
1997; Chicurel et al, 1998), whole organisms and plants (Johnson et al, 1998). Studies
with cultured cells confirm that mechanical stresses can directly alter many cellular
processes, including signal transduction, gene expression, growth, differentiation and
survival (Chen and Ingber, 1999). In principal, all eukaryotic cells are mechanosensitive
and physical forces, including gravity, tension, compression, and shear, influence growth
and remodelling in all living tissues at the cellular level (Ingber, 1997).
1.2.2 Mechanotransduction and Bone.
It has been known for many decades, that the shape, mass and general morphology of
bones are moulded, to a certain degree, by the strains to which they are exposed in their
daily environment (Turner et al, 1998; Sakai et al, 2002). Therefore, bone develops not
only as a structure designed specifically for mechanical tasks, but is able to adapt during
the life of an individual towards a more effective mechanical performance. This has
been accepted for a great number of years, emerging initially in the ideas ofRoux (Roux
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et al, 1905), Meyer (Meyer, 1867), and most significantly Julius Wolff (Wolff et al,
1892). Wolffs mathematical law of bone transformation, published in 1892 states that
the form of bone is related to mechanical stresses to which it is exposed. This law is still
generally accepted, although many of its components have since been disproved.
Evidence for a relationship between mechanical forces and skeletal form is abundant.
Prolonged skeletal disuse in humans, whether due to spaceflight (Mack et al, 1967;
Morey et al, 1978, Vico et al, 1998), bed rest (Leblanc et al, 1990), or immobilization
(Prince et al, 1988), results in osteopenia due to a decrease in bone formation while bone
resorption remains unchanged or is transiently increased (Cann et al, 1983; Turner et al,
1985). Conversely, increased skeletal loading can increase bone formation and decrease
bone resorption (Rubin et al, 1984; Sessions et al, 1989). Although the relationship
between bone tissue formation and mechanical strain has been known for a number of
years, until fairly recently the mechanisms involved have remained poorly understood.
Frosts mechanostat theory provides a hypothesis of how bone might adapt to strain
(Frost, 1987; Frost 1998). The mechanostat theory hypothesises that when bone cells
are in equilibrium with the surrounding environment, a basal / physiological level of
stress (200 - 2500 pstrain) exists. At this level of stress there is assumed to be no net
formation of bone, with an equilibrium existing between bone formation by osteoblasts
and bone resorption by osteoclasts. At the upper end of the physiological scale of strain,
there exists a maximum effective strain (2500 pstrain), which results in osteoblast
recruitment and matrix deposition. Similarly, at the lower end of the physiological scale
of strain, a mimimum level of strain exists (200 pstrain) below which there is net bone
loss. Although the mechanisms involved in the events described by the mechanostat
theory are unknown, the theory assumes that biophysical forces are detected by the cell
and converted into a biochemical response, thereby allowing the organism to respond
and adapt accordingly (Figure 1.4).
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Figure 1.4 - Frosts mechanostat theory (adapted from Frost, 1987). The theory states
that, under physiologically normal loading, bone formation and resorption are in
equilibrium. Low strains experienced during disuse result in bone resorption, while
overuse results in bone formation.
It is expected that the detection of the applied mechanical forces is performed either by
each individual cell, and the sensation is restricted to the cellular level, or by certain
sensor cells which generate biochemical signals, which can activate various cell
signalling pathways and cascades which modulate bone formation and resorption and
maintain bone homeostasis (Sikavitsas et al, 2001). In the latter case, the sensation is at
the tissue level.
Osteocytes and osteoblasts are the two most likely cell types involved in
mechanotransduction in bone (Blooinfield, 2001). A number of studies have proposed
roles for both of these cell types. The techniques employed and the major findings of
these studies will now be described.
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1.2.3 Techniques employed in in-vitro Mechanical Stimulation of Bone
Cells.
Because of the complexity of the in-vivo environment, study of cellular response to
mechanical stimulation has relied heavily on the development and use of in-vitro
systems designed to mimic the in-vivo situation. It is known that normal, physiological
loading of bone cells results in bending forces resulting in mechanical stretch and
pressure gradients within the lacuno-canalicular porosity leading to stress on the
membranes of osteocytes, osteoblasts and bone lining cells (and fibroblasts).
There are four main classes of in-vitro model systems commonly used in the
investigation of mechanical loading of bone. These systems generate fluid shear,
hydrostatic compression, biaxial stretch, uniaxial stretch, or a combination of two or








Figure 1.5 - Cell deformation in response to in-vitro loading. The four main types of
mechanical loading systems generate fluid shear, hydrostatic compression, uniaxial
stretch or biaxial stretch on cultured bone cells. Figure adapted from Duncan and
Turner, 1995.
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1.2.3.1 Fluid Shear Systems.
A wide range of cellular phenomena are recognized as being influenced by fluid shear,
including both mechanoreception (e.g. by membrane bound receptors, ion channels, and
integrins) and cell response (e.g. changes intracellular calcium and nitric oxide (NO))
(Davies et al, 1995). To date, there have been two devices used to study fluid shear
alone. The first is the cone and plate system (Dewey et al, 1984; Mohtai et al, 1996,
Hermann et al, 1997), which generates continuous laminar shear by stirring medium in a
100 mm-diameter dish. This system achieves spatially homogeneous fluid shear stresses
on both of the respective surfaces. It has been used to investigate the effect of fluid
shear on the release of TGF-P, insulin growth factors-1 and 2 (IGF-1 and 2) and IL-6 in
osteosarcoma cell lines. It was found that TGF-P mRNA was increased following 3
hours of continous fluid flow whereas mRNA levels for IGF-1, IGF-2 and IL-6 were
undetectable.
The second fluid shear system is the parallel plate flow chamber, which produces
homogeneous shear between two openings at either end of the chamber (Levesque et al,
1985; Frangos et al, 1988; Hung et al, 1995; Tseng et al, 1995; Chun et al, 1997). The
parallel plate flow chamber has many advantages, including the homogeneity of the
stress stimulus, simplicity of the equipment, ability to microscopically monitor changes
in the culture and ease of medium sampling and exchange. This system has been used to
demonstrate increases in NO and prostaglandin E2 (PGE2) production in mouse MC3T3-
E1 cells, UMR-106-01 cells, ROS17/2.8 cells and rat calvarial cells in response to fluid
shear (Smalt et al, 1997, Tjandrawinata et al, 1997; McAllister and Frangos, 1999). In
addition to being used to monitor the release of factors into the cell culture media
following periods of fluid shear, the parallel flow chamber has also been used to study
the effects of fluid shear on the conformation and appearance of cytoskeletal
components. It has been demonstrated that MC3T3-E1 cell respond to a shear force of
12 dyn/cm2 for 60 minutes with recruitment of a-actinin and Pi-integrin receptor subunit
to the focal adhesion sites, which is likely to promote intracellular signalling.
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Expression of the early response gene c-fos was also increased following fluid shear
(Pavalko et al, 1998).
1.2.3.2 Hydrostatic Compression.
The hypothesis that cytoskeletal elements, in particular focal adhesions, are important in
the process ofmechanotransduction and signal transduction has led to the development
of hydrostatic devices. The effect of hydrostatic compression cannot be used to study
free-floating cells because of the high water content of the cytoplasm. However, in
monolayer culture, cells attach to the culture substratum via integrin receptors located at
focal adhesions and perturbation of the attached cells by hydrostatic forces may result in
the generation of shear stresses along this interface although this is a focus of debate as
there is no evidence of fluid shear as a result of hydrostatic compression of cells in
culture. The hydrostatic system described commonly in the literature is capable of
delivering both intermittent / pulsatile and continuous compressive forces to the cells
(Klein-Nulend et al, 1986). This system has been used successfully to examine articular
cartilage development during joint loading (Klein-Nulend et al, 1986). It has also been
used to study osteoblastic function, expression of osteoblast markers and production of
second messenger signalling molecules such as PGE2 in osteoprogenitor-like and
osteoblast-like cells (Roelofsen et al, 1995; Glantschnig et al, 1996, Klein-Nulend, 1997;
Macdonald et al, 1999).
1.2.3.3 Uniaxial Stretch Systems.
Loading systems have been used widely, which utilise controlled uniaxial stretching of a
deformable substrate upon which cells have been cultured. Such systems are generally
considered acceptable as stretching in one direction is accompanied by compression of
the membrane in the perpendicular plane, which resembles the in-vivo environment
(Murray et al, 1990; Smalt et al, 1997).
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1.2.3.4 Biaxial Stretch Systems.
Another model used to investigate the effects of mechanical forces on bone cells in-vitro
involves systems, which produce biaxial cell stretch. The term biaxial stretch is used to
describe the stretching of a deformable membrane (usually circular) and hence the
adherent cells, in all directions. The first system of this type was reported in 1985 by
Hasagawa et al (1985), and consisted of a plastic culture dish whose base was pressed
upon a convex template by means of a static weight. Anderson and Norton, (1991),
employed a similar system and various modifications of this system have since been
designed. Vandenburgh et al, (1988), used pulsating prongs to create an upward tent in
a deformable membrane from below, while Soma et al, (1997), used a similar
mechanism to tent deformable membranes in a downward direction, from above. Banes
et al, (1985), introduced a system which utilised specially designed flexible-bottomed
culture dishes whose bases were made from a deformable material. These plates were
used in conjunction with a vacuum system controlled by a programmable device and
when the vacuum was applied, the base of the culture dish was stretched downwards,
thus imparting strain to the culture layer. This system had the advantage that it was
easily programmable and relatively easy to set up and operate. Because of these factors,
this system has been extensively redesigned and was commercially manufactured in
1987, and known as the Flexercell® system. This system has been used extensively to
investigate the effects of cyclic biaxial stretch on a variety of cell types including
osteoblasts (Buckley et al, 1990; Stanford et al, 1995).
A modification of the Flexercell® system was introduced in 1989 (Winston et al, 1989),
which used positive pressure as opposed to negative, vacuum pressure. The system used
circular membranes, which were clamped peripherally by 'O'-rings, and caused to bulge
upward by increased air pressure from below, at a controlled frequency.
The main disadvantage of any biaxial strain system presently available is heterogeneity
of strain. Strain varies across the diameter of the dish falling to zero in the centre of the
dish and therefore, cells at different locations of the dish are subject to different amounts
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of strain (Gilbert et al, 1990). It is also difficult to assess the actual amount of strain that
individual cells are subjected to. Another potential complication of the biaxial stretch
system is the influence of fluid shear, as it is likely that some of the effects of cyclic
stretch in such systems may be as a result of agitation of the culture medium and
therefore production of fluid shear.
1.2.4 Osteocytes and Bone Mechanotransduction.
Unlike osteoblasts, osteocytes are literally entombed in bone matrix. They are derived
from differentiated osteoblasts, and form contacts with the osteoblastic cells on the cell
surface and with other osteocytes via an intricate network of slender cell processes and
gap junctions (Burger et al, 1999). This three dimensional network presents a very
attractive system for the possible detection of local mechanical stimuli (Sikavitsas et al,
2001). Osteocytes have proved very difficult to study, owing to the fact that they are
post-mitotic (Smith et al, 1997), and their location deep within the bone matrix makes
them extremely difficult to extract and purify. They also appear to be inactive in respect
of protein synthesis.
It is known that in-vivo, osteocytes express mRNA for P-actin, osteocalcin, connexin-43,
IGF-1, c-fos and c-jun, but not tumor necrosis factor-a (TNF-a) or tartrate-resistant acid
phosphatase (TRAP) (Mason et al, 1996; Moalli et al, 2000). In-vitro it has been shown
that they establish a network allowing communication with other osteocytes via their
cell processes and gap junctions (Nijweide et al, 1986; Van der Plas et al, 1992; Van der
Plas et al, 1994; Tanaka et al, 1995). Osteocytes also produce small amounts of
fibronectin and type 1 collagen (although in lesser amounts than osteoblasts) but
produce greater quantities of the bone matrix proteins osteocalcin, osteonectin and
osteopontin than osteoblasts (Aarden et al, 1996).
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Evidence for the involvement of osteocytes in bone cell mechanotransduction has been
accumulating over the last decade. Early strain related changes in glucose-6-phosphate
dehydrogenase were found in osteocytes following bone-loading in-vivo (Skerry et al,
1989). These results have been confirmed in in-vitro studies (Dallas et al, 1993; Van der
Plas et al, 1994). Expression of c-fos mRNA was transiently induced in cortical bone
osteocytes of rat tail vertebrae, in-vivo, one hour after a 5 minute period of loading
(Inaoka et al, 1995), whereas in the same study, no effect was observed in the mRNA
levels of IGF-1. In contrast, a separate study demonstrated that rat caudal vertebrae
osteocytes increased IGF-1 expression after mechanical stimulation (Lean et al, 1995).
IGF-1 is known to promote bone formation (Conover, 1996) and stimulate the
differentiation of osteocytes from osteoblasts (Gohel et al, 1995). Hypoxia was
observed in osteocytes from avian ulnae that were subjected to unloading for 24 hours.
A briefperiod of loading restored oxygenation to these cells, which may suggest that
mechanotransduction plays a role in oxygenation of osteocytes (Dodd et al, 1999).
Osteopontin is a member of a family of phosphorylated sialoproteins found in
mineralized bone matrix and is believed to have a general role in cell attachment
(Miyauchi et al, 1991). The expression of osteopontin is known to be mechanically
regulated in bone and it has been shown that mechanical loading increases osteopontin
mRNA expression in-vitro in osteocytes (Toma et al, 1997; Klein-Nulend et al, 1997).
Similar results have also been demonstrated in osteocytes in-vivo (Miles et al, 1998).
It is clear that mechanical loading at physiologically appropriate magnitudes results in
the activation of several metabolic processes in osteocytes including energy metabolism,
growth factor production, and alterations in gene expression and matrix synthesis. Such
findings provide evidence for a role for osteocytes in bone mechanotransduction
(Mikuni-Takagaki et al, 1999). At the present time, however, it is not clear how
osteocytes sense mechanical loading and transduce it into a cellular response. A number
of investigations have provided evidence to suggest that the flow of interstitial fluid is
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the most likely mechanism of delivering information to osteocytes about the degree of
mechanical loading (Kufahl et al, 1990; Weinbaum et al, 1994; Cowin et al, 1995;
Klein-Nulend et al, 1995, Knothe-Tate et al, 1998). This will be discussed in the
following section.
1.2.4.1 Effect of Interstitial Fluid Flow on Osteocytes in-vitro.
Strain-derived flow of interstitial fluid through the lacuno-canalicular pores is believed
to mechanically activate osteocytes as well as ensuring transport of cell signalling
molecules, nutrients and waste products. Flow of interstitial fluid occurs because the
application ofmechanical strain causes the volume of some pores to decrease slightly
and the volumes of other pores to increase slightly, creating differences in bone fluid
pressure, resulting in fluid flow. Although fluid flow is important in the lacuno-
canalicular porosity, it is negligible in the Haversian canals and Volkmans canals,
because these are 1000 times larger and their pressure is more uniform being almost
equal to blood pressure (Cowin et al, 1998).
It has been shown that osteocytes are extremely responsive to fluid flow and hydrostatic
compression (Klein-Nulend et al, 1996; Ajubi et al, 1996). Pulsating fluid flow with a
mean stress of 0.5 Pa and 5 Hz pulses of 0.02 Pa had an immediate effect on osteocytes;
release of PGE2 and PGI2 increased fivefold and their NO release increased twofold after
the application of flow (Klein-Nulend et al, 1995). Prostaglandins are essential agents in
the transduction ofmechanical stimuli into bone formation. PGE2, in particular,
stimulates osteoblastic cell proliferation and bone formation. NO is a highly diffusible
free radical implicated in neurotransmission and vasodilation and has recently been
shown to inhibit osteoclastic activity and stimulate osteoblastic proliferation
Flow of fluid over the cell surface subjects the cell to two types of stimuli, fluid shear
stresses (or fluid-induced drag forces) and streaming electrical potentials (Salzstein et al,
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1987). Although many studies have provided evidence to suggest that streaming
electrical potentials are primarily responsible for initiating cellular responses in bone
(Weinbaum et al, 1994; Cowin et al, 1995), other studies have produced results which
argue that fluid shear stresses and direct perturbance of the cell membrane is the
stimulus that conveys the mechanical message to bone cells (Hung et al, 1996).
It appears that the lacuno-canalicular network, with its cellular part (osteocytes and gap
junctions) and its porosity is very important for mechanotransduction in bone. It is
known that mechanical stimulation of bone is required to keep osteocytes viable, by
enhanced displacement of nutrients and waste but also to provide them with a basal level
of mechanical stimulation by fluid shear stress. Under these conditions, no osteoblasts
or osteoclasts are recruited. However, overstimulation of the osteocytes by abnormally
high fluid shear stresses will result in recruitment of osteoblasts to the bone surface. The
extra bone produced by the osteoblasts restores the dynamic equilibrium in bone and
bone growth stops. Disuse, in contrast, reduces osteocyte shear stress stimulation as
well as reducing transport of nutrients and waste products. The latter will reduce
osteocyte viability and may even lead to osteocyte apoptosis (Burger et al, 1999).
1.2.5 Osteoblasts and Bone Mechanotransduction.
A number of studies have demonstrated that in addition to osteocytes, osteoblasts are
also involved in the recognition and conversion ofmechanical signals into a cellular
response.
It has been shown that osteoblasts respond to mechanical stimulation in-vitro (Somjen et
al, 1980, Buckley et al, 1988; Murray et al, 1990; Harter et al, 1995) although opinion is
divided upon whether osteoblasts are more sensitive to mechanical strain or fluid flow.
Results obtained to date suggest that the response of the osteoblast to mechanical stimuli
is dependent on both the magnitude and the type of stimulus applied. Osteoblasts
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exposed to high levels ofmechanical strain (>10,000 pstrain) respond with increases in
cell proliferation, DNA synthesis, and PGE2 production and secretion. In addition,
production of osteoblastic phenotypic markers, such as alkaline phosphatase are
decreased. At more physiological levels of strain (2000 - 4000 pstrain), the response of
the osteoblast indicates a more differentiated state, with an increase in production of
type 1 collagen, osteopontin, osteocalcin (Harter et al, 1995), and alkaline phosphatase
(Buckley et al, 1990), while osteoblast proliferation and matrix mineralization are also
increased (Murray et al, 1990; Chambers et al, 1993; Turner et al, 1996).
Experiments have also been performed which provide evidence that osteoblasts are
responsive to fluid shear stresses and that fluid shear stresses may act as mechanical
stimuli in osteoblasts (Owan et al, 1997; Kapur et al, 2003). Continuous fluid shear
rapidly increases NO release (Johnson et al, 1996; Bakker et al, 2001), cyclic adenosine
monophosphate (cAMP) production (Reich et al, 1990), inositol triphosphate (IP3) and
PGE2 release (Reich and Frangos, 1991; Reich et al, 1997; Bakker et al, 2001) and
intracellular calcium levels in osteoblast cultures. It is known that in marrow stromal
cells, prostaglandins induce the production of cAMP so therefore, it is possible that the
increased level of cAMP in osteoblasts may be induced by shear stress indirectly via an
autocrine mechanism involving increased prostaglandin secretion. It has been
demonstrated that PGE2 release is stimulated by shear stress in a dose dependent
manner, together with increased levels of IP3 (Reich et al, 1991). NO release is rapidly
increased in rat calvarial osteoblasts in response to fluid shear stresses of 6 dyn/cm2 and
is sustained for up to 12 hours post stimulation (Jonhson et al, 1996). The addition of an
NO synthase inhibitor blocked NO production in response to fluid flow. Similar results
have been obtained using human primary osteoblast like cells (Klein-Nulend et al, 1998)
and it has been proposed that fluid flow stimulated NO release in osteoblastic cells is
biphase and follows two distinct signalling pathways, a G-protein calcium-dependent
pathway and a G-protein calcium-independent pathway (Klein-Nulend et al, 1998).
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Fluid flow has also been shown to up-regulate the mRNA level of the early response
gene egr-1, by a tyrosine kinase-mediated mechanism (Fitzgerald et al, 1999). Fluid
flow enhances the tyrosine phosphorylation ofmany proteins including the adaptor
protein She (Ogata et al, 2000) and the extracellular-signal regulated kinases-1 and 2
(ERK-1 and 2) (Jessop et al, 2002; Kapur et al, 2003). ERK-1 and ERK-2 are members
of the mitogen activated protein kinase (MAPK) family and both ERK-1 and ERK-2 are
essential mediators of growth factor induced cell proliferation and differentiation in
various cell types including osteoblasts. The activation of ERK-1/2 is involved in
various cellular responses induced by mechanical stimuli, such as collagen synthesis
(Gebken et al, 1999), cyclo-oxygenase (COX)-2 expression (Wadhwa et al, 2002), and
osteopontin production (You et al, 2001).
In an attempt to clarify the nature of the actual sensing mechanism of
mechanotransduction in osteoblasts, several studies have compared the mechanosensing
in osteoblasts exposed to shear stress to mechanosensing in osteoblasts exposed to
mechanical strain. As it is known that fluid shear stresses induce PGE2 and NO
production, these two substances have been monitored when rat calvarial osteoblasts, rat
long bone cells, MC3T3-E1 cells, ROS 17/2.8 cells and UMR-106-01 cells have been
subjected to shear stress and linear mechanical strain whilst attached to tissue-culture
treated polystyrene film. The results have shown that production of PGE2 and NO was
rapidly increased in the osteoblast and osteoblast-like cells when exposed to wall shear
stresses of 148 dyn/cm2. When the osteoblasts were subjected to unidirectional linear
strains in the range of 500-5000 pstrain no apparent increase in NO and PGE2
production has been observed (Smalt et al, 1997), suggesting that osteoblasts are more
responsive to fluid flow than mechanical strain or that different mechanotransduction
pathways are activated by the different types ofmechanical stimuli.
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1.2.6 The Cellular Cytoskeleton and Mechanotransduction.
Another mechanism that bone cells may use to sense mechanical forces is cytoskeletal -
integrin interactions. The integrins are a heterodimeric family of transmembrane
adhesion molecules composed of an a - and a P-subunit. Sixteen a and eight (3 integrin
subunits have been cloned. These subunits combine to from the 22 described integrin
heterodimers. These subunits are the products of two different genes and the expression
of both subunits is required for cell surface expression (O'Toole et al, 1989). Integrins
physically bridge the extracellular matrix proteins outside the cell with the cytoskeletal
proteins within the cell (Hynes, 1992). In addition to their structural function of
anchoring cells to the extracellular matrix, the integrins are also known to be intimately
involved in the generation and propagation of intracellular signalling (Parsons, 1996;
Longhurst et al, 1998; Vuori, 1998). Such conclusions are supported by studies which
have demonstrated that ligation of integrins with either inhibitory antibodies or by
binding to their ligands leads to changes in the intracellular pH, intracellular calcium
concentration, and the tyrosine phosphorylation of several proteins (Juliano et al, 1993;
Clark et al, 1995). Clustering of integrins due to ligand binding causes the attachment of
stress fibres to integrin receptors at specialised sites called focal adhesions. Linker
proteins, including a-actinin, vinculin and talin, anchor actin filaments to the integrins
(Dedhar et al, 1996; Hemler et al, 1998). There is substantial evidence to suggest that
the development of internal tension by actin and myosin plays a central role in signal
transduction from the extracellular matrix to the nucleus to regulate gene expression
(Ingber et al, 1999).
Experiments in-vitro have suggested a role for mechanosensitive ion channels and
integrins as mechanotransducers. Salter et al, (1997), have shown that the
hyperpolarisation response associated with cyclic mechanical stimulation of human bone
cells is associated with the activation of small conductance calcium activated potassium
channels. The transduction pathways involved in the hyperpolarisation response to
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cyclical mechanical stimulation also involve the asPi integrin (Salter et al, 1997). The
downstream intracellular signalling pathways are inhibited by anti-integrin as and Pi
antibodies. These results suggest that the asPi integrin in an important human bone cell
mechanotransducer and a potential regulator of human bone cell function.
Application of fluid shear stress causes an increase in the early response gene product c-
fos and cyclooxygenase-2 (COX-2), the reorganization of actin filaments into contractile
stress fibres and involves the recmitment of Pi-integrins and a-actinin to focal adhesions
(Pavalko et al, 1998). Treatment of cells with cytochalasin D, which disrupts
filamentous actin, blocks the upregulation ofCOX-2. Similarly, microinjection of a
proteolytic fragment of a-actinin, which competes with the endogenous protein for
binding with the integrin receptor, blocked both COX-2 and c-fos upregulation. Finally,
cells transfected with a dominant negative mutant of the GTPase, Rho, which blocks
stress fibre and focal adhesion formation, also inhibited c-fos and COX-2 upregulation,
suggesting that stress fibres and their anchorage to the membrane at focal adhesion
points in response to fluid flow may facilitate the transduction of applied forces into
intracellular signals (Pavalko et al, 1998).
Osteopontin possesses an RGD (Arg-Gly-Asp) sequence that binds to certain integrins
leading to alterations in intracellular calcium levels (Miyauchi et al, 1991). Several
studies have demonstrated that osteopontin levels are increased in cultured osteoblasts in
response to mechanical stimulation (Harter et al, 1995; Kubota et al, 1993; Owan et al,
1997). One such study investigated the expression of osteopontin mRNA in embryonic
chick osteoblasts following exposure to a dynamic spatially uniform biaxial strain at
0.25 Hz for 2 hours (Toma et al, 1997). It was found that osteopontin mRNA expression
increased fourfold, 9 hours after the embryonic chick osteoblasts had been exposed to
the stimulation and that cytochalasin-D blocked the upregulation of the osteopontin
gene, while colchicine (which inhibits microtubule assembly and disassembly) did not
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block osteopontin expression. These results offer additional evidence in the
involvement of the actin cytoskeleton in osteoblast mechanotransduction.
A separate study demonstrated that osteopontin mRNA expression can also be induced
in the absence of shear following plating of chicken calvaria osteoblasts on fibronectin
coated surfaces (Carvalho et al, 1998). This induction disappeared when the cells were
seeded on uncoated plastic. The observed osteopontin induction was not affected by
cytochalasin-D, which is known to block the mechanically stimulated up-regulation of
the osteopontin gene, while the addition of cyclohexamide, which inhibits protein
synthesis, blocked the induction of the osteopontin mRNA expression following
adhesion to fibronectin but left unchanged the up-regulation of the osteopontin gene by
mechanical forces. These results imply that fibronectin itselfmay induce osteopontin
expression via integrin receptors but by a different mechanism than that following
mechanical stimulation (Carvalho et al, 1998).
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1.3 The Human Bone Cell (HBC) Mechanotransduction
Pathway Studied by the Use of Electrophysiological
Techniques.
1.3.1 Responses of the Plasma Membrane to Cyclic Mechanical
Stimulation in-vitro: Evidence for the Presence of Stretch
Activated Ion Channels.
Salter et al (1997) investigated the effects of cyclic mechanical stimulation on the
membrane potentials of cultured human bone cells (HBC). The cells were mechanically
stimulated by culturing HBC on plastic culture dishes, which were placed in a sealed
polypropylene chamber with gas inlet and outlet ports. Cyclical pressurisation (using
nitrogen or helium gas) was applied to the pressure chamber, and caused deformation of
the base of the culture dish to which the HBC were adherent and therefore deformation
(strain) was applied to the HBC. Hyperpolarisation of the HBC plasma membrane was
induced by cyclic mechanical stimulation at 0.33Hz, 120 mmHg for 20 minutes, whereas
depolarisation of the plasma membrane was induced by cyclic mechanical stimulation at
0.104 Hz, 120 mmHg for 20 minutes. It has been demonstrated in similar experiments
using human articular chondrocytes, that the amplitude of the hyperpolarisation response
is proportional to the strain (measured in pstrain) to which the cells were subjected
(Wright et al, 1992; Wright et al, 1996). It has also been demonstrated that the
hyperpolarisation response did not occur when chondrocytes were subjected to the same
regime of cyclic mechanical stimulation when plated on rigid glass culture dishes or
when the plastic culture dishes were placed in the pressurisation chamber in such a way
as to avoid deformation of the base of the dish (Wright et al, 1996).
To investigate possible ion channels involved in the electrophysiological response of
HBC to cyclical mechanical stimulation, the effects of a panel of pharmacological
36
inhibitors of ion channel activity were investigated (Salter et al, 1997). Inhibitors of ion
channel activity included, tetrodotoxin, which blocks Na2+ channels (Chesnoy-Marchais
et al, 1988), apamin and quinidine which blocks Ca2+activated K+channels (Blatz et al,
1986; Lew et al, 1976) and gadolinium, which blocks stretch activated ion channels
(Yang et al, 1989).
None of the ion channel inhibitors studied had an effect on the resting membrane
potential of the HBC. Gadolinium abolished the hyperpolarisation response to 0.33 Hz
cyclical mechanical stimulation, but had no effect on the depolarisation response to
0.104 Hz cyclical mechanical stimulation. Apamin and quinidine also inhibited the
hyperpolarisation response to 0.33 Hz cyclical mechanical stimulation. The effect of
apamin and quinidine on 0.104 Hz cylical mechanical stimulation was not studied. In
contrast, tetrodotoxin inhibited the membrane depolarisation following 0.104 Hz cyclical
mechanical stimulation, suggesting a role for Na+ channels in this response, but had no
effect on membrane hyperpolarisation at 0.33 Hz stimulation (Salter et al, 1997).
Osteoblast like cells are known to possess a number of mechanosensitive ion channels
(el Haj et al, 1999; Walker et al, 2000), nonselective cation and K+- selective channels,
which may cause alterations in membrane potential following mechanical stimulation
(Dixon et al, 1984; Ypey et al, 1988; Davidson et al, 1990). Studies from our group
have shown that human chondrocytes and fibroblasts also show changes in membrane
potential in response to cyclical mechanical stimulation. Fibroblasts however, unlike
HBC and chondrocytes, show membrane depolarisation following stimulation at 0.33
Hz, suggesting cell type-specific responses to mechanical stimulation. The
hyperpolarisation response is a result of activation of small conductance Ca2+ activated
K+ (SK) channels, resulting in an efflux of K+ ions from the cell and cell
hyperpolarisation. Bone cells also possess a gadolinium sensitive stretch activated ion
channel that may be modulated by parathyroid hormone and chronic, intermittent load-
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bearing. The results obtained by Salter et al, (1997) are consistent with a role for
gadolinium sensitive ion channels in HBC responses to cyclical mechanical stimulation.
1.3.2 Evidence for a Role for a5Pi Integrin Receptor as a HBC
Mechanoreceptor.
The integrin family of transmembrane proteins, are known to be involved in the
transduction ofmechanical forces to cells via the ECM. The integrins are a family of
heterodimeric (a and p chain) transmembrane glycoproteins, which form specific
receptors for a variety ofECM proteins (Hynes et al, 1992). Integrin receptors are
expressed by cells in all tissues including bone. All bone types express as and Pi
integrins while «4 and av integrins are heterogeneously expressed by cells of the
osteoblast lineage and a2 and the avP3 complex are expressed exclusively by osteoclasts
(Clover et al, 1992; Hughes et al, 1993; Grzesik et al, 1994). As well as acting as
adhesion molecules, integrins have been shown to act as signalling molecules (Clark et
al, 1995; Schoenwaelder et al, 1999), and are known to act as mechanotransducers in a
variety of cell types including bone cells. A series of experiments were undertaken to
investigate a possible role for integrin molecules and integrin-associated signalling
pathways in mediating the hyperpolarisation response in cultured HBC following cyclic
mechanical stimulation (Salter et al, 1997).
Anti-integrin antibodies, including those against ai, a2, a3, as, ay, Pi, ayP3, and ayP5
were used to test for a role for the specific integrin subunits in the mechanotransduction
process. None of the antibodies tested had any effect on resting membrane potential but
showed variable effects on HBC responses to cyclic mechanical stimulation. The anti-pi
antibody inhibited both the depolarisation response to 0.104 Hz stimulation and the
hyperpolarisation response to 0.33 Hz stimulation. The avP5 antibody reduced the
depolarisation response to 0.104 Hz but had no effect on the hyperpolarisation response
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to 0.33 Hz, whereas the avP3 antibody had no effect on the membrane potential response
at either frequency of stimulation. Of the antibodies used against the a-integrin subunits
expressed by bone cells, only two showed significant effects. The anti-ay antibody
inhibited the response to 0.104 Hz stimulation but had no effect on the 0.33 Hz
stimulation response. In contrast, the anti-as antibody inhibited the 0.33 Hz
hyperpolarisation response but had little effect on the 0.104 Hz depolarisation response.
Antibodies to ai, a2, and a3 integrins did not inhibit the membrane potential responses
of bone cells to either frequency of cyclical mechanical stimulation. The results suggest
that changes in membrane potential as a result of stimulation by different frequencies
involve different integrins. The results suggest that a5 and Pi integrins are involved in
the transduction of strain at 0.33 Hz, resulting in the hyperpolarisation response via a
Ca2+ activated K+ channel, whereas, the depolarisation response mediated by a
tetrodotoxin sensitive Na+ channel seen at 0.104 Hz involves ay, pi and avPs integrins
(Salter et al, 1997).
A number of integrins recognise and interact with ECM proteins via RGD (arg-gly-asp)
sequences. RGD dependent integrin binding has been shown for a number ofECM
proteins, such as fibronectin, osteopontin, thrombospondin, type 1 collagen and
vitronectin (Hynes et al, 1992; Grzesik et al, 1994; Sommermann et al, 1988; Davies et
al, 1989) and therefore experiments have been carried out to see whether RGD-
containing oligopeptides known to interfere with integrin-mediated cell binding
influenced HBC responses to 0.33 Hz and 0.104 Hz cyclical mechanical stimulation.
The exposure ofHBC to GRGDSP peptide, which competitively inhibits integrin
binding to RGD-containing substrates, resulted in the inhibition of both the
hyperpolarisation and depolarisation responses, whereas the control GRADSP peptides
had no effect on either of these responses. These results suggest that RGD-mediated
interactions are involved in the transduction of strain to HBC at both 0.33 Hz and 0.104
Hz (Salter et al, 2000).
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Using inhibitors to the intracellular second messenger signalling molecules activated by
integrin signalling, the hyperpolarisation response induced by 0.33 Hz cyclical
mechanical stimulation was investigated (Salter et al, 1997; Salter et al, 2000). It was
found that the hyperpolarisation response was inhibited by cytochalasin D (which
disrupts the actin cytoskeleton) (Casella et al, 1981; Wang et al, 1994), genistein (which
inhibits tyrosine kinase activity) (Akiyama et al, 1987; O'Dell et al, 1991), neomycin
and W7 (inhibitors of phospholipase C / IP3 pathway) (Hidaki et al, 1981; Liscovitch et
al, 1991), indomethacin (inhibitor of arachadonic acid metabolism) and calphostin C
(inhibitor of protein kinase C activity). However, caffeic acid (inhibitor of lipo-
oxygenase) (Cho et al, 1991; Sudina et al, 1993) had no effect on the membrane
potential response to 0.33 Hz cyclical mechanical stimulation, suggesting that the lipo-
oxygenase pathway is not involved in the hyperpolarisation response of HBC to 0.33 Hz
cyclic mechanical stimulation.
Therefore, the above studies suggest that the mechanotransduction pathway activated by
0.33 Hz cyclical mechanical stimulation involves the CX5P1 integrin receptor, the actin
cytoskeleton, tyrosine kinase activity, the phospholiase C (PLC) / IP3 pathway and
protein kinase C (PKC) activity.
1.3.3 Interleukin-ip in HBC Mechanotransduction.
A number of studies have reported the production of a number of soluble factors such as
prostaglandins (Somjen et al, 1980; Ayajiki et al, 1996; Sterck et al, 1998) and NO
(Pitsillides et al, 1995; Klein-Nulend et al, 1998), by bone cells and endothelial cells in
response to mechanical stimulation. These factors could potentially act in an
intermediate, autocrine or paracrine step to regulate cell function in the response of cells
to mechanical stimulation.
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Studies have been undertaken to investigate whether soluble mediators are involved in
the hyperpolarisation response ofHBC to 0.33 Hz cyclical mechanical stimulation.
Conditioned medium from mechanically stimulated HBC, when transferred to
unstimulated cells, caused membrane hyperpolarisation of these cells of a similar
magnitude to that of the directly mechanically stimulated cells, suggesting the presence
of a soluble transferable factor secreted by the mechanically stimulated HBC. These
conditioned medium experiments were repeated in the presence of anti-integrin
antibodies. Medium from cells which had been incubated with anti-Pi antibody
inhibited the direct hyperpolarisation response ofHBC to 0.33 Hz cyclical mechanical
stimulation. Similarly, medium from HBC which had been mechanically stimulated in
the presence of anti-pi antibody, when transferred to unstimulated cells did not alter the
membrane potential of these cells, suggesting that the anti-Pi antibody inhibited the
production of the transferable factor. In contrast, an anti-avPs integrin antibody did not
inhibit 0.33 Hz induced hyperpolarisation nor did it inhibit the production of a
transferable factor which could induce membrane hyperpolarisation of unstimulated
HBC. These results suggest that the secretion of the transferable factor is Pi, and not
avPs integrin mediated (Salter et al, 2000).
As HBC are known to secrete and respond to a number of chemical mediators, including
prostaglandins and cytokines, a series of experiments were undertaken to investigate
whether such agents might be involved in the hyperpolarisation response ofHBC to
cyclic mechanical stimulation. HBC were incubated with a panel of cytokines,
including IL-la, IL-lp, IL-4, IL-6 and TGF-pi and the eicosanoids PGE2 and PGF2a-
IL-la, IL-ip and PGE2 each induced a hyperpolarisation response that was similar in
extent to that seen following 0.33 Hz cyclical mechanical stimulation, whereas the other
cytokines studied and PGF2a induced membrane depolarisation. Dose response studies
showed that IL-ip could induce significant membrane hyperpolarisation at levels as low
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as 1 pg/ml. Neutralizing antibodies to IL-ip abolished the hyperpolarisation response to
cyclical mechanical stimulation, whereas antibodies to IL-la, IL-6 and TGF-pi had no
effect. Similarly, anti IL-1 p antibodies, added to the conditioned medium after
mechanical stimulation but before transfer of that medium to unstimulated cells,
prevented the subsequent hyperpolarisation. These results demonstrate the IL-1 p is
necessary for the membrane hyperpolarisation response to mechanical stimulation
(Salter et al, 2000).
The hyperpolarisation response ofHBC to recombinant IL-ip and PGE2 was unaffected
by gadolinium (an inhibitor of stretch activated ion channels), genestein (a tyrosine
kinase inhibitor) and cytochalasin D (which disrupts the actin cytoskeleton), which have
previously been shown to inhibit the HBC hyperpolarisation response to 0.33 Hz
cyclical mechanical stimulation (Salter et al, 1997). These results indicated that
mechanically-induced secretion of IL-1 P in the mechanotransduction pathway is
downstream of the activation of stretch-activated ion channels, tyrosine kinases and the
actin cytoskeleton. However, indomethacin (inhibitor of arachadonic acid metabolism),
neomycin, flunarizine, W7 (inhibitors of the PLC / IP3 pathway), calphostin C (inhibitor
of PKC) and apamin (SK channel blocker) each inhibited the HBC hyperpolarisation
response to recombinant IL-1 p. These results indicate that IL-1 P secretion is upstream
of activation of PLC and IP3 - mediated Ca2+ release and the resultant opening of SK
channels (Salter et al, 2000).
Similarly, apamin and calphostin C inhibit PGE2-induced cell membrane
hyperpolarisation but neomycin, flunarizine and W7 did not. This would suggest that
PGE2 production lies downstream of the PLC / IP3 signalling, and that PKC may be




When HBC are mechanically stimulated at 0.33 Hz, they undergo hyperpolarisation of
the plasma membrane via the activation of Ca2+ activated K+ channels. The
mechanotransduction pathway involved includes the a5Pi integrin and stretch activated
ion channels. Downstream intracellular signalling molecules include the actin
cytoskeleton, tyrosine kinases and the production and secretion of IL-lp. IL-ip acts in
an autocrine / paracrine way to activate downstream signalling, components ofwhich
include the PLC and IP3 pathways. The proposed mechanotransduction pathway is
summarised in Figure 1.6.
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Since 1948, when Farber et al, showed that the antifolate aminopterin could induce
remissions in children with acute leukaemia, folate dependent enzymes have become a
major target of chemotherapy, because they are known to play an essential role in the
synthesis ofDNA precursors (Heunnekens et al, 1994; Chu et al, 1996). Methotrexate
(MTX), the most widely used anti-folate in cancer chemotherapy, has an essential role in
the treatment of such diverse diseases as acute lymphocytic leukaemia, non-Hodgkin's
lymphoma, osteosarcoma, head and neck cancer and breast cancer (Chabner, 1982). It
has also become an important therapeutic treatment for various autoimmune diseases
such as rheumatoid arthritis and psoriasis (Weinstein, 1977) and for the prevention of
graft versus host disease after transplantation (Blume et al, 1980; Gorlick et al, 1996).
1.4.1 Cellular Effects ofMTX.
1.4.1.1 MTX Disrupts DNA Synthesis Via Dihydrofolate Reductase (DHFR)
Inhibition.
The folate vitamins are a class of essential cofactors that carry single carbon groups.
Reduced folate (tetrahydrofolate) is the proximal single carbon donor in several
reactions involved in the synthetic pathways for purine and pyrimidine precursors of
DNA and RNA required for cell proliferation. Also, tetrahydrofolate plays a part in a
second important biochemical step: the methionine homocysteine cycle, which is
necessary to provide a methyl group for several downstream reactions such as
methylation ofDNA, RNA proteins and others (Seeger et al, 1949; Huennekens et al,
1994; Chu et al, 1996). Thus, in the design of inhibitors ofDNA synthesis, folic acid
and its derivatives are a logical target.
The physiological folate cofactors all share the common structural features, as shown in
Figure 1.7. The structure consists of three main elements: a multi-ring pteridine group
linked to para-aminobenzoic acid, which in turn connects with a terminal glutamic acid
residue. Although folates found in the blood have a single terminal glutamate, most
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intracellular folates are converted to polyglutamates, which contain multiple glutamate
groups linked by gamma peptide bonds (McGuire et al, 1980; McGuire et al, 1981). The
polyglutamate forms of folic acid have unique properties. They are preferentially
retained within cells and are usually more efficient cofactors than the monoglutamated
compounds. A second, important feature of folate biochemistry is that the cofactors
must be reduced to their tetrahydo form, with hydrogen atoms in positions 5, 6, 7 and 8
of the pteridine ring (tetrahydrofolates [FH4]), in order to be active in enzymatic
reactions (Figure 1.7a). The enzyme dihydrofolate reductase (DHFR), which is
responsible for the conversion of oxidized folates to their active reduced form, is
potently inhibited by MTX.
MTX is a folate analogue with an amino group (NFF), methyl group (CH3), and a fully
oxidised pteridine ring, rendering the molecule inactive as a cofactor (Figure 1.7b)
(Seegar et al, 1949). Once administered, MTX is delivered to cells via the same active
transport system used by the parenteral folates. After entering the cell, MTX quickly
binds to and inactivates DHFR. As DHFR has an essential role in the maintenance of
intracellular FH4 levels by reducing dihydrofolate (FH2), the critical result produced by
inhibition of DHFR is depletion of intracellular pools of reduced folate. The reaction
most sensitive to folate depletion is thymidylate synthesis, which requires N5"
10 • • R
methylene-FH4. This reaction ceases at concentrations of 1x10" M ofMTX (Chabner
et al, 1973). N10-formyl-FH4, the folate involved in purine synthesis (Smith et al, 1981)
is also depleted, leading to the cessation of purine synthesis at slightly higher
concentrations (approximately 1 xlO"7M) ofMTX (Zaharko et al, 1977). The lack of
either thymidylate or purines block synthesis ofDNA (Figure 1.8).
Like the pareteral folates, MTX is metabolised extensively intracellularly to yield
polyglutamate derivatives (MTX-glu) (Whitehead et al, 1975; Rosenblatt et al, 1978;
Witte et al, 1980; Gewirtz et al, 1980). Upon administration, 3-12% ofMTX is
hydroxylated in the liver and circulates as 7-hydroxy-MTX (7-OH -MTX) (Baugh et al,
1973; Jacobs et al, 1977). MTX-glu synthesis increases in respect to drug concentration
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and duration of exposure. MTX-glu generally represent long-lived MTX derivatives
(Rosenblatt et al, 1978; Jolivet et al, 1982; Jolivet et al, 1983), and may be detected for
as long as two weeks after a single administration ofMTX. Because there is a latent
period of several weeks before the effects ofMTX are observed in patients receiving
treatment, it may be the intracellular MTX-glu derivatives which are the true therapeutic
agents (Cutolo et al, 2001; Ramanan et al, 2003).
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Figure 1.7 - Structure of tetrahydrofolate (a) and methotrexate (b) polyglutamates. In (a)
one-carbon groups (R) are transported on nitrogen 5 or 10 or both. Figure adapted from
Jolivet et al, 1983.
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Figure 1.8 - The mechanism of action ofmethotrexate via dihydrofolate reductase
inhibition.
MTX = methotrexate, DHFR = dihydrofolate reductase, TS = thymidylate
synthetase, FH4 = tetrahydrofolate, FH2 = dihydrofolate, Glu = glutamyl, dTMP =
dioxythymidylate and dUMP = dioxyuridylate.
Broken lines indicate enzyme inhibition. Figure adapted from Jolivet et al, 1983.
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1.4.1.2 MTX Effects Via Adenosine Induced Immunosuppression.
In addition to inhibiting DHFR, MTX may also interfere with de novo purine
biosynthesis by inhibition of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR)
transformylase, an enzyme involved in the purine biosynthetic pathway (Baggot et al,
1986). This has several consequences, one ofwhich is an overproduction of adenosine
(Cronstein et al, 1991; Cronstein et al, 1992; Cronstein et al, 1993; Kremer et al, 1995;
Montesinos et al 2000; Cutolo et al, 2001). It is thought that a number of anti¬
inflammatory effects exerted by MTX may be related to an increase in the extracellular
concentration of adenosine and its interaction with specific cell membrane receptors.
It is known that MTX inhibits the enzyme AICAR transformylase, which results in a
relative increase in AICAR levels (Figure 1.9). AICAR inhibits important steps of
degradation of adenosine monophosphate (AMP) and adenosine by AMP deaminase
(AMPDA) and adenosine deaminase (ADA) respectively. Inhibition of degradation of
AMPDA and ADA leads to increased intracellular and extracellular AMP and
adenosine. Extracellular adenosine can bind to adenosine receptors, which are seven
transmembrane spanning in nature. To date, four sub-types of adenosine receptor have
been characterised, namely Ai, A2a, A2b and A3 (Collis et al, 1993; Palmer et al, 1995;
Klotz, 2000). The rank order of affinity of adenosine binding to these receptor subtypes
is Ai > A2a > A2b (Mazzoni et al, 1993). The Ai and A3 receptors are coupled to
inhibitory G-proteins (Gai/0), whereas the A2a and A2b receptors are coupled to
stimulatory G-proteins (Gas). Therefore, binding to the Ai or A3 receptor subtypes
decreases intracellular cAMP, whereas binding of adenosine to either of the two A2
receptors increases intracellular cAMP. If the pathways through the two different
receptor subtypes (Ai or A2a/2b) were functionally intact one would expect a prominance
of the Ai pathway owing to the higher affinity of adenosine to the Ai receptor subtype,
resulting in a decrease of cAMP. Evidence to date, however, suggests that low dose
MTX exerts its anti-inflammatory effects by inducing extracellular adenosine which acts
predominantly via A2a receptors (Cronstein et al, 1993; Cronstein et al, 1997; Morabito
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et al, 1998; Montesinos et al, 2000), and it would appear that Ai receptor signalling is in
someway 'switched off (Straub et al, 1999) (Figure 1.9).
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1.5 Methotrexate and Bone.
1.5.1 Effects of Intensive Chemotherapy Regimes on Bone Turnover
and Growth.
Although extremely efficacious in the treatment of both malignant disease and
autoimmune disease, MTX has a number of side effects in a variety of organ
systems. High dose regimes may induce myelotoxicity, nephrotoxicity (Abelson et
al, 1983), mucositis, ocular irritation (Doroshow et al, 1981), reversible elevation of
hepatic enzymes and nausea (Frei et al, 1980). MTX also has detrimental effects on
bone formation, and there have been reports ofpoor growth in children receiving
MTX treatment, especially during periods of intensive chemotherapy (Clayton et al,
1988; Moell et al, 1988; Thun-Hohenstein et al, 1992; Hokken-Koelega et al, 1993;
Wallace et al, 1996). Growth rate may return to normal during less-intensive periods
of treatment and may show evidence of further catch-up upon completion of
chemotherapy (Caruso-Nicoletti et al, 1993; Holm et al, 1994; Ahmed et al, 1997).
Also of great concern are reports of reduced bone mineral content and bone mineral
density at various sites which are associated with increased fracture risk, reduced
peak bone mass, and a theoretical risk of osteoporosis in later life, a condition known
as MTX osteopathy (Ragab et al, 1969; O'Regan et al, 1973; Stanisavljevic et al,
1976; Stevens et al, 2001; Wijnands et al, 2001). In addition to patients receiving
intensive chemotherapy regimes, MTX may also have detrimental effects on bone in
patients receiving long term, low dose MTX treatment for rheumatoid arthritis
(Preston et al, 1993).
A number of bone markers exist that can be used as indicators of the dynamic
process ofbone turnover and growth. Using these markers, it has been demonstrated
that at diagnosis, children with acute lymphoblastic leukaemia (ALL) have reduced
bone alkaline phosphatase (a marker of the differentiated osteoblast), reduced
circulating C-terminal propeptide of type 1 procollagen (which reflects type 1
collagen synthesis and is a marker of the osteoblast in its early proliferative stage),
reduced C-terminal telopeptide of type 1 collagen (which reflects the breakdown of
type 1 collagen), and reduced insulin growth factor-1 and insulin growth factor-1
binding protein-3 (which are important regulators of osteoblast activity and bone
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turnover). During the first year of treatment, periods of intensive chemotherapy were
associated with further suppression ofmarkers of collagen turnover, with marked
increases in the levels of these markers during periods of less-intensive treatment
(Crofton et al, 1998; Crofton et al, 1999; Crofton et al, 2000). Children are,
however, given combinations of chemotherapeutic agents during treatment, and it is
therefore impossible to determine from clinical studies the relative contribution of
each individual agent administered to the resulting osteopenia. There are
surprisingly few in-vitro investigations examining the local effects of individual
chemotherapeutic agents on bone cells and the majority of in-vitro studies of the
effects of chemotherapeutic agent on bone cells have been with MTX,
dexamethasone or prednisolone (Scheven et al, 1995; Cheng et al, 1994).
1.5.2 Effects of MTX on Osteoblasts.
The mechanism of action ofMTX on bone at the cellular level is unclear but may
involve interaction with the function of osteoblasts and their precursors. Several
studies have reported that MTX affects osteoblasts in-vitro and in-vivo, including
adverse influences on recruitment and differentiation ofmesenchymal precursors
(Minaur et al, 2002), and inhibition of osteoblast function including bone formation
(Uehara et al, 2001). The mechanisms by which MTX has these effects have yet to
be defined and, although inhibition of folate metabolism is likely to be important in
prevention ofproliferation-associated events, it is also likely that MTX influences
the ability of osteoblasts to respond to environmental cues such as growth factors
(Beresford et al, 1984), cytokines or mechanical stimulation (Buckley et al, 1990,
Lanyon et al, 1992; Harter et al, 1995; Owan et al, 1997), which are important in
maintaining bone homeostasis.
The effect ofboth high and low dose MTX regimes has been the focus ofmany
laboratory based and clinical studies. The major findings of these studies will be
described in the following sections.
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1.5.2.1 In - Vivo Investigations.
The majority of in-vivo laboratory studies have been conducted using a rat model,
with the aim to give a better understanding of the effects ofMTX on the normal
physiological remodelling of the intact skeleton. Tross et al, (1980), demonstrated,
using the rat, that MTX decreased bone turnover and strength, 14 days after
administration of a single dose, whereas May et al, (1994), provided evidence to
show that prolonged administration of low-dose MTX in normal rats causes
significant osteopenia via suppression of osteoblast activity and stimulation of
osteoclast recruitment, resulting in increased bone resorption. The animals in this
study received weekly injections of 3 mg/kg ofMTX for 16 weeks before being
sacrificed at the end ofweek 16. The results of this study demonstrated that
prolonged administration ofweekly low-dose MTX caused a reduction serum
alkaline phosphatase and osteocalcin levels and mineral apposition rates, although
osteoblast numbers were not affected. Thus, the decrease in bone formation is likely
to be a consequence of reduced osteoblastic activity rather than depletion of
osteoblast numbers. Another study (Freidlander et al, 1984), also using a rat model,
noted a significant reduction in cancellous bone volume, osteoid surface and
osteoblast number 14 days after treatment with a 5-day course ofMTX
(0.75mg/kg/day), although no changes were found in the torsional strength, stiffness,
energy absorbed at failure, osteoclast surface or mean cortical thickness over this 14-
day period. These findings further support the hypothesis that, in rats, the
mechanism ofMTX-induced osteopenia is a result of decreased osteoblast activity.
Wheeler et al, (1995) investigated the effect of long-term MTX administration on the
rat skeleton. MTX decreased cancellous bone volume, cancellous bone formation
and increased cancellous bone resorption. Osteoblast (and osteoclast) recovery was
not observed at the conclusion of the study, which was 170-days afterMTX
administration, and therefore as a result, cancellous bone mass remained at a reduced
level in the MTX treated animals.
Studies have also been performed to investigate the effect of low dose MTX therapy
on bone mass in adjuvant-induced arthritic rats. Segawa et al (1997) showed that
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MTX decreases bone formation in both adjuvant-induced arthritic rats, and control
(no-arthritis) rats but that the effect ofMTX on osteoclast activity differed between
arthritic rats and control rats. While MTX appears to increase osteoclast activity in
the control rats, it prevents the increase in trabecular osteoclast number in arthritic
rats. As a result, normal bone mass can be maintained (Segawa et al, 1997).
1.5.2.2 In - vitro Investigations.
Several in-vitro studies have investigated the effects ofMTX on bone cells in culture
(Preston et al, 1993; Scheven et al, 1995; May et al, 1996; Van der Veen 1996;
Uehara et al, 2001; Davies, 2002). May et al (1996) investigated the effects of
different concentrations ofMTX (0.5 nM - 0.6 pM) on mouse bone cells in culture
7-days after addition to the culture. The lowest concentration used (0.5 nM) is
comparable to that found in human synovium and bone (0.28 nM and 0.29 nM,
respectively) following administration of intramuscular MTX (Preston et al, 1993),
and the highest concentration (0.6 pM) is similar to that found in serum during
standard dosing (Kremer et al, 1986). The results of this study provide evidence to
show that MTX dose dependently inhibits osteoblastic cell function, as indicated by
reduced osteocalcin levels and decreased matrix calcification. The authors
concluded that the diminished matrix calcification was likely to be related to the
reduced osteocalcin production, although no alteration in osteoblast proliferation was
noted following MTX exposure.
Three further studies (Scheven et al, 1995; Van der Veen et al, 1996), have also
investigated the in-vitro effects ofMTX on human osteoblasts. These studies
conclude that MTX decreases osteoblast proliferation by as much as 30% after 4
days of exposure. These results contradict those obtained by May et al (1996). This
may be due to differences in MTX sensitivity between mouse and human osteoblasts,
or because the response to MTX was measured in the human osteoblasts after just 4-
days as opposed to 7-days in the mouse osteoblasts. MTX had no effect on alkaline
phosphatase expression in either study. It is somewhat surprising that alkaline
phosphatase levels, which are representative of cellular differentiation, remain
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unaffected following incubation with MTX while cellular proliferation is diminished.
It has been suggested (May et al 1996; Van der Veen et al, 1996), that MTX may be
able to selectively 'target' and eliminate immature osteoblasts without affecting fully
differentiated cells. Consistent with the above studies, Uehara et al (2001) have
provided further evidence to support the hypothesis that MTX can inhibit the
differentiation of immature osteoblasts. This study investigated the inhibitory effects
ofMTX on the differentiation ofMC3T3-E1 cells, which have the ability to
differentiate into mature osteoblasts or osteocytes. The results show that the
inhibitory effects ofMTX on alkaline phosphatase activity decrease according to the
length of time the cells have been in culture before the addition ofMTX. Therefore,
these results suggest that MTX predominantly affects early osteoblastic cells that do
not express alkaline phosphatase, and inhibits their differentiation into mature
osteoblasts, but has little influence on either the function or proliferation ofmore
mature osteoblasts.
Although the adverse effects of chemotherapy on bone have always largely been
attributed to steroid therapy and the administration ofMTX, Davies et al, 2002, have
provided evidence to suggest that more chemotherapeutic agents than previously
appreciated may have deleterious effects on bone metabolism. The relative
chemosensitivity of osteoblast-like cells representing different stages of cell
differentiation were evaluated. The chemosensitivity of an established human
osteoblast-like cell line (MG63) was compared to that of a human osteoprogenitor
cell line (HCC1) and primary HBC. Cell numbers were reduced by MTX,
mercaptopurine, thioguanine, cytarabine, vincristine, etoposide, daunorubicin,
asparaginase, prednisolone and dexamethasone in all cell types although there was a
varied response between agents at equimolar concentrations. The less differentiated
osteoblast phenotypes were significantly more chemosensitive than the more
differentiated phenotypes. These results suggest that a variety of chemotherapeutic
agents may contribute to osteopenia in childhood malignancy by direct effects on
osteoblast numbers (Davies et al, 2002).
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1.6 Hypothesis and Aims.
The work described in this thesis was undertaken with the goal ofproviding new
insights into the mechanisms involved in the responses ofHBC to mechanical
stimulation, and to investigate the effects ofMTX on these responses. As such, these
experiments have involved the characterisation ofHBC grown from trabecular bone
fragments, and investigation of the signalling pathways activated following
mechanical stimulation in control and MTX treated cells.
Hypothesis.
The hypothesis of this project was that detrimental effects ofMTX on bone growth
and resultant osteopenia, can be attributed to inhibitory effects ofMTX on bone cell
responses to mechanical stimulation, which are known to increase bone mass.
Scientific Questions
Chapter 3 - Do HBC obtained by outgrowth from trabecular bone fragments exhibit
characteristics typical of the osteoblastic phenotype?
Chapter 4 - What is the electrophysiological response of cultured HBC to cyclical
mechanical stimulation? What are the signalling mechanisms involved? Does
cyclical mechanical stimulation result in alterations in gene expression?
Chapter 5 - Does MTX affect HBC responses to cyclical mechanical stimulation?
How does MTX affect HBC viability? What are the mechanisms involved in MTX
inhibition ofHBC responses to cyclical mechanical stimulation?
Chapter 6 - Is adenosine signalling involved in MTX inhibition ofHBC responses to
mechanical stimulation? Does adenosine inhibit HBC responses to mechanical




All human bone tissue was handled in a BioMAT Class 1 Microbial Safety Cabinet.
2.1 Human Bone Cell (HBC) Culture.
2.1.1 Isolation of HBC.
HBC cultures were established from trabecular bone explants as described previously
(Beresford et al, 1984). Bone was collected at surgery with informed consent from
children undergoing corrective osteotomy, or from adults undergoing above or below
knee amputation as a result of diseases unrelated to the osteoarticular system. The
inner, soft trabecular bone was removed from the hard outer cortical bone using both
sterile forceps and a scalpel and was retained. The cortical bone was discarded. The
trabecular bone was chopped into 0.5 cm fragments using a sterile scalpel and then
placed in a sterile universal container. The fragments were washed with sterile
phosphate buffered saline (PBS), by shaking vigorously so that any non-adherent
marrow associated cells were removed. This washing step was repeated three times.
The trabecular fragments were then transferred to a sterile tissue culture petri dish
(Nunc) containing 20ml complete medium consisting of, Minimal Essential Medium
(MEM) (Sigma, Poole, UK) supplemented with 10% foetal calf serum (FCS)
(Sigma), 10 I.U/ml penicillin, 10 pg/ml streptomycin (Gibco, Paisley, UK) and 2
mM L-glutamine (Gibco) (complete medium). The petri dish was placed overnight
in an incubator at 37°C in an atmosphere of 95% O2, 5% CO2. The following day
the fragments were examined microscopically for any signs ofmicrobial infection
and if none was present the fragments were transferred to a fresh sterile tissue culture
petri dish (Nunc) containing 20 ml of the complete medium and returned to the
incubator in the same culture conditions as above. Bone cell outgrowth from the
trabecular bone fragments was usually apparent after 1-2 weeks, and the dish was
confluent with HBC after 4-6 weeks.
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2.1.2 Passaging Adherent Human Bone Cells
Once the petri dish was confluent with HBC, the trabecular bone fragments were
removed to a fresh sterile tissue culture grade petri dish (Nunc) using sterile forceps.
Complete media (20 ml) was added to the petri dish and the fragments were cultured
at 37°C, 95% O2, 5% CO2 as described previously, until the dish was confluent with
HBC. Bone fragments were recultured in this manner a maximum of three times.
After the bone fragments had been removed from the culture dish, the confluent cells
were washed by the addition of 10 ml sterile PBS. The dish was gently agitated for
5-10 seconds and the PBS removed using a sterile pipette. 10 ml of 0.02% EDTA
(Sigma) was added to the confluent HBC and the dish incubated at 37°C, 95% O2,
5% CO2 for 5 minutes. EDTA chelates divalent cations and metal ions and thus
promotes loss of cell adhesion. Remaining adherent cells were then scraped from the
dish using a sterile cell scraper (Greiner, Shroudwater Business Park,
Gloucestershire) and the cell suspension was pipetted into a sterile universal
container. The universal container was then filled to the 25 ml mark with sterile PBS
and centrifuged at 300g (1000 rpm) for 10 minutes. The EDTA/PBS solution was
discarded and the cell pellet was resuspended in 25 ml sterile PBS before being
centrifuged again at 300g (1000 rpm) for a further 10 minutes. The cell pellet was
resuspended in 5 ml complete medium, which was then transferred to a sterile tissue
culture flask (Nunc) containing 75 ml complete medium. The cells were passaged as
required. Cells were not used beyond passage 5.
2.1.3 Plating of Cells for Experiments
HBC were grown in sterile tissue culture flasks until the cells covered approximately
75% of the base of the tissue culture flask. To remove the cells, 10 ml EDTA
(0.02%) was added to the flask and incubated at 37°C, 95% O2, 95% CO2 for 5
minutes. After the incubation period, the flask was tapped gently to dislodge any
cells still adhering to the plastic. The cells were then removed from the flask using a
sterile pipette, transferred to a sterile universal container, which was filled to the 25
ml mark with sterile PBS and were centrifuged at 300g (1000 rpm) for 10 minutes.
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The EDTA/PBS solution was discarded and the cells were resuspended in 25 ml
fresh PBS before being centrifuged again at 300 g (lOOOrpm) for a further 10
minutes. The cell pellet was then resuspended in 5 ml of complete medium and then
filtered through a 100-micron cell strainer (Falcon, Becton Dickinson, UK) to
remove any large cell clumps or pieces of debris. The cell number in the suspension
was then assessed using a Neubauer haemocytometer. With a coverslip in place, 10
pi cell suspension was added to one chamber by touching the tip of the pipette to the
edge of the coverslip and allowing the chamber to fill by capillary action. The
number of cells was assessed by counting all the cells in the 1 mm centre square and
two of the 1 mm corner squares (Figure 2.1). Each 1mm square represents a total
volume of 10"4 cm3, and since 1 cm3 is equal to 1 ml, the number of cells per ml is
equal to the average count per 1 mm square x 104. The total number of cells is equal
to the number of cells per ml x 5.
Cells were seeded in complete medium in tissue culture grade dishes and multiwell
plates (Nunc) at differing densities, depending on the experiment to be performed
(Table 2.1). After seeding, all dishes/plates were incubated at 37°C for 48 hours to
allow cells to adhere to the base of the dish/well. For all experiments, complete
media was removed and replaced with MEM containing 10 I.U/ml penicillin, 10
pg/ml streptomycin and 2 mM L-glutamine (serum free medium) 30 minutes before
commencing the experiment.
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Figure 2.1 - Diagrammatic representation of the Neubauer haemocytometer used to
assess cell number.
Experiment Cell Density Seeding Vessel Total Volume
(cells/ml) (per dish/well)
Electrophysiology 5 x 104 58 mm petri dish 5 mis
Acridine Orange Staining 5x 104 6-well plate 2 mis
MTT Assays 5 x 104 96-well plate 100 pi
Immunofluorescence 5x 104 58 mm petri dish 5 mis
Immunocytochemistry 5 x 104 58 mm petri dish 5 mis
RNA Extraction 5 x 104 58 mm petri dish 5 mis
Lactate Dehydrogenase Assays 1 x 105 12-well plate 1 ml
Table 2.1 - Different seeding conditions for the various experimental techniques
performed throughout this study.
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2.2 Induction ofMechanical Stimulation
The system used to mechanically stimulate the cells (Figure 2.2) is a modification of
that described previously (Wright et al 1992, 1996). Flexible 58 mm tissue culture
dishes (Nunc) were placed in a sealed polypropylene stimulation chambers with inlet
and outlet ports (Figure 2.3). The culture dish was supported by a rubber 'O'-ring in
the central well of the stimulation chamber, below which there is a space through
which nitrogen gas could circulate via inlet and outlet ports. The lid was screwed
down and held the dish in position. The lid and the 'O'-ring ensured an airtight seal
between the chambers below and above the dish (Figures 2.3 and 2.4).
Nitrogen gas enters the space below the culture vessel via the inlet port, the
frequency being dictated by an electronic timer, which controls both the inlet and
outlet valves. When nitrogen gas enters the lower chamber, there is an increase in
the pressure in the lower chamber, which causes the base of the dish to balloon
upwards - therefore the base of the dish and its adherent HBC are exposed to strain.
In these studies, a gas pressure of 30 mmHg (0.025 atmospheres) was used which
results in ~ 4000 microstrain on the base of the dish (Figure 2.5). The system had
been extensively calibrated by Dr Malcolm Wright and Mr Paul Parker using strain
gauges which were glued to the base of the culture dish to measure the strain induced
by various pressures. The standard stimulation regime used was a frequency of 0.33
Hz (2 seconds pressure on, 1 second pressure off) at 37°C. Each experiment was
















Figure 2.2 - Apparatus for the induction of cyclic mechanical stimulation. Nitrogen
gas entered the system from a nitrogen cylinder, via a pressure regulator, which
controlled the inlet and outlet valves. A delay/timer allowed variation in duration of
pressure pulse and time between pulses. The pressure in the system was monitored
by a digital monometer.
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Figure 2.3 - Details of the mechanical stimulation chamber. Nitrogen gas enters the
lower chamber via the gas inlet port resulting in an increase in the pressure in the lower






Figure 2.4 - Photograph of the mechanical stimulation chamber.
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Pressure (mmHg)
Figure 2.5 - Calibration graph for mechanical stimulation system. In the following
studies a gas pressure of 30mm Hg (0.025 atmospheres) was used which results in ~




A batch ofmicroelectrodes was manufactured prior to each experiment from
borosilicate glass capillaries, 1.5mm inner diameter and 1.86 outer diameter with
inner filament (Harvard Apparatus, Edenbridge, Kent, England). The electrodes
were made using a Narshege microelectrode puller (Narshege, Japan) and were
stored in a clean container with their tips uppermost.
2.3.2 Filling of electrodes
Prior to use, the electrodes were filled with 3M potassium chloride solution (3M
KC1). A glass tissue culture beaker was filled with 3M KC1 and plasticine was
pressed firmly around the rim of the beaker. Electrodes were then pressed onto the
plasticine so that their tips were submerged in the KC1. The tips filled by capillarity
and the shafts of the electrodes were filled using a syringe and lumbar puncture
needle. After filling the electrodes were left for at least 3 minutes to allow the tips to
fill by capillary action. Electrodes were used when there were no air bubbles visible






Figure 2.6 - Filling ofMicroelectrodes with 3M KC1.
68
2.3.3 Electrophysiological Recording
Electrophysiological studies were carried out at room temperature (~ 20°C). Dishes
of cells were placed on the stage of a Wild M40 inverted microscope (Figure 2.7)
and were observed under x200 magnification. A silver/silver chloride (Ag/AgCl)
earth wire was placed in the periphery of the cell culture dish making contact with
the culture medium. The other end of this wire was connected to the ground terminal
of the input headstage of the Axoclamp Amplifier. The microelectrode was
connected to the headstage via a microelectrode holder, which housed an Ag/AgCl
wire. A pre-filled micreoelectrode was connected to the microelectrode holder so
that the Ag/AgCl wire of the holder passed down the shaft of the microelectrode
making contact with the 3M KC1. The microelectrode was secured firmly by the
pipette seat of the holder (Figure 2.8). The microelectrode holder was connected to
the input of the headstage of the Axoclamp Amplifier. Using a Zeiss
micromanipulator (Figure 2.7), the microelectrode was manoeuvred until its tip was
just below the surface of the culture medium. The tip of the microelectrode was then
located in the field of view using the x200 magnification. Once the tip of the
microelectrode had been located and focussed, the experiment was ready to
commence.
Power to the Axoclamp-2B (Microelectrode Clamp, Axon Instruments) was switched
on (Figure 2.9). Any voltage observed at this time was offset to the zero baseline on
the oscilloscope (Gould Advance type OS 4000/4001), using the input offset
potentiometer of the Axoclamp-2B.
A Wheatstone bridge circuit incorporated into the circuits of the Axoclamp-2B
allowed the determination ofmicroelectrode resistance whilst the experiment was in
progress. A command current of 5 nA was set with the step command thumbwheel
switch. A voltage pulse was observed on the oscilloscope. The bridge balance
control was advanced until this voltage step was eliminated. The bridge was then in
balance. The microelectrode tip resistance was read from the bridge balance dial and
was usually in the range of 30-50 MQ, which was acceptable for experimentation.
Lower tip resistances indicated that there was some damage to the tip or that the
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electrodes had a large tip diameter. High tip resistances (> 100 MQ) indicated the
probability of air bubbles in the electrode tip, due to inadequate filling by the
capillary. Therefore, electrodes with tip resistances <30 MQ or >100 MQ were
discarded and not used for experimentation.
2.3.4 Electrophysiological Procedure
A suitable HBC was selected for impalement. As the culture was mixed and
contained fibroblasts as well as HBC cells, for cells to be chosen for impalement they
had to exhibit several criteria.
• Polygonal morphology (opposed to the spindle morphology of
fibroblasts).
• Isolated, with no visible contact with neighbouring cells as it has been
previously shown that resting membrane potentials are higher in cells
which are in contact with one or more neighbouring cells (Bard,
1974).
The voltage dependent oscillator was switched on. This produces a tone, which is
dependent on voltage, and changes in accordance with changes in membrane
potential (Figure 2.10). This piece of equipment provides the advantage that the
experimenter can observe the microelectrode on cell impalement and not have to
continually check the oscilloscope monitor, as a change of note alerts the
experimenter that the electrode has entered the cell. The microelectrode tip was
positioned over the cell using the micromanipulator. The electrode tip was then
lowered whilst listening to the note of the voltage dependent oscillator. When the
electrode tip entered the cell, the note changed suddenly from high to a lower
frequency. The digital readout ofmembrane potential was then observed on the
Axoclamp-2B and this was noted. The electrode tip was then removed from the cell
using the micromanipulator.
The results from individual cells were accepted, if, upon impalement there was a
rapid change in voltage which remained constant for at least 20 seconds. A
microelectrode was changed if there was a dramatic increase or decrease in electrode
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resistance as this usually indicated that the electrode had become blocked with
debris, or cellular material or that the electrode had become damaged during cell
impalement.
Membrane potentials of aminimum of 5 cells were measured before and after
addition of each reagent to be tested and again following mechanical stimulation.
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Figure 2.9 - Photograph of electrophysiological equipment.
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Figure 2.10 - Diagram ofAxoclamp-2B system.
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2.4 Chemical Reagents
To investigate the mechanotransduction pathway induced by mechanical stimulation
and the effect ofmethotrexate (MTX), a variety of reagents including cytokines and
receptor antagonists were added to cell cultures separately, or in conjunction with
MTX. Chemical reagents were still in contact with HBC during the standardised
stimulation procedure and also when the post-stimulation measurements were being
made. These chemical reagents and the concentrations utilised are detailed in Table
2.2.
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10 nM Scheven et
al, 1995.





































A3 receptor antagonist 100 nM Mitchell et
al; 1999.
IL-ip R&D* Recombinant cytokine 10 ng/ml Salter et al;
2000.
Table 2.2 - Chemical Reagents used throughout these studies. *Abingdon, England.
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2.5 Methylene Blue Cell Adhesion Assays
Flat bottomed, 96 well tissue culture plates (Nunc) were coated with 10 pg/ml of the
extracellular matrix (ECM) proteins fibronectin (FN) (Sigma) or type 1 collagen
(Coll 1) (Gibco) in 50 pi PBS overnight at 4°C. The following day, the ECM
proteins were removed using a sterile pipette and non-specific binding was blocked
with 100 pi filter sterilised bovine serum albumin (BSA) (2 mg/ml) for 1 hour at
37°C, 95% O2, 5% CO2. HBC were removed from tissue culture flasks using EDTA
and washed with PBS as described in section 2.1.2. Following the PBS washes, cells
were resuspended in serum free medium. The cell suspension was filtered through a
100-micron cell strainer (Falcon) and the cell number was assessed using a
haemocytometer as described in section 2.1.3. The cell suspension was made up to a
final concentration of 3.0x105 cells per ml in serum free medium. lOOpl of cell
suspension was transferred to respective wells in the test plate and the plate was
incubated at 37°C, 95% O2, 5% CO2, for 3 hours. After the incubation period, wells
were washed gently with 100 pi PBS, taking especial care not to touch the bottoms
of the wells with the pipette tip as so not to dislodge any adherent cells and 100 pi of
4% formalin was added to each well. The cells were fixed at room temperature for 1
hour. The plate was centrifuged at 1000 rpm for 5 minutes and the formalin removed
using a pipette. Pre-filtered methylene blue (100 pi, 1% in dFEO) was added to each
well and the plate was incubated at room temperature for 30 minutes. The methylene
blue was removed and the wells were washed several times in distilled water until
the washes ran clear. HC1 (100 pi, 0.1N) was added to each well for 5 minutes and
mixed thoroughly to ensure the dye was properly resuspended. The plate was read at
630 nm. The number of cells present is proportional to the absorbance at 630 nm
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Figure 2.11 - Methylene blue cell adhesion assay standard curve. The
absorbance at 630 nm is proportional to the amount ofmethylene blue bound,
which is proportional to the number of adherent cells. Values are
representative of three experiments carried out in triplicate ± SEM.
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2.6 Cell Viability Assays.
2.6.1 Lactate dehydrogenase (LDH) assays.
To examine the effects ofMTX on cell toxicity LDH assays were performed using a
commercially available kit (Sigma), which is based upon the technique developed by
Cabaud and Wroblewski (Cabaud and Wroblewski, 1960). This colorimetric assay
kit was originally developed to allow determination of LDH concentrations in serum
and the protocol was modified accordingly to allow quantification of LDH levels in
HBC supernatants. LDH is a stable cytosolic enzyme, which is released from the
cell upon its death and therefore the presence of LDH is an indication of cell
necrosis.
HBC, cultured in 12-well plates (Table 2.1) were incubated with 1 pM, 50 nM or 1
nM MTX or sterile PBS for 90 minutes at 37°C. Triton-X 100 (0.2%) was used as a
positive control. Following the incubation period, the culture medium (sample
supernatant) was removed and stored at room temperature. Sigma pyruvate solution
(1 ml) was added to a Sigma NADH vial and heated in a 37°C H2O bath for 5
minutes. Aliquots (100 pi) of the pyruvate / NADH mixture were pipetted into
microfuge tubes and 10 pi of sample supernatant added to appropriate tubes. The
tubes were vortexed to mix and placed in a 37°C water bath for 30 minutes. The
tubes were removed from the water bath and Sigma colour reagent (100 pi) was
added to each tube and incubated at room temperature for 20 minutes. NaOH (1 ml
of 0.4N in distilled water) was added to each tube and vortexed to mix. Samples
were transferred to a sterile flat-bottomed 96 well plate (200 pi per well). After at
least 5 minutes, but not more than 30 minutes absorbance was read at 450 nm versus
distilled water as a reference. The absorbance at 450 nm is inversely proportional to
the LDH concentration.
2.6.2 Acridine orange staining.
To check for altered levels of apoptosis following incubation with MTX, HBC were
stained with acridine orange (Sigma), a fluorescent nucleic acid stain (Carmichael et
al, 1980). HBC, cultured in 6-well plates (Table 2.1) were incubated with 50 nM
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MTX or PBS control at 37°C for 90 minutes. Following the incubation period, the
medium was removed from the wells and the cells were washed gently with 2 ml
sterile PBS using a pipette. 1 ml acridine orange (100 pg/ml in PBS) was added to
each well, the wells were coverslipped using alcohol cleaned coverslips and the cells
were examined immediately under a Zeiss axiphot fluorescence microscope for the
presence of apoptotic nuclei.
2.6.3 MTT ([3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazonium
bromide] assays
The MTT assay is a simple and reliable colorimetric assay to assess cell number in
drug toxicology studies. It is based on the ability ofmitochondrial succinate
dehydrogenase to catalyse conversion ofMTT to a blue formazan product. The cells
must be viable for the reaction to occur. HBC, cultured in 96-well plates (Table 2.1)
were incubated with 50 nM MTX (or PBS control) at 37°C, 95% O2, 5% CO2, for
various lengths of time before the assay was performed (24h, 6h, 3h or lh). Triton-X
100 (0.2%) was included as a positive control. After the incubation period, the
culture supernatant was removed and the cells were washed gently with PBS. MTT
working solution was made up by adding 1.6 ml ofMTT stock (10 mg/ml in PBS)
(Sigma) to 5.4 ml of serum-free MEM. 100 pi ofworking solution was added to
each well and the cells were incubated at three hours in the dark at 37°C, 95% O2,
5% CO2. Following incubation, the MTT solution was removed and the cells were
gently washed with PBS. 100 pi dimethyl sulfoxide (DMSO) was added to each
well to dissolve the formazan salt and the plate agitated gently for a few seconds.
The plate was then read using a spectrophotometer at a wavelength of 630 nm within
30 minutes of the addition of the DMSO. The absorbance is proportional to the
number of viable cells.
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2.7 Immunofluorescent staining of cultured HBC using
rhodamine (TRITC) labelled phalloidin.
Effects ofMTX on the integrity of the actin cytoskeleton were investigated using
rhodamine (TRITC) labelled phalloidin, a fluorescent phallotoxin that can be used to
identify filamentous actin (Faulstich et al, 1983). HBC, cultured in 58 mm culture
dishes were incubated with 50 nM MTX or sterile Tris buffered saline (TBS) for 30
mins at 37°C, before being mechanically stimulated as described previously in
section 2.2. Following mechanical stimulation, cells were fixed using 4% buffered
formalin at room temperature, for 5 minutes. The formalin was removed using a
sterile pipette and the cells were permeabilised using 1 ml 1% Triton-X 100 for 5
minutes at room temperature. Triton-X 100 was removed using a pipette and the
cells were washed using 2 ml TBS accompanied by gentle agitation at room
temperature for 5 minutes. This wash step was repeated a further two times. The
TBS was removed using a pipette and the cells were treated with 1 ml rhodamine
conjugated phalloidin (Sigma) (1:100 in 1 ml TBS) for 30 minutes. As rhodamine
conjugated phalloidin is light sensitive, the plate was wrapped in aluminium foil
during this and all subsequent steps. The phalloidin was removed and the cells were
washed using 2 ml TBS with gentle agitation at room temperature for 5 minutes.
This wash step was repeated a further two times. The cells were then mounted in
alcohol-cleaned coverslips using Vectashield (Vector Laboratories, Burlingame), to
help prevent fluorescence quenching. The edges of the coverslip were sealed with
clear nail varnish. The cells were visualised using a Zeiss axiphot fluorescence




For immunocytochemistry, HBC cultured in 58 mm culture dishes were fixed using 2
ml methanol/acetone (1:1) at -20°C for 20 minutes. The methanol/acetone was
removed using a pipette and the plates were air dried and then washed with 2ml PBS.
The PBS was removed using a pipette and the cells were permeabilised with 0.1%
Triton -X 100 for 5 minutes at room temperature with agitation. Triton-X 100 was
removed using a pipette and the cells were washed using 2 ml PBS at room
temperature, for 5 minutes with agitation. This wash step was repeated a further two
times. Non-specific binding by the cells was blocked by incubating them with
normal rabbit serum (diluted 1:5 with PBS) for 10 minutes at room temperature with
agitation. The serum was discarded and cells were incubated with 1 ml of the
appropriate primary antibody for 1 hour at room temperature with agitation.
Antibodies were diluted optimally in PBS (Table 2.3). The antibody was discarded
and cells were washed using 2 ml PBS at room temperature, for 5 minutes with
agitation. This wash step was repeated a further two times. Non-specific binding
was blocked using normal rabbit serum (diluted 1:5 in PBS) for 10 minutes at room
temperature with agitation. Cells were incubated with biotinylated rabbit-anti-mouse
secondary antibody (diluted 1:300 in 20% normal rabbit serum). Cells were washed
using 2 ml PBS at room temperature, for 5 minutes with agitation. This wash step
was repeated a further two times. Cells were incubated in Avidin-biotin complex -
horseradish peroxidase (ABC-HRP) complex for 30 minutes at room temperature
with agitation. ABC-HRP was removed and cells were washed using 2 ml PBS at
room temperature before being visualised using diaminobenzidine (DAB) substrate
for 3 minutes. DAB substrate was removed and discarded and cells were washed
gently in running tap water and lightly counterstained in haematoxylin. Cells were
'blued up' using Scotts Tap Water Substitute (STWS) and mounted using
glycerokPBS (9:1). The edges of the coverslip were sealed using nail varnish. The
cells were visualised using an Olympus CX2 microscope.
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2805.31 R&D Systems 1:10
Mouse Anti-
Human IL-1 RI
35730.111 R&D Systems 1:20
Mouse Anti-
Human IL-1 RII
32437.111 R&D Systems 1:20
Table 2.3 - Monoclonal primary antibodies used to perform immunocytochemistry.
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2.9 Staining for Alkaline Phosphatase.
HBC, cultured in 6-well plates were stained for alkaline phosphatase, which is a
useful indicator of the differentiated osteoblast phenotype. Cell culture medium was
removed and the cells were washed using 2 ml sterile PBS. Nitro blue tetrazolium
chloride / 5-bromo-4-chloro-3-indolyl phosphate, toluidine salt (NBT/BCIP) stock
solution was diluted 1:50 in buffer (0.1 M Tris-buffer, pH 9.5, 0.05 M MgCh, 0.1 M
NaCl) and 2ml of this solution was added to each well. The plates were covered in
aluminium foil and incubated at room temperature for 2 hours. During the
incubation period, the plates were placed upon a rocking platform. Following the
incubation period, HBC were washed two times using sterile PBS and the colour was
allowed to develop on the bench for 2-3 minutes. The cells were then fixed in 2 ml
70% (v/v) ethanol at 4°C for 5 minutes. The ethanol was removed, and the cells
were counterstained with neutral red for 1 minute at room temperature. Neutral red
was removed by rinsing with tap water, the cells were cover slipped using an
aqueous mount, and the edges were sealed with nail varnish. The cells were




HBC, cultured on 58 mm culture dishes, were incubated for 30 minutes with 50 nM
MTX or PBS control for 30 minutes before induction of 20 minutes mechanical
stimulation. Following mechanical stimulation, RNA was extracted immediately or
the dishes were incubated at 37°C, 95% O2, 5% CO2 for 1, 3, 6 or 24 hours before
RNA extraction.
To extract the RNA, the culture medium was poured from the dishes and the cells
washed gently with 5 ml sterile PBS. 750 pi RNA extraction medium (4 M
guanidine isothiocyanate, 0.75 M sodium citrate, 10% (wt/vol) lauryl sarcosine and
7.2 pl/ml P-mercaptoethanol) was added directly to the cells. The plates were
swirled gently for 1 minute at room temperature to ensure all cells were lysed. Plates
were sealed with parafilm and stored at -20°C until required.
The plates were thawed at an angle to pool the solution and as much of the solution
as possible was transferred to a DNase / RNase - free microfuge tube. To each tube,
75 pi of 2 M sodium acetate (pH 4.5) was added and the tubes were inverted several
times to mix the solution. To each tube, 750 pi of a phenol (pH 4.5)/chloroform mix
(1:1 mix) was added and the tubes were vortexed to mix and incubated on ice for 15
minutes. Following the incubation period, tubes were centrifuged at 13,000 g for 15
minutes at 4°C. Following centrifugation, as much of the clear aqueous phase as
possible was transferred to a fresh RNase / DNase-free microfuge tube. The tubes
were centrifuged at 13,000 g for 10 minutes at room temperature to pellet RNA. The
RNA pellet was washed in 500 pi ethanol and air-dried at 37°C. Once dry, the pellet
was resuspended in 30 pi sterile RNase-ffee water and stored at -80°C until required.
2.10.2 RNA Quantification
RNA was quantified using a Biomate II spectrophotometer and 600 pi quartz
cuvettes. The absorbance of 6 pi RNA in a total of 600 pi was measured using
RNase-free water. RNase-free water was used to zero the instrument. Quantified
RNA was stored at -80°C until required for reverse transcription reactions.
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2.11 Polymerase Chain Reaction (PCR) Methods.
2.11.1 Primer design
The sequences used for PCR primers came from publications or were designed in-
house using mRNA sequences obtained from the GenBank database held at the
National Centre for Biotechnology Information web site (Table 2.4). Wherever
possible primers were designed which were intron spanning to minimise the chances




Sequence 5'=> 3' (S=sense, AS=anti-sense) Product
Size (bp)
Reference
GAPDH J0438 S = CCA CCC ATG GCA AAT TCC ATG GCA
AS = TCT AGA CGG CAG GTC AGG TCC ACC
600 Designed in-
house.
Collagen 1 AF017178 S = AAG ATG GAC TCA ACG GTC TC
AS = AAC CAG ACA TGC CTC TTG TC
523 Designed in-
house.
Osteopontin NM_000582 S = ATG AGA ATT GCA GTG ATT TG
AS = TTT TGA CCT CAG TCC ATA AA
468 Designed in-
house.
BMP-4 X56848 S = CAG CGG TCC AGG AAG AAG AAT AAG
AS = TCT GCA CAA TGG CAT GGT TG
188 Ikegame et
al, 2001.
Osteocalcin NM_000711 S = ATG AGA GCC CTC ACA CTC CT
AS = GTCAGC CAA CTC GTC ACA GTC C
255 Kuliwaba et
al, 2000
Table 2.4 - Details ofPCR primers used throughout these studies.
2.11.2 Reverse Transcription (RT) Reactions.
RT reactions were performed using sterile 0.5 ml RNAse / DNAse-free tubes and
each RT reaction contained 0.5 pg RNA, 0.25 ng Oligo dT and 38.2U RNAse
inhibitor. The reaction volume was made up to 11 pi using RNAse free water.
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Tube contents were mixed thoroughly and then pulsed in a micro-centrifuge to
ensure contents were gathered at the bottom of the tube. Contents were then
denatured by heating for 10 min at 70°C on an Omn-EIM thermal cycler (Hybaid,
Teddington, Middlesex, UK). Following this 10-minute denaturation, 0.01M
Dithiothreitol (DTT), 0.1mM of each 2' Deoxynucleoside 5'-Triphosphates (dNTPs),
lx RT reaction buffer and 200U superscript II was added to each tube (Note - The
above volumes are those added for 0.5 pg RNA. For larger quantities all reagents
are scaled up accordingly except RNAse inhibitor - 38.2U is sufficient for up to 60
pi final volume).
The tubes were then placed on the Omn-ErM thermal cycler for 1 hour at 42°C and
70°C for 10 minutes to allow the RT reaction to proceed. Once the RT reactions
were complete, synthesised cDNA was stored at -20°C until required for PCR.
2.11.3 PCR Protocol.
PCR reactions were performed using sterile 0.5 ml RNAse / DNAse-free tubes and
each PCR reaction was made up to a final volume of 20 pi. A typical 20 pi PCR
reaction contained 16 mM ammonium sulphate, 67 mM Tris/HCl, pH 8.8, 0.01%
(vol/vol) Tween 20, 1 pM of each primer, 2 pi cDNA and 0.25 U Taq polymerase.
The magnesium chloride (MgCl2), dNTP and BSA concentrations varied according
to the primer pair and are summarised in Table 2.5.
Primer Pair MgCl2 dNTP's BSA
(mM) (pM) (wt/vol)
GAPDH 2.5 100 0.1%
Collagen 1 2 50 0.1%
Osteopontin 2 100 0.1%
BMP-4 1 200 nil
Osteocalcin 1.5 200 0.1%
Table 2.5 - Primer specific conditions required for PCR reactions.
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2.11.4 PCR Programs.
The following programs were run on an Omn-E™ thermal cycler with tube
temperature control (Hybaid) (Table 2.6). Once the appropriate number of cycles
had been completed or the program had finished, PCR samples were stored at -20°C
until required for agarose gel electrophoresis.





































Table 2.6 - Conditions used for PCR reactions.
2.11.5 Agarose gel electrophoresis
PCR samples were run on 1% agarose (Sigma) gels. Agarose gels were
manufactured bymixing 1.5 g agarose with 150 mis lx Tris/acetic acid/EDTA
(TAE) buffer in a glass conical flask and heating in a microwave until all the agarose
had dissolved. After heating the agarose solution was allowed to cool at room
temperature. Once the agarose had cooled enough to comfortably hand hold, but was
still liquid, it was poured into the a gel tray and the relevant number ofwells were
created by inserting combs, ensuring no air-bubbles were present. Once solid, the
agarose gel (and tray) were transferred into the gel tank which was filled with lx
TAE so that the gel was completely submerged in the buffer.
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PCR samples were allowed to defrost at room temperature. Once liquid, 20 pi of 2x
Orange-G gel loadng dye was added to each sample and mixed thoroughly. The
samples were then pulsed in a micro centrifuge to ensure the contents were gathered
at the bottom of the tube before loading the sample in to the appropriate wells in the
agarose gel using a pipette. Gel electrophoresis was run at 75V for 30-60 min
depending on how far it was necessary to run the samples. Once the gel had run far
enough, the power was disconnected and the gel was removed from the gel tank and
gel tray and transferred to a box specifically used for ethidium bromide staining. The
gel was completely submerged in ethidium bromide (2 pg/ml) and left to soak for 15-
30 min. Once the gel was stained the ethidium bromide was poured back into the
bottle for re-use and the gel was visualised.
2.11.6 Gel Visualisation
Gels were visualised by UV trans-illumination. Images were saved to floppy disk
and were printed using the Enhanced Analysis System (EASY, Scotlab, Coatbridge,
Lanarkshire, Scotland). This program allows semi-quantitative analysis ofPCR
products. It designates the brightest band on the gel a value of 1000 (background =
0) and thus can designate all the other bands a value between 0 and 1000 depending
on their intensity. Therefore this program allows the intensity ofPCR bands (which
is proportional to the amount ofPCR product) to be semi-quantitatively assessed
following a range of different treatments and conditions.
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.12 Statistics
• The following generalised linear model was fitted to the data obtained from
adult and juvenile bone cells before / after mechanical stimulation.
Mij = k + ocj + pj
where k, a and p are parameters to be estimated from the data for i = c (child)
or a (adult) and j = b (before MS) or af (after MS). We set ac = -aa and pb =
"Paf-
This model was used to investigate two hypotheses;
1. Mechanical stimulation has no effect on membrane potential.
2. The membrane potentials of adult and juvenile bone cells are not
significantly different.
• For all other experiments, the mean, standard deviation (SD) and standard
error of the mean (SEM) were determined in each experiment. For statistical
comparisons, when the F-ratio of the two variances reached significance, the
non-parametric Mann-Whitney test was used. When the ratio did not reach
significance, the Student's t test was used.
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CHAPTER 3.
THE PHENOTYPE OF HUMAN BONE CELLS
(HBC) IN CULTURE.
3.1 The Morphology of Cultured HBC.
HBC were obtained by outgrowth from trabecular bone fragments obtained from
patients undergoing orthopaedic surgery (Figure 3.1). Morphologically, the cultures
obtained were heterogeneous, containing approximately equal proportions of spindle
shaped fibroblastic cells and polygonal osteoblast-like cells.
Osteoblasts exhibit several characteristics useful in their identification, including
alkaline phosphatase activity (Doty et al, 1984), the ability to form a mineralised
extracellular matrix comprised of type 1 collagen, and certain bone specific NCP's
such as osteocalcin and osteopontin (Gehron Robey et al, 1989). To identify whether
the osteoblast-like cells obtained in-vitro expressed similar markers to those of
osteoblasts in-vivo, these cells were assessed for expression of alkaline phosphatase
and mRNA for the bone cell markers type 1 collagen, osteocalcin, osteopontin and
bone morphogenetic protein 4 (BMP-4).
Alkaline phosphatase staining was performed both on resting HBC and HBC which
had been incubated for various lengths of time (0-4 days) with 1-25-
dihydroxyvitamin D3 (Vitamin D3). Vitamin D3 has been shown to be a potent
inducer of osteoblast differentiation (Scheven et al 1995). Alkaline phosphatase is
secreted by osteoblasts (Gehron Robey et el, 1989) and is commonly used as a
biochemical (Osdoby et al, 1981; Beresford et al, 1986) and histochemical (Osodby
et al, 1981; Thavarajah et al, 1993) marker to identify osteoblasts. Osteoblasts stain
positively for alkaline phosphatase whereas fibroblasts are negative for alkaline
phosphatase staining. The results demonstrated considerable alkaline phosphatase
staining in the HBC cultures (Figure 3.2a) and this staining was increased in a time
dependent manner following exposure to Vitamin D3 in culture (10 nM) for 0-4 days
(Figure 3.2b).
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Further characterisation of the HBC was achieved by the use of RT-PCR. RT-PCR
was performed using primers specially designed to investigate expression of collagen
type 1, osteocalcin (Kuliwaba et al, 2000), osteopontin and BMP-4 (Ikegame et al,
2001). Collagen type 1 fibres comprise 95% of the organic part of bone (Athanasou,
1999), the remainder consisting of non-collagenous proteins of bone, which include
osteocalcin and osteopontin (Athanasou, 1999). Osteocalcin, also known as bone-gla
protein, is one of the most abundant non-collagenous proteins of bone. The exact
role of osteocalcin in bone metabolism is still not known but may involve bone
resorption (Gehron Robey, 1989). The presence of osteocalcin appears to be unique
to bone (Nishimoto et al, 1979) and dentine (Linde et al, 1980). Osteopontin is an
acidic sialoprotein, which is implicated in general cell attachment (Robey, 1989).
BMP-4 is a member of a cytokine family that stimulates proliferation of both
osteoblasts and chondrocytes, and causes an increase in matrix production
(Buckwalter et al, 1996; Rosen et al, 1992). The results obtained using RT-PCR in
this study demonstrate that, in-vitro, HBC produce collagen type 1, osteocalcin,






Figure 3.1 — The appearance ofHBC in culture.
HBC are obtained by outgrowth from trabecular bone fragments obtained from
orthopaedic surgery. The culture is heterogeneous, consisting of both fibroblasts and






















Figure 3.2 - Expression of alkaline phosphatase by HBC in culture.
(a) Alkaline phosphatase expression by unstimulated HBC (purple staining). Cells
are counterstained with neutral red (original magnification x 200).
(b) Alkaline phosphatase expression following incubation over a 4-day period with
10 nM Vitamin D3. Results are expressed as % ofpositively stained cells, n = 2














Figure 3.3 — RT-PCR shows expression of collagen 1, osteocalcin (OC), osteopontin
(OP) and bone morphogenetic protein-4 (BMP-4) mRNA.
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3.2 HBC in Culture Express Interleukin ip (IL-ip) and
Interleukin ip Receptors Type I and II (IL-ip RI and
II).
It has been shown that following mechanical stimulation, HBC in culture exhibit
considerable cell membrane hyperpolarisation, and that this occurs as a result of the
activation of a novel signalling pathway which involves an Interleukin- ip (IL-ip)
autocrine/paracrine loop (Salter et al 1997; Salter et al 2000).
Immunocytochemistry was performed to identify whether the HBC in culture express
IL-ip and its receptors IL-ip RI and II. The cells were subjected to
immunocytochemical staining using monoclonal antibodies against IL-ip and IL-ip
RI and II. The expression of IL-ip was studied in both non-stimulated cells and cells
which had been mechanically stimulated at 0.33 Hz, 30 mmHg for 20 minutes. The
results demonstrated that IL-ip is present in both non-stimulated and mechanically
stimulated cells (Figure 3.4a). The results also suggest that IL-ip expression is
higher in non-stimulated cells when compared to mechanically stimulated cells, as
the resting cells are more intensely stained when compared to cells stained post
mechanical stimulation. It is appreciated however, that immunocytochemistry is, at
best only a rough guide, and not a quantitative technique. The expression of IL-lp
RI and II was studied only in non-stimulated cells. The results show that HBC in



















Figure 3.4a — Immunocytochemical staining of cultured HBC: expression of IL-ip in
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Figure 3.4b - Imxnunocytochemical staining of cultured HBC: expression of IL-lp RI
and II in non-stimulated cells (original magnification x 100).
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3.3 Discussion.
3.3.1 HBC Obtained by Outgrowth from Trabecular Bone
Fragments Exhibit an Osteoblastic Phenotype.
This study has demonstrated that HBC can be obtained by outgrowth from human
trabecular bone fragments, and that these cells exhibit a phenotype which is
characteristic of osteoblastic cells. Alkaline phosphatase activity is high in resting
osteoblasts and increases following incubation with vitamin D3. Although the
production of alkaline phosphatase is helpful in the identification of osteoblasts,
alkaline phosphatase expression is not specific to bone cells and is expressed in a
number of different cell types including endothelial cells (Goldring, 1978; Beresford
et al, 1984). More important distinguishing features of osteoblastic cells include the
production of an extracellular matrix comprising predominantly of type 1 collagen
(without type III collagen) and certain bone-specific non-collagenous proteins such
as osteocalcin (Aufmkolk et al, 1985; Robey et al, 1985) and osteopontin. In the
present study, RT-PCR has been used to show that the HBC obtained by outgrowth
from trabecular bone fragments exhibit a phenotype consistent with that of the
osteoblast in-vivo. Using RT-PCR, it has been demonstrated that these cells express
mRNA for type 1 collagen, osteocalcin, osteopontin and BMP-4.
Every bone explant is extremely heterogeneous, containing a wide range of different
cell types. These cell types include osteoblasts, fibroblasts, osteocytes, osteoclasts,
marrow stromal cells, endothelial cells and haemopoietic cells. Given this cell type
heterogeneity, the method used to extract the bone cells will ultimately determine the
characteristics of the resulting culture.
The HBC cultures obtained in these studies are grown directly from trabecular bone
fragments which have been washed vigorously in sterile PBS to remove any non¬
adherent marrow stromal cells, but have not been subjected to any form of enzymatic
digestion (Beresford et al, 1984). The resulting culture is heterogeneous containing a
mixture of osteoblast-like cells and fibroblasts. Osteocytes are not usually seen as
they are buried deep within the trabecular bone, housed within their lacunae. This
method ofbone cell extraction has several advantages and disadvantages when
100
compared to other extraction methods. Whereas no in-vitro system can truly
represent the in-vivo environment, it can be argued that this method of bone cell
extraction is comparable to the in-vivo situation as a mixture of different cell types
are present (osteoblast-like cells and fibroblasts) which are very diverse in terms of
differentiation state (evidenced by increases in alkaline phosphatase expression
following vitamin D3 incubation). However, depending on the nature of the sample
(male versus female, young versus old) there is potential for outgrowth of different
populations of cells in varying proportions (Robey et al, 1985), so that cultures from
individual donors may be very diverse in terms of the ratios of different cell types
present, and therefore difficult to compare. The heterogeneity of the culture also
makes it difficult to study the effects of stimuli on osteoblasts specifically, as all the
cells in the culture are exposed to the stimuli. This is especially a consideration
when performing techniques such as RT-PCR where, following stimulation, all the
cells in the culture are lysed and subjected to analysis. Therefore, one cannot be sure
which cells in the culture are responding to the stimulation. It is not known if all the
cells in the culture respond to the stimulation in a similar or a different manner, or if
only a proportion of the cultured cells respond. In the case of electrophysiology, the
problem is not quite as prevalent as one can distinguish between osteoblasts and
fibroblasts when observing the cells down the microscope, and thus ensure that the
desired cell type is impaled. Distinguishing between different cell types becomes
more difficult as cell confluency increases, as the close proximity of the cells makes
it difficult to distinguish the spindle shaped morphology of the fibroblast from the
polygonal morphology of the osteoblast. This is therefore the reason why
electrophysiological experiments are performed on sub confluent cultures.
Another method commonly employed in the extraction of bone cells from trabecular
bone fragments is the release of cells by sequential digestion with collagenase and
trypsin (Luben et al, 1976). Using this technique, osteoblastic cells are typically
released at the 1 to 2 hour time points (Wong et al 1975). This technique has the
advantage that it can provide cells of a later, more mature osteoblastic phenotype,
since less well differentiated outer surface cells have been removed by the enzymatic
digestion. In addition, this method minimises contamination by fibroblastic cells,
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which reduces the problem of fibroblastic overgrowth in the culture and makes it
easier to elucidate osteoblast specific responses. This method has the limitation
however that relatively low numbers of osteoblasts are obtained and that in order to
achieve sufficient numbers of osteoblasts for experimentation, the cells are subject to
lengthy periods of culture and multiple passaging. It has been suggested that older
cell cultures may dedifferentiate towards a fibroblastic or preosteoblastic phenotype,
as it has been shown that older HBC cultures express increasing levels of collagen III
which is known to be expressed in fibroblasts but not in osteoblasts (Scott et al;
1980). A modification of this technique is to eliminate all soft-tissue elements (even
though some are of the osteoblast lineage), by pre-treatment of the fragment with
collagenase followed by culture of the 'bare bone' explant (Robey et al, 1985; Robey
et al 1995). Scanning electron microscopy has documented the emergence of cells
from these collagenase treated fragments which have osteoblastic phenotype.
Irrespective of the exact method of bone cell extraction from trabecular bone
fragments, it is clear that the cells obtained will be of osteoblastic lineage (Marie,
1989; Gundle, 1995; Voegele, 2000). As such, they serve as useful tools in the
determination of bone cell responses to stimuli, the evaluation of intracellular
signalling pathways, and can provide a source ofprotein or mRNA for studies at the
protein or genomic level (e.g. Davies et al, 2000).
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CHAPTER 4.
THE EFFECT OF CYCLIC MECHANICAL
STIMULATION ON HBC IN CULTURE.
4.1 Electrophysiological Response of HBC to Cyclical
Mechanical Stimulation.
HBC obtained from adult and juvenile donors were subjected to mechanical
stimulation at 0.33 Hz for 20 minutes. Pressure pulses of 0.025 atmospheres above
atmospheric pressure (30 mmHg) were used and resulted in -4000 pstrain on the
base of the 58 mm plastic culture dish. The electrophysiological response of both
adult and juvenile HBC in culture to this regime ofmechanical stimulation was
found to be membrane hyperpolarisation. The baseline resting membrane potential
and degree of response varied from experiment to experiment when cells from
different donors were used. Possible reasons for this are discussed in section 4.4.1.
The data are assumed to be normally distributed, an assumption that seems
reasonable given a visual inspection of dotplots compiled from the data (Figure 4.1),
and to have equality of variances, which also seems reasonable. Therefore, a
generalised linear model was fitted to the data collected pre- and post mechanical
stimulation from both adult and juvenile HBC (Appendix 1). The model used was;
Pij=k+ cti + pj
where k, a and p are parameters to be estimated from the data for i = c (child) or a
(adult) and j = b (before MS) or af (after MS). We set ac = -aa and Pb = -Paf-
This model was used to investigate two hypotheses;
1. Mechanical stimulation has no effect on membrane potential.
2. The membrane potentials of adult and juvenile bone cells are not
significantly different.
Initially, a model including an interaction term between donor age category and pre-
or post mechanical stimulation was fitted which allowed investigation of the
hypothesis that the magnitude of response of adult and juvenile cells is not
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significantly different. This interaction term was not found to be significantly
different from zero, indicating that both juvenile and adult membrane potentials
increase equally following mechanical stimulation, (illustrated graphically in
Figure 4.2). Such findings lead to the acceptance of this hypothesis and therefore, as
a result, this parameter was excluded from the model. The effects of transforming
the data, (i.e. into natural logarithms and square roots) were also investigated. Such
transformations did not improve the fit much and so were omitted.
The resulting parameter estimates are given in Table 4.1.
Parameter Estimate Standard Error P-Value
k (constant) 40.9194 0.4102 <0.0001
«c -0.9806 0.4102 0.017
aa 0.9806 0.4102 0.017
Pb -10.1543 0.4100 <0.0001
Paf 10.1543 0.4100 < 0.0001
Table 4.1 - Parameter estimates for generalised linear model.
The p-values in the above table correspond to the null hypothesis that the parameter
is 0. The p-values are all significant, indicating that ac * aa and (3b * paf.
This means that the null hypothesis that the experiment has no effect on membrane
potential can be rejected, as pcb is significantly different from pcaf. Similarily, pab is
significantly different from paaf.
The results also mean that the null hypothesis that the membrane potentials of adult
and juvenile bone cells are equal can be rejected, as there is a significant difference
between pCb and pab and between pcaf and paaf. This difference appears to be small
however (estimated at 1.9612). What we can say however, is that the effect ofMS
on membrane potential is the same on both adult and juvenile HBC, due to the
rejection of a significant interaction term.
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In conclusion:
• Mechanical stimulation causes significant cell membrane
hyperpolarisation in both juvenile and adult cells.
• There is a significant difference between the resting membrane
potentials levels between adult and juvenile cells. Similarily, there is
a significant difference in the membrane potentials observed (Figure
4.2) following mechanical stimulation between adult and juvenile
cells.
• There is no significant difference in the magnitude of the response to
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Figure 4.1 - Dotplot to show distribution of data.
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Child
Figure 4.2 - Graph to illustrate the results of the statistical analyses.
(i) There is a significant difference between the resting membrane potentials levels
between adult and juvenile cells (x). Similarily, there is a significant difference in the
membrane potentials observed following mechanical stimulation between adult and
juvenile cells (y).
(ii) There is no significant difference in the magnitude of the response to mechanical
stimulation when comparing adult and juvenile cells (straight lines constructed for
juvenile and adult raw data have equal gradients).
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4.2 Interleukin-13 (IL-ip) is Released From Mechanically
Stimulated HBC and Can Induce Membrane
Hyperpolarisation.
The full numerical results of individual electrophysiological experiments from which
the values given in the Tables in this chapter are derived are given in Appendix I.
Results shown in this chapter are from a single representative experiment.
Experiments were repeated from HBC derived from at least 3 adult or juvenile
donors and were reproducible between donors.
Previous research has identified a transferable factor, shown to be IL-ip, which is
released from HBC following mechanical stimulation and which acts in an autocrine
/ paracrine manner to induce cell membrane hyperpolarisation (Salter et al, 1997;
Salter et al, 2000). The stimulation chambers used in the present study are, however,
amodification of those used in the prior experiments, and therefore, it was necessary
to repeat experiments to ensure that the results obtained using the new stimulation
chambers are consistent with those previously obtained.
Conditioned Medium (CM) experiments were performed to confirm that, following
mechanical stimulation, a transferable factor (IL-1P) is released by the cells which
can cause cell membrane hyperpolarisation when transferred to resting cells. For
these experiments, a dish of HBC was stimulated by 0.33 Hz cyclic mechanical
stimulation and the medium (CM) immediately transferred to a dish of unstimulated
HBC, membrane potential being assessed 20 minutes after transfer ofmedia. In all
studies, at least three experiments were performed on different days under each
condition.
The results show that CM from cells stimulated by 0.33Hz mechanical stimulation,
when added to unstimulated bone cells for 20 minutes, resulted in cell membrane
hyperpolarisation of these cells (Table 4.2). These observations confirm the
presence of a soluble transferable factor secreted by 0.33 Hz mechanically stimulated
HBC. Recombinant IL-1 p (10 pg/ml) when added to resting HBC for 10 minutes,
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induced a membrane hyperpolarisation response that was similar in extent to that
seen following 0.33 Hz mechanical stimulation or CM transfer (Table 4.3). Previous
experiments, utilising neutralizing anticytokine antibodies against IL-lp, have
confirmed that IL-1 (3 is necessary for the membrane hyperpolarisation response to
mechanical stimulation (Salter et al 2000).
Table 4.2 - Effect of CM from HBC mechanically stimulated for 20 minutes, on the
membrane potential of previously unstimulated HBC.
Membrane potential f-mV)
(mean ± 1 SEM)
Stimulus n Resting Post MS Resting With-CM
(% change) (%> change)
0.33 Hz MS 5 27.6 ± 1.65 43.0 ±3.26 24.8 ± 1.03 37.8 ±1.07
(±56%)* (±52%)*
Results shown are from a single experiment and are consistent between experiments
and between cells from 4 different donors (Appendix I).
*
p < 0.05. MS = mechanical stimulation.
Table 4.3 - Effect of recombinant IL-ip on HBC membrane potential.
Membrane Potential (-ml)
(mean ±1 SEM)
Reagent n Resting With Reagent % change
IL-1P 5 29.4 ± 1.33 51.4 ±2.42 ±74.8*
Results shown are from a single experiment and are consistent between experiments
and between cells from 3 different donors (Appendix I).
*p <0.001.
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4.3 The Effect ofMechanical Stimulation of HBC on
Relative Levels of Collagen type 1 and Bone
Morphogenetic Protein - 4 (BMP-4) mRNA Expression.
Semi-quantitative RT-PCR was performed to investigate ifmechanical stimulation
has any effect on the relative levels of type 1 collagen (coll 1) and bone
morphogenetic protein-4 (BMP-4) mRNA expression in HBC. Throughout the semi¬
quantitative RT-PCR experiments, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was used as a control. GAPDH is a suitable control for these experiments,
as GAPDH transcription levels do not alter following mechanical or cytokine
stuimulation. Therefore, the use ofGAPDH primers serve as an internal reference,
allowing the experimenter to determine whether the transcription levels of the
mRNA of interest have altered in response to the experimental / test conditions.
Before commencing the semi-quantitative RT-PCR experiments, it was necessary to
determine the logarithmic phase of amplification for each primer pair used. This was
necessary to ensure that subsequent semi-quantitative RT-PCR experiments are
carried out within the exponential range for both the GAPDH primer pair and the
primer pair of interest.
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4.3.1 Determination of the Logarithmic Phase ofAmplification for
PCR Primer Pairs.
Prior to performing semi-quantitative RT-PCR, the exponential range of amplification
was determined for the GAPDH, collagen type 1 and BMP-4 primer pairs. In the cases
ofGAPDH and collagen type 1, PCR products were removed upon completion of every
second cycle between 18 and 34. In the case ofBMP-4, PCR products were removed
upon completion of every cycle between 22 and 36. PCR products were separated upon
a 1% agarose gel and quantified using the EASY imaging software.
For GAPDH, cycle numbers that lie between 22 and 30 fall in the exponential range
(Figure 4.3).
Cycle No
Figure 4.3 - PCR titration to determine the exponential range of amplification for
GAPDH primers, (a) Pooled data for 3 donors performed in duplicate (n=6). (b)
Representative scanned agarose gel.
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Figure 4.4 - PCR titration to determine the exponential range of amplification for
collagen type 1 primers, (a) Pooled data for 3 donors performed in duplicate (n=6).
(b) Representative scanned agarose gel.
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Figure 4.5 - PCR titration to determine the exponential range of amplification for BMP-
4 primers, (a) Pooled data for 3 donors performed in duplicate (n=6).
(b) Representative scanned agarose gel.
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4.3.2 Collagen type 1 mRNA Expression is Upregulated Following
Cyclical Mechanical Stimulation.
HBC, cultured in 58 mm culture dishes, were mechanically stimulated at 0.33 Hz, 30
mmHg for 20 minutes. Following stimulation, HBC were incubated at 37°C, 95%
CO2, 5% O2 for various lengths of time (0, 1,3, 6 or 24 hours). Following this
incubation period, RNA was extracted and quantified. RNA was reverse transcribed
to obtain cDNA. Semi-quantitative PCR was than performed to investigate the effect
ofmechanical stimulation on collagen 1 mRNA levels in HBC.
The results are shown in Figure 4.6. On the basis of previous experiments to obtain
the logarithmic phase of amplification for the GAPDH and collagen type 1 primers,
PCR samples were removed following either 26 or 30 cycles of amplification,
separated on a 1% agarose gel and quantified using the EASY imaging software.
Figure 4.6 demonstrates that collagen type 1 mRNA expression is increased in
response to 20 minutes 0.33 Hz mechanical stimulation after 1, 3, 6 and 24 hours
incubation compared to the non-stimulated (NS) control, although these increases do
not reach statistical significance (Mann-Whitney U-test). The increase in collagen
type 1 mRNA levels is gradual, reaching a peak 6 hours after stimulation. Collagen
type 1 mRNA levels are reduced at 24 hours post stimulation (compared to 6 hours)












Figure 4.6 - The effect ofmechanical stimulation on collagen type 1 mRNA expression
in HBC. Increased collagen type 1 mRNA expression following mechanical stimulation.
Pooled data for 3 donors performed in duplicate (n=6). Error bars are +1 SEM.
NS: non-stimulated; 0, 1, 3, 6 and 24: time in hours after 0.33 Hz mechanical
stimulation.
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4.3.3 BMP-4 mRNA Expression is Decreased Following Mechanical
Stimulation.
HBC, cultured in 58 mm culture dishes, were mechanically stimulated at 0.33 Hz, 30
mmHg for 20 minutes. Following stimulation, HBC were incubated at 37°C, 95%
CO2, 5% O2 for various lengths of time (0, 1, 3, 6 or 24 hours). Following this
incubation period, RNA was extracted and quantified. RNA was reverse transcribed
to obtain cDNA. Semi-quantitative PCR was than performed to investigate the effect
ofmechanical stimulation on BMP-4 mRNA levels in HBC.
The results are shown in Figure 4.7. On the basis of previous experiments to obtain
the logarithmic phase of amplification for the GAPDII and BMP-4 primers, PCR
samples were removed following either 26 or 30 cycles of amplification, separated
on a 1% agarose gel and quantified using the EASY imaging software. Figure 4.7
demonstrates that BMP-4 mRNA expression is significantly decreased (p < 0.01) in
response to 20 minutes 0.33 Hz mechanical stimulation after 3, 6 and 24 hours
incubation compared to the non-stimulated (NS) control (Mann-Whitney U-test).
There is also a decrease in BMP-4 mRNA expression 1 hour after mechanical


















Figure 4.7 - The effect ofmechanical stimulation on BMP-4 mRNA expression in
HBC. Decreased BMP-4 mRNA expression following mechanical stimulation (p <
0.01). Pooled data for 3 donors performed in duplicate (n=6). Error bars are +1 SEM.
NS: non-stimulated; 0,1,3,6 and 24: time in hours after 0.33 Hz mechanical stimulation.
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4.4 Discussion.
4.4.1 Mechanical Stimulation Activates an Integrin Dependant
Signalling Pathway in HBC.
It has previously been demonstrated that mechanical stimulation at 0.33 Hz results in
membrane hyperpolarisation ofHBC (Salter et al; 1997). The mechanotransduction
pathway involved has been shown to include as Pi integrin, stretch activated ion
channels, the actin cytoskeleton and tyrosine kinase activity. It has also been shown
that, following 0.33 Hz mechanical stimulation, IL-ip is released which acts in an
autocrine / paracrine way to initiate a signalling cascade which involves
phospholipase C, diacylglycerol (DAG) and protein kinase C (PKC), leading to the
activation of small conductance Ca+ activated K+ (SK) channels and resultant
membrane hyperpolarisation (Salter et al; 2000). Experiments utilising neutralising
antibodies have demonstrated that antibodies to IL-ip but not to other cytokines
studied, inhibited the hyperpolarisation response to mechanical stimulation (Salter et
al; 2000). It has also been shown that specific blockade of the asPi heterodimer with
inhibitory antibodies, incubation with Arg-Gly-Asp (RGD) containing peptides, or
disruption of the actin cytoskeleton with cytochalasin D inhibits mechanically
induced membrane hyperpolarisation but has no effect on the hyperpolarisation
produced by exogenously added IL-ip (Salter et al, 2000). These results suggest that
the integrin antibodies and RGD peptides have a role upstream of IL-ip release in
the mechanotransduction pathway, and also that aspi integrin acts as an HBC
mechanoreceptor, causing the activation of a distinct signalling pathway which leads
to the release of IL-ip.
The mechanical stimulation system used in the present study is a modification of that
described previously (Wright et al, 1992; Wright et al, 1996; Salter et al 1997,
Wright et al, 1997; Salter et al, 2000; Lee et al, 2000), and therefore a range of
experiments were repeated to confirm that the results obtained were consistent with
those previously reported. The new mechanical stimulation system differs from the
old system in several ways.
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In the new system a 58 mm culture dish ofHBC is supported on a rubber 'O' ring in
the stimulation chamber, creating a chamber above and below the culture dish. The
lid is screwed down and holds the dish in position. The lid and the 'O'-ring ensure
an airtight seal between the chambers below and above the dish. When pressure is
applied to the system, the gas enters the chamber below the culture dish via an inlet
valve. This causes an increase in pressure in the chamber below the culture dish,
which causes the base of the culture dish to curve upwards. As a consequence the
cells are subjected to strain (measured in pstrain).
In the old system, the culture dish was supported on a small cylinder, which was
attached to the base of the stimulation chamber. A tight seal was present between the
top of the cylinder and the culture dish. A space of volume 8 ml was present
between the base of the culture dish and the base of the chamber and the gas entered
this space via 18 holes, each 2.2 mm in diameter in the small cylinder. Cyclical
pressurisation of this system induced deformation and strain of the base of the culture
dish and its adherent cells due to a differential rate of rise ofpressure above and
below the tissue culture dish.
The new system has several advantages when compared to the old system. The
culture dish is deformed as a result of increased gas pressure on the underside of the
dish while the pressure of the upper side remains unchanged. Therefore, the cells are
subjected to stretch without being subjected to an increase in pressure or exposure to
nitrogen gas. Both systems have the disadvantage, however, that they do not have
the 95% O2, 5% CO2 humidified atmosphere of the tissue culture incubator, and
therefore cells being exposed to mechanical stimulation are deprived of both O2 and
CO2 throughout the course of the stimulation. It could therefore be argued that CO2
and O2 starvation (and not the cyclical mechanical stimulation) may account for the
change in membrane potential observed following 20 minutes stimulation. This
problem is overcome by placing the non-stimulated control plates in the stimulation
incubator alongside dishes being stimulated, which exposes them to the same O2 and
CO2 conditions as the stimulated dishes. As there is not a significant change to the
membrane potential of the control dishes following exposure to these conditions, it
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can be concluded that changes in the membrane potential of test plates must be as a
direct result of the cyclical mechanical stimulation. Both stimulation systems also
have the added complication that fluid shear may contribute to the strain sensed by
the cells, and thus to the response initiated by the cells. During the cyclical
mechanical stimulation, the strain on the base of the culture dish is 4000 pstrain,
which is equivalent to 0.40% deformation. Movement of fluid is slight but
noticeable to the naked eye, but it is not known how much this fluid shear contributes
to the mechanical stimulation sensed by the cells.
The present studies have demonstrated that HBC derived from trabecular bone show
a consistent and reproducible membrane hyperpolarisation response to 0.33 Hz when
mechanically stimulated using the modified system. CM experiments also suggest
that following mechanical stimulation, IL-ip is released and acts as a transferable
factor. These results are confirmed by experiments which utilise recombinant IL-ip
in place ofmechanical stimulation. Attempts to quantify IL-1P concentrations using
commercially available ELISA kits have proved unsuccessful. Possible reasons for
this include (a) that the concentration of IL-1 P is below the limit of detection for the
assay and (b) that IL-1 P release is a tightly regulated process and that, upon its
release, IL-1 p is immediately taken up by other HBC. In the present studies,
immunocytochemistry has been used to demonstrate the presence of IL-1 P in both
unstimulated and mechanically stimulated HBC. The presence of IL-1 Receptors I
and II have also been demonstrated in HBC. Whilst these observations are useful, a
quantitative assay would have provided more information.
It was noted whilst performing electrophysiological experiments that there was a
degree of variation between the baseline resting membrane potential when
comparing HBC obtained from different donors, although the degree of
hyperpolarisation observed following cyclical mechanical stimulation did not differ
significantly between donors. Cell confluency is thought to contribute to this, and
although cells were plated at the same density (5 xlO4 cells/ml) for every
electrophysiological experiment performed, after the 48-hour incubation period there
were noticeable variations in cell confluency between donors. Biological variance
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(i.e. age and sex of donor) is the most likely explanation for these differences. It has
been previously reported that resting membrane potential increases as the density of
the culture increases (Bard et al, 1974) (Figure 4.8), and it has been suggested that,
as cell confluency increases, there may be alterations in the permeability of the cell
membrane to sodium, chloride or potassium, the three ions principally responsible
for maintaining and altering membrane potential levels. It has also been shown that
the substrate on which cells are cultured can have effects on resting membrane
potential level (Bard et al, 1974), with fibroblastic cells cultured on collagen having
higher resting membrane potentials than the same cells cultured on plastic. Thus,
confluent cells may have higher resting membrane potentials, as they are likely to
have produced a considerable amount of extracellular matrix which they will have









Figure 4.8 - Effect of cell confluency on resting membrane potential.
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4.4.2 Collagen type 1 mRNA Expression is Upregulated Following
Cyclical Mechanical Stimulation.
This study has demonstrated that, following a single 20 minute period of 0.33 Hz
mechanical stimulation, collagen type 1 mRNA levels increase and remain elevated
for up to 24 hours post stimulation.
Several studies, utilising several different osteoblast-like cells and different in-vitro
mechanical stimulation techniques, have provided somewhat variable evidence
regarding the effect ofmechanical stimulation on collagen type 1 synthesis and
secretion. Some studies have reported increases in collagen type 1 synthesis
following mechanical stimulation whereas others have observed a decrease in
collagen type 1 synthesis following mechanical stimulation.
One study (Harter et al, 1995) reported that, following 48 hours mechanical
stimulation at a frequency of three cycles per minute, there is a 3.4 fold increase in
collagen type 1 mRNA expression compared to non-stimulated controls. This study
also utilised immunofluorescence to demonstrate that the increase in collagen type 1
mRNA can be attributed to an increase in the production ofprocollagen. Another
study (Buckley et al, 1990) has measured the synthesis and secretion of collagenous
and non-collagenous proteins following 24 - 72 hours ofmechanical stimulation at a
frequency of 3 cycles per minute. They reported that, following 24 hours of
mechanical stimulation, there is a small but not-significant increase in cellular
collagen type 1 synthesis. Following 72 hours of mechanical stimulation there was a
significant increase in collagen type 1 synthesis, although there did not appear to be
any significant changes noted in collagen secretion.
In contrast to the above results and those in the present study, several studies have
presented evidence that collagen type 1 synthesis is decreased following mechanical
stimulation (Ozawa et al, 1990; Brighton et al, 1991). One study (Brighton et al;
1991) reported that calvarial bone cells isolated from rats responded to mechanical
stimulation with increased proliferation but decreased production of collagen type 1
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and alkaline phosphatase. They also noted that these effects could be elicited by
strain durations of as little as 15 minutes per day.
These conflicting observations of levels of collagen type 1 synthesis are not unique.
It would appear that the response of the osteoblast to mechanical strain is variable on
a number of levels. Several studies have reported increases in cell proliferation
(Buckley et al, 1988; Hasagawa et al, 1985) and total protein production (Hasagawa
et al, 1985), whereas others have reported a decrease in these responses following
mechanical stimulation (Burger et al, 1992; Veldhuijzen et al, 1979). The lack of a
consistent response may be attributed to several factors, which vary considerably
between these investigations.
1. The source of the osteoblast like cells are likely to be an important factor, as is
whether the cultures were derived from primary cells or a transformed cell line.
2. The method of cell extraction utilised and the purity of the resulting cultures are
extremely important to the characteristics of the culture and are likely to affect the
results obtained.
3. Stimulation frequency has been shown to be extremely important in the responses
of cells to mechanical stimuli, and it is known that different intracellular signalling
pathways are activated by different stimulation frequencies. It has previously been
shown that HBC mechanically stimulated at 0.33 Hz for 20 minutes undergo
membrane hyperpolarisation via a pathway involving a5(3i integrin and Ca++
activated K+ channels, but that the same cells, stimulated for 20 minutes at 0.104 Hz
at the same pressure undergo membrane depolarisation via a separate pathway
involving avPs integrin and tetrodotoxin-sensitive Na++ channels (Salter et al, 1997).
4. The system used to stimulate the cells is of importance when considering their
response. Many systems have been developed to allow mechanical stimulation of
cells in-vitro, while attempting to recreate the in-vivo environment (Brown, 2000).
Such systems include compressive loading systems, which allow direct
pressurisation of cells in a contained vessel (Bourret et al, 1976; Lippiello et al,
1985; Klein-Nulend et al, 1986; Burger et al, 1992; Brighton et al 1996), substrate
stretch systems in which cells are grown on a deformable substrate (Ives et al, 1986;
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Bottlang et al, 1997), out-of-place circular substrate distension systems (as used in
the present study) and fluid shear systems (Hermann et al, 1997; Chun et al, 1997).
5. It has been proposed that the magnitude ofmechanical stimulation is of great
importance to the cellular responses (Burger and Veldhuijzen, 1993). At high levels
of strain, it is believed that the osteoblast responds with proliferative activity and a
decrease in the production of osteoblast phenotyopic markers such as alkaline
phosphatase and bone matrix proteins, but that at lower levels of strain the response
of the osteoblast indicates a more differentiated state, with an increase in alkaline
phosphatase activity and matrix protein production, and a decrease in proliferation.
The cells in the present study are subjected to approximately 4000 pstrain, which
results in 0.4% deformation on the base of the tissue culture plate. This strain
magnitude is extremely small when compared to previous studies. Harter et al
(1995), applied deformations of 12% to the base of the culture dish, which was
equivalent to 120,000 pstrain, whereas Buckley et al (1990), applied deformations of
24% to the base of the tissue culture dish, which is equivalent to 240,000 pstrain.
Both of these studies reported an increase in collagen type 1 synthesis and secretion,
which may appear to contradict the hypothesis ofBurger and Veldhuijzen. Both
studies have used the Flexercell ® system however, which applies a heterogeneous
magnitude of strain across the base of the tissue culture plate which falls to 0 pstrain
at the centre of the dish (Gilbert et al, 1994). Therefore, in actuality, the strain
delivered to the osteoblasts is significantly lower than the maximum strain across the
majority of the tissue culture plate. It has previously been demonstrated that the
heterogeneity of strain across the base of the culture dish affects collagen type 1
secretion (Harter et al, 1995). Collagen type 1 synthesis appeared to be much higher
in areas of the tissue culture plate that experienced moderate levels of strain. In
addition, at the edge of the plate, where osteoblasts experienced the greatest strain,
there was little or no secretion of collagen type 1. In the present study, which utilises
strain levels much lower than those previously reported, most of the cells will be
exposed to moderate or low strain magnitudes. Therefore, this is a possible
explanation as to why collagen type 1 levels increase following 20 minutes 0.33 Hz,
30 mmHg cyclical mechanical stimulation.
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4.4.3 Bone Morphogenetic Protein - 4 (BMP- 4) mRNA Expression
is Decreased Following Cyclical Mechanical Stimulation.
The present study has demonstrated that following a single 20 minute period of 0.33
Hz mechanical stimulation, BMP-4 mRNA levels are decreased and remain
depressed for up to 24 hours post stimulation.
BMP's are a family ofmultifunctional proteins, which were originally identified as
substances that initiate bone and cartilage formation (Reddi, 1992; Reddi, 1994).
Several proteins belong to the BMP family, including BMP-2-6 (Wozney et al, 1988;
Celeste et al, 1990) and osteogenic proteins (OP) 1 and 2 (Ozkaynak et al, 1990;
Ozkaynak et al, 1992). BMP's have various biological effects on different cell
types. They promote differentiation and maturation of preosteoblastic cells and up-
regulate features of the mature osteoblast, including alkaline phosphatase activity,
collagen synthesis, and osteocalcin expression, whereas in chondroblasts, they
stimulate proteoglycan synthesis (Vukicevic et al, 1989).
Although it is well established that BMP family members play important roles in the
patterning and development of skeletal tissues during embryogenesis, many studies
have failed to show any BMP-4 expression in adult bone tissue. One exception,
demonstrated the presence of the BMP-4 gene in normal bone tissue from neonatal
animals using RT-PCR (Ikegame et al; 2001). This study also demonstrated that
mechanical stimulation induces osteoblast differentiation in mouse calvarial sutures
in culture, which was accompanied by an increase in BMP-4 gene expression as
evaluated by RT-PCR. These results prompted the investigation of the effect of
cyclic mechanical stimulation on BMP-4 mRNA levels in HBC in the present study.
The results obtained contradict those published previously (Ikegame et al, 2001). It
was found that following 20 minutes cyclic mechanical stimulation at 0.33 Hz there
was a significant decrease in BMP-4 mRNA levels when compared to the non-
stimulated controls. Although the reasons why these results are different from those
obtained by Ikegame et al, (2001), are not known for certain, there are several major
differences between the two studies.
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The method ofmechanical stimulation is different when comparing the two studies.
In the present study, cells were subjected to cyclic mechanical stimulation for 20
minutes at a frequency of 0.33 Hz and RNA extracted Oh, lh, 3h, 6h or 24h after
stimulation, whereas in the study of Ikegame et al, (2001), cells were subjected to
continuous tensile stress for lh, 6h, 24h or 48h before RNA extraction. This
difference in stimulation regimes is likely to be significant as degree and duration of
stress may be important to the activation ofpathways responsible for BMP-4 mRNA
expression.
The cells used in the present study are derived from human long bones, whereas the
cells used by Ikegame et al, (2001) were obtained from mouse calvarial sutures. This
is likely to be significant not only due to the species difference but also as long bones
and calvarial sutures are formed by different forms of ossification (endochondral
versus intramembranous), which may give rise to differing signalling pathways.
Also, the cells derived from the calvarial sutures are likely to be of a very immature
osteoblast phenotype and high in BMP-4 levels whereas those used in the present
study are more mature and are likely to contain lower BMP-4 levels. The fact that
mechanical stimulation causes a decrease in relative BMP-4 mRNA levels which is
accompanied by an increase in relative type 1 collagen levels may indicate that the
mechanical stimulus that is being provided in the current model is inducing a




THE EFFECT OF MTX ON NORMAL HBC
RESPONSES TO CYCLICAL MECHANICAL
STIMULATION.
5.1 Methotrexate (MTX) Dose Dependency Inhibits the
Electrophysiological Response of HBC to Mechanical
Stimulation.
There is a great deal of evidence to suggest that chemotherapy has effects on normal
bone growth and mass in-vivo (Halton, 1996; Arikoski et al, 1999; Kaste, 1999).
Several clinical studies have demonstrated that patients who chemotherapeutic
regimes incorporating MTX often experience fractures and pain throughout the
course of the treatment, which is commonly accompanied by a decrease in bone mass
(O'Regan et al 1973; Preston et al, 1993; Eckland, 1997; Warner, 1999; Stevens et
al, 2001; Wijnands et al, 2001). A seperate study (May et al; 1994) demonstrated
that low-dose MTX, when administered to rats, caused significant osteopenia. The
results also demonstrated that this occurred as a result of suppression of osteoblast
activity and stimulation of osteoclast recruitment, resulting in increased bone
resorption. In-vitro studies have also provided evidence that MTX has inhibitory
effects on osteoblast function. It has been shown that MTX diminishes osteoblastic
cell function by significantly decreasing osteocalcin levels, matrix calcification and
cell adhesion to the culture substrate (May et al, 1996). Similarily, it has also been
reported that MTX suppresses bone formation in-vitro in human and mouse cell lines
by inhibiting the differentiation of osteoblastic cells (Uehara et al, 2001).
Bone responds to mechanical stimulation with increases in bone mass and osteoblast
function (Rubin et al, 1985). Therefore, the possibility exists that MTX may
interfere with normal bone cell responses to mechanical stimuli.
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The full numerical results of individual experiments from which the values given in
the Tables in this chapter are derived are given in Appendix I. Results shown in this
chapter are from a single representative experiment. Experiments were repeated
from HBC derived from at least 3 adult or juvenile donors and were reproducible
between donors.
Experiments were performed to investigate the effects of three concentrations of
MTX (1 pM, 50 nM and 1 nM) on the responses ofHBC in culture to 0.33Hz
mechanical stimulation. These concentrations were chosen, based on the studies of
May et al (1996), in which a similar concentration range ofMTX had significant
effects on mouse osteoblastic cell function in-vitro.
The resting membrane potential of 5 cells was assessed prior to the addition of 1 pM,
50 nM or 1 nM MTX. HBC were incubated with MTX for 30 minutes at 37°C
following which time, the membrane potentials of another 5 cells were measured.
The cells were then subjected to cyclical mechanical stimulation for 20 minutes at
0.33 Hz, 30 mmHg. Following the mechanical stimulation, the membrane potential
of a further 5 cells was assessed. MTX itselfwas found to have no effect on the
membrane potential of resting cells, but it dose dependently inhibited the
hyperpolarisation response which is normally induced by cyclical mechanical
stimulation. Both 1 pM and 50 nM MTX completely inhibited the hyperpolarisation
response to cyclical mechanical stimulation and although a degree of
hyperpolarisation was observed in mechanically stimulated HBC which had been
incubated with 1 nM MTX this hyperpolarisation did not consistently reach control
levels (Table 5.1).
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5.2 The Inhibitory Effects ofMTX on the
Electrophysiological Response of HBC to Mechanical
Stimulation is not a Result ofMTX Cytotoxicity.
The results presented above suggest that MTX dose dependently inhibits the HBC
electrophysiological response to mechanical stimulation. Three different types of
cell toxicity assay were performed to investigate whether this observation was a
result of a cytotoxic effect ofMTX.
5.2.1 Lactate Dehydrogenase Assays.
Lactate dehydrogenase assays were performed to assess levels of cell necrosis
following exposure to differing concentrations ofMTX. Lactate dehydrogenase is a
stable cytosolic enzyme, which is released from a cell upon its death. Therefore, the
concentration of lactate dehydrogenase present in cell culture supernatants can be
used to determine the viability of the culture. Lactate dehydrogenase levels were
assessed in supernatants removed from control (no MTX) cells, and cells that had
been incubated with 1 pM, 50 nM or 1 nM MTX for 90 minutes at 37°C (Figure
5.1). The results show that MTX, at the concentrations studied, and over a 90-
minute incubation period does not cause cell necrosis in HBC. Results are expressed
as a percentage of the negative control (no MTX). Triton-X 100 (0.2%) was
included as a positive control. Other concentrations ofMTX and other incubation
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Figure 5.1 - Lactate dehydrogenase assays to investigate any cytotoxic effect of 1 pM,
50 nM or InMMTX on HBC over a 90 minute period. Results are expressed as a
percentage of the negative control (no MTX). Triton-X 100 is included as a positive
control. n = 4. p<0.01.
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5.2.2 Acridine Orange Staining.
The lactate dehydrogenase assays suggest that over the concentration range /
incubation period studied, MTX does not induce cell necrosis. These experiments
are not sufficient to investigate whetherMTX has apoptotic effects on HBC. To
investigate this, acridine orange staining was performed. Acridine orange is a non¬
specific nucleic acid stain, which can be used to demonstrate the presence of
apoptotic nuclei (Carmichael et al, 1980). Apoptotic cells have small, condensed
nuclei, which are dense and often fragmented. Acridine orange staining was
performed in control cells (no MTX) and also in cells which had been incubated with
50 nM MTX for 90 minutes at 37°C.
The results demonstrate that at this concentration and over a 90 minute time period,
MTX does not induce apoptosis in HBC, as nuclear size and density do not vary




Figure 5.2 - Acridine orange staining ofHBC to investigate whether 50 nM MTX




MTT assays were performed to investigate the effect of 50 nM MTX over a 24-hour
period in unstimulated HBC. The MTT assay is a colometric assay, which allows the
assessment of viable cells in drug toxicology studies. The assay is based on the ability
ofmitochondrial succinate dehydrogenase to catalyse conversion ofMTT to a blue
formazan product.
Cells were incubated with MTX for 1 hour, 3 hours, 6 hours or 24 hours prior to
performing the assay. Sterile PBS and 0.2 % Triton-X 100 were used as negative and
positive controls respectively.
The results show that, over a 24-hour incubation period, MTX does not have cytotoxic
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Figure 5.3 - The effect ofMTX on HBC. MTX was added to cells for the appropriate
times and all time points were assayed after 24 hours. Triton-X 100 was added to HBC
for 1 hour and is included as a positive control.
Error bars are +1 SEM, n = 3, * p < 0.05 (Mann-Whitney U test).
133
5.3 MTX inhibits IL-lp release but has no effect on IL-lp
signalling.
Electrophysiological experiments have shown that MTX dose dependently inhibits
hyperpolarisation responses occurring in HBC following 0.33 Hz mechanical
stimulation. Toxicity assays have confirmed that the inhibition of cell signalling by
MTX is not a result of cell toxicity.
At this stage, it is not known at which point or by what mechanism MTX exerts its
inhibitory effects on the cell-signalling pathway following stimulation. MTX may
affect any stage of the signalling pathway - it may inhibit integrin function, focal
adhesion formation, actin cytoskeleton organisation, tyrosine phosphorylation, the
release of IL-1 (3, the binding of IL-ip to the IL-1 receptor, the action ofPLC, DAG
or PKC or the activation of the small conductance Ca2+ activated K+ (SK) channels.
To elucidate whether MTX acts upstream or downstream ofIL-1p, a series of CM
experiments involving MTX were performed as follows.
(a) CM was transferred from mechanically stimulated cells, which had been
incubated with 50 nM MTX for 30 minutes at 37 °C prior to stimulation to
unstimulated cells.
(b) CM was transferred from mechanically stimulated cells to unstimulated cells,
which had been incubated with 50 nM MTX for 30 minutes at 37°C.
When CM is transferred from mechanically stimulated cells, which have been
incubated with MTX prior to stimulation, no hyperpolarisation is observed in the
unstimulated cells following the media transfer (Table 5.2a). This suggests either
that IL-ip is not present in the transferred media or that the presence ofMTX in the
media inhibits IL-lp signalling in the unstimulated cells.
When CM is transferred from mechanically stimulated cells to cells, which have
been incubated with MTX for 30 minutes at 37°C, hyperpolarisation is observed in
the unstimulated cells (Table 5.2b), These results suggest that MTX does not inhibit
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IL-lp signalling in unstimulated cells. Therefore, these results, in conjunction with
those presented in Table 5.2a provide evidence that MTX acts in the upstream part
of the pathway and that IL-lp release is inhibited.
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The effect of 50 nM MTX on recombinant ILl-p induced membrane
hyperpolarisation ofHBC was then examined. Resting membrane potentials were
obtained following which, the cells were incubated with 50 nM MTX for 30 minutes
at 37°C. Consistent with previous results, MTX has no effect on resting membrane
potential. Recombinant ILl-p (10 ng/ml) was then added to the cells and they were
incubated for a further 10 minutes at 37°C.
The results show that in the presence of 50 nM MTX, HBC show a membrane
hyperpolarisation response to IL1-P, which is similar in magnitude to control (no
MTX) cells (Table 5.3). These results are consistent with those presented in Table
5.2 and provide further evidence that the action ofMTX lies upstream of IL-P and
thus in some way is inhibiting the release ILl-p.





Stimulus Reagent n Resting + MTX IL1-/3 (Resting-Post-IL l-(5)
IL-ip Nil 5 29.4 ±1.3 n/a 51.4 ±2.4 ±74.8*
IL-ip 50 nM MTX 5 31.2 ±2.0 29.4 ±2.8 51.4 ±2.8 ±74.8**
Results shown are from a single experiment and are consistent between experiments
and between cells from 3 different donors.
*
p < 0.0005; **p< 0.005.
The results presented to this point indicate that MTX prevents the release of IL-1 p by
inhibiting component(s) of the signalling pathway, which lie upstream of its release,
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thus disrupting normal signal transduction. To gain further clarification ofwhere in
the signal transduction pathwayMTX acts, experiments were performed which
allowed study of effects ofMTX on specific components of the integrin-associated
signalling pathway known to lie upstream of IL-1 p.
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5.4 MTX Decreases HBC Adhesion to Fibronectin and
Type 1 Collagen Coated Surfaces.
To investigate the effect, if any, ofMTX on 0C5P1 integrin function, methylene blue
cell adhesion assays were performed. The adhesion ofHBC to the ECM proteins
fibronectin and type 1 collagen was studied following the addition ofMTX. It is
known that the asPi integrin binds fibronectin and that type 1 collagen is bound by
integrin heterodimers which contain the Pi subunit.
HBC were incubated with 1 pM, 50 nM or 1 nM MTX for 90 minutes before being
allowed to adhere to either fibronectin or type 1 collagen coated surfaces. After 3
hours, non-adherent cells were removed by pouring off the supernatant and gently
washing the adherent cells with PBS. HBC were stained using methylene blue, a
non-specific DNA stain. The amount of staining is proportional to the number of
bound cells (Figure 2.11).
The results show that HBC adhesion to both fibronectin (Figure 5.4) and type 1
collagen (Figure 5.5) coated surfaces is significantly decreased to a similar
magnitude by all concentrations ofMTX studied. There is not any significant
difference in the magnitude of decreased cell adhesion when comparing different
concentrations ofMTX. Experiments were performed in triplicate, using cells from
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Figure 5.4 - The effect ofMTX on the adhesion of HBC to fibronectin (FN).
The adhesion ofHBC to FN was compared to the adhesion of cells treated with 1 pM,
50 nM or 1 nM MTX for 90 minutes at 37°C. The values shown represent the mean of 3
experiments carried out in triplicate +1 SEM. All concentrations ofMTX tested
significantly decrease the adhesion of HBC to FN when compared to adhesion in the
absence ofMTX. Raw data can be found in Appendix I.
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Figure 5.5 - The effect ofMTX on the adhesion ofHBC to type 1 collagen (coll 1).
The adhesion ofHBC to coll 1 was compared to the adhesion of cells treated with 1 pM,
50 nM or 1 nM MTX for 90 minutes at 37°C. The values shown represent the mean of 3
experiments +1 SEM. All concentrations ofMTX tested significantly decrease the
adhesion ofHBC to type 1 collagen when compared to adhesion in the absence ofMTX.
Raw data can be found in Appendix I.
*
p < 0.01 (Mann Whitney U test).
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5.5 MTX Does Not Disrupt the Organisation of the
Intracellular Actin Cytoskeleton.
Integrin signalling is known to involve the actin cytoskeleton (Clarke et al, 1995),
and previous work has shown that the disruption of the actin cytoskeleton with
cytochalasin D inhibits cell membrane hyperpolarisation following mechanical
stimulation (Wright et al, 1997). Experiments were therefore undertaken to
investigate ifMTX has any effect on the organisation of the actin cytoskeleton.
The actin cytoskeleton was visualised using rhodamine (TRITC) labelled phalloidin
in unstimulated HBC which had been incubated with 50 nM MTX for 90 minutes at
37°C, 95% O2, 5% CO2. HBC, which had not been incubated with MTX, were used
as controls. No differences were observed when comparing the conformation of the
actin cytoskeleton in control and MTX treated cells. The actin stress fibres appear
well organised and are tethered to sites of focal adhesions at the plasma membrane of
the cells (Figure 5.6).
The conformation of the actin cytoskeleton was then visualised in HBC which had
been mechanically stimulated for 20 minutes at 0.33 Hz in the presence / absence of
50 nM MTX (Figure 5.7). As in Figure 5.6, there are no significant differences
observed when comparing the conformation of the actin cytoskeleton in control and
MTX treated cells.
Therefore, these results suggest that 50 nM MTX has no effect on the conformation





+ 50 nM MTX.
Figure 5.6 — Visualisation of the actin cytoskeleton using rhodamine (TRITC) labelled
phalloidin in unstimulated cells in the absence or presence of 50 nM MTX (original
magnification x 630).
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■ (a) Stimulation(no MTX).
■ (b) Stimulation+ 50 nM MTX.
Figure 5.7 - Actin cytoskeleton visualisation. Rhodamine (TRITC) labelled phalloidin
was used to visualise the organisation of the intracellular actin cytoskeleton in
mechanically stimulated cells ± 50 nM MTX. The results show that MTX has no effect
on actin cytoskeleton conformation in mechanically stimulated HBC's (original
magnification x 630).
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5.6 Effects ofMTX on Type 1 Collagen mRNA
Expression Following Mechanical Stimulation
This study has shown that type 1 collagen mRNA expression is upregulated
following mechanical stimulation and remains elevated for up to 24 hours post
stimulation (Figure 4.4). Although the increase in type 1 collagen mRNA
expression is statistically non-significant, a clear trend can be observed. The effect
of 50 nM MTX on type 1 collagen mRNA expression following mechanical
stimulation has been examined. MTX was added to HBC for 30 minutes prior to the
induction ofmechanical stimulation at 0.33 Hz for 20 minutes. Following
stimulation, HBC were incubated at 37°C for 0, 1, 3, 6 or 24 hours. Following this
incubation period, RNA was extracted and quantified. RNA was reverse transcribed
to obtain cDNA. Semi-quantitative PCR was than performed to investigate whether
50 nM MTX had an effect on type 1 collagen mRNA expression in HBC following
mechanical stimulation.
The results are shown in Figure 5.8. PCR samples were removed following either
26 or 30 cycles of amplification. The results demonstrate that in the presence of 50
nM MTX, type 1 collagen mRNA expression is increased in RNA extracted from
HBC 0, 1, 3, 6 and 24 hours after a single 20 minutes period of 0.33 Hz mechanical
stimulation, when compared to the non-stimulated (NS) control. These results only
reach statistical significance at the 6-hour and 24 hour time points (p < 0.05; Mann-
Whitney U-test). The increase in type 1 collagen mRNA levels with time is gradual,
reaching a peak 6 hours after stimulation. If the results from Figure 5.8 are
presented together with those in Figure 4.4 (Figure 5.9) it is clear that although
MTX does not inhibit the increases in type 1 collagen mRNA expression observed
following mechanical stimulation the relative levels of type 1 collagen mRNA are
lower following incubation with MTX, although the decrease in type 1 collagen
levels observed in the presence ofMTX is not statistically significant.
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Figure 5.8 - The effect of mechanical stimulation on type 1 collagen mRNA expression
in the presence of 50 nM MTX. Type 1 collagen mRNA expression increases with
respect to time following 20 minutes 0.33 Hz mechanical stimulation. These increases
only reach statistical significance at the 6 and 24 hour time points (p Mann-Whitney Li¬
test). Pooled data for 3 donors performed in duplicate (n=6). Error bars are +1 SEM. *
= p < 0.05.
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Figure 5.9 - The effect of 20 minutes, 0.33 Hz mechanical stimulation on HBC type 1
collagen mRNA expression in the absence and presence of 50 nM MTX. Error bars are
+1 SEM.
NS: non-stimulated; 0,1,3,6 and 24: time in hours after 0.33 Hz mechanical stimulation.
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5.7 Effects ofMTX on BMP-4 mRNA Expression
Following Mechanical Stimulation.
This study has shown that levels of BMP-4 mRNA expression in HBC, are
significantly decreased following 20 minutes cyclic mechanical stimulation at the 3,
6 and 24 hour time points (Figure 4.5). The effect of 50 nM MTX on levels of
BMP-4 mRNA expression following mechanical stimulation has also been
examined. As before, the HBC were incubated with 50 nM MTX for 30 minutes at
37°C prior to the induction of 20 minutes, 0.33 Hz mechanical stimulation.
Following stimulation, HBC were incubated at 37°C for 0, 1, 3, 6 or 24 hours.
Following this incubation period, RNA was extracted and quantified. RNA was
reverse transcribed to obtain cDNA. Semi-quantitative PCR was than performed to
investigate whether 50 nM MTX had an effect on BMP-4 mRNA expression in HBC
following mechanical stimulation.
The results are shown in Figure 5.10. PCR samples were removed following either
26 or 30 cycles of amplification. The results show, that in the presence of 50 nM
MTX, BMP-4 mRNA expression is significantly decreased in response to 20 minutes
0.33 Hz mechanical stimulation after 3, 6 and 24 hours incubation compared to the
non-stimulated (NS) control (p < 0.05; Mann-Whitney U-test). If the results from
Figure 5.10 are presented together with those in Figure 4.5 (Figure 5.11), it is clear
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Figure 5.10 - The effect ofmechanical stimulation on BMP-4 mRNA expression in the
presence of 50 nM MTX. BMP-4 mRNA expression decreases with respect to time
following 20 minutes 0.33 Hz mechanical stimulation. These increases reach statistical
significance at the 3, 6 and 24 hour time points (p Mann-Whitney U-test). Pooled data
for 3 donors performed in duplicate (n=6). Error bars are +1 SEM. * = p < 0.05.




















Figure 5.11 - The effect of 20 minutes, 0.33 Hz mechanical stimulation on HBC BMP-4
mRNA expression in the absence and presence of 50 nM MTX. Error bars are +1 SEM.




5.8.1 The Effect of MTX on IL-ip Production / Release from
Mechanically Stimulated HBC.
The aims of the present study were to determine ifMTX has any effects on the
responses ofHBC in culture to 0.33 Hz cyclical mechanical stimulation.
The results show that MTX blocks the hyperpolarisation response ofHBC to 0.33 Hz
mechanical stimulation in a dose dependant manner but that it has no effect on
membrane hyperpolarisation induced by a transferable factor, IL-ip (medium
transfer) or by the addition of recombinant IL-1 p. These results suggest that the
mechanisms responsible forMTX mediated inhibition of hyperpolarisation are
involved early in the mechanotransduction pathway; upstream of IL-p, or that the
secretion of IL-1 p from the cell is affected.
Whilst it is generally accepted that MTX has effects on IL-ip / IL-ip signalling
(Segal et al, 1989, Novaes et al, 1996, Bendele et al, 1999, Williams et al, 1999)
opinion in the scientific literature is divided upon whether MTX affects the
production and subsequent secretion of IL-1 p or whether it affects the ability of IL-
ip to bind to its receptor thus inhibiting IL-1 P signalling without altering its
production or secretion. The present study appears to be the first time that the effects
ofMTX on bone cell mechanotransduction have been studied. Results on the effects
ofMTX on IL-ip secretion and signalling are largely confined to in-vivo and in-vitro
models ofRA and inflammation (Novaes et al, 1996, Bendele et al, 1999). In
agreement with the results presented in this study, Novaes et al, (1996), have
demonstrated that MTX reduces IL-1 p production in the early phase of antigen
induced arthritis in rabbits. Similarly, Williams et al, (1999), have reported that
several liposomally conjugated MTX formulations are potent inhibitors of
lipopolysaccharide induced IL-1 p release. In contrast, Segal et al, (1989), have
demonstrated that MTX has no significant effect on IL-1 p synthesis in-vitro or in RA
patients or mice treated with MTX, but concluded that the activity of IL-1 P was
affected. This work did not address whether the effect ofMTX on IL-1 p activity
was direct or indirect although suggestions have been made that there may be a
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physical or chemical interaction between MTX and IL-1 p, that MTX may down
regulate IL-1 receptors or that there may be a post receptor inhibition of intracellular
mechanisms requiring IL-1 (Brody et al, 1993). There is also some evidence that
MTX causes an increase in adenosine production (Cronstein et al, 1992; Cronstein et
al, 1993; Cronstein et al, 1997) and subsequent adenosine signalling via adenosine
receptors may promote the IL-1 receptor antagonist (IL-IRa) transcription and
presumably its production (Seitz et al, 1995). Recent studies seem to confirm this
possibility because it has been shown that MTX treatment generates a less
inflammatory type of circulating monocyte in RA patient by inhibiting IL-1 and IL-8.
5.8.2 The Effects ofMTX on Cell Adhesion to Fibronectin and Type
1 Collagen.
It was noted in the present study that, whilst performing electrophysiological
experiments involving MTX, that following mechanical stimulation some cells
appeared loosely adherent, rounded and often detached upon impalement. Such
observations were not noted in the control (no MTX) dish. Loss of cell adhesion in
mouse osteoblastic cells following MTX administration has been previously
observed (May et al, 1996). This group reported that following exposure to various
concentrations ofMTX (0.6 pM - 0.5 nM) for 7 days, caused mouse osteoblastic
cells to lose adhesion and become rounded, with total cell detachment by day 14.
The degree of cell detachment varied dose dependently with the concentration of
MTX added.
In the present study methylene blue cell adhesion assays were performed to assess
effects ofMTX on HBC adhesion to the ECM proteins fibronectin (FN) and Type 1
collagen (coll 1). These assays have confirmed that, following exposure to MTX (1
pM, 50 nM or 1 nM) there is a significant decrease in cell adhesion to fibronectin
and collagen 1 coated surfaces when compared to control (no MTX) HBC. The
degree of the decrease in cell adhesion did not vary with MTX concentration. These
results raise the possibility that integrin function (in particular the Pi integrin
subunit) may be affected by MTX as it is known that the 0C5P1 integrin heterodimer
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binds to fibronectin and that type 1 collagen is bound by integrin heterodimers which
contain the p i subunit.
There is limited evidence regarding the effects ofMTX on integrin function.
Although the mechanism ofMTX action in RA is at the present time unclear (Cutolo
et al, 2001), there is some evidence to suggest that MTX may decrease neutrophil
chemotaxis and adhesion at sites of inflammation by inhibiting conformational
changes in the P2 integrin CD1 lb/CD18, which are necessary for adhesion
(Cronstein et al, 1992). The authors speculate that MTX induced increases in
adenosine concentrations are responsible for this, although no explanation is offered
regarding the link between adenosine signalling and integrin function. There does
not appear to be any published data regarding the effects ofMTX on OC5P1 integrin
function.
Studies have also been undertaken to investigate MTX effects on cell adhesion
molecules. There have been reports that MTX decreases the expression of the
adhesion molecules E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in
patients with RA (Dolhain et al, 1998), and as a result there is a decrease in the influx
of various leucocytes to the site of inflammation. It is also known that the expression
of adhesion molecules on vascular endothelium can be upregulated by cytokines such
as TNF-a and IL-ip (Klein et al, 1994). Therefore, the changes in adhesion
molecule expression in synovial tissue during therapy withMTX might be explained
by a reduction in cytokine production, which would be consistent with the inhibition
of IL-ip release observed in this study.
5.8.3 MTX Does Not Disrupt the Conformation of the Actin
Cytoskeleton.
The conformation of the actin cytoskeleton is extremely important to integrin
mediated signalling (Wang et al, 1993, Miyamoto et al, 1995; Yamada, 1995).
Integrins act as a transmembrane link between the ECM, cytoskeletal proteins and
actin filaments. Binding of integrins to the ECM causes the formation of complex
protein structures called focal adhesions, which tether actin stress fibres to the
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cytoplasmic face of the plasma membrane. At these sites the cytoplasmic domains of
the integrin subunits associate with the cytoskeletal proteins talin and a-actinin,
serving to link the ECM to the actin cytoskeleton (Burridge et al, 1988; Jockusch et
al, 1995). Focal adhesions however, play more than a structural role in anchoring the
cell to the ECM, as ligand binding to the integrins leads to activation of a range of
biochemical signalling events / pathways (Longhurst et al, 1998), including that
activated by 0.33 Hz cyclic mechanical stimulation in HBC (Salter et al, 1997, Salter
et al, 2000). Previous work by our group has shown that disruption of the actin
cytoskeleton by cytochalasin D inhibits membrane hyperpolarisation in response to
0.33 Hz mechanical stimulation (Wright et al, 1997). Therefore it is possible that
MTX mediated inhibition ofmechanically induced signalling in HBC may be due to
disruption of the intracellular actin cytoskeleton. In the present study the
organization of the actin cytoskeleton was studied in unstimulated and mechanically
stimulated HBC in the presence and absence of 50 nM MTX. No effect ofMTX on
actin cytoskeleton organisation was observed in either unstimulated or mechanically
stimulated cells. The stress fibres are visible and remain well organised, tethered to
focal adhesions. Therefore, it is unlikely that the inhibitory effects ofMTX arise as a
result of disruption of the actin cytoskeleton.
5.8.4 MTX Effects on Type 1 Collagen 1 mRNA Levels Following
Mechanical Stimulation.
Type 1 collagen mRNA levels are increased in HBC following 20 minutes 0.33 Hz
mechanical stimulation, increasing gradually post stimulation and reaching a
maximum 6 hours after stimulation. In the presence of 50 nM MTX type 1 collagen
mRNA expression increases following mechanical stimulation and the trend
observed is almost identical to that seen in the absence ofMTX. Although MTX had
no effect on relative levels of type 1 collagen following mechanical stimulation,
levels were consistently decreased in the presence ofMTX raising the possibility of
effects on gene expression through different routes. These results also indicate that
the mechanotransduction pathway by which type 1 collagen gene expression is
regulated is not reliant on ILl-(3 function. In the present study however it is not
possible to ascertain whether these responses are mediated via asPi or dependent
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upon other mechanically responsive membrane components such as stretch activated
ion channels.
It is known that m-vivo MTX has considerable effects on type 1 collagen levels
(Crofton et al, 1998; Crofton et al, 2000). Much of the published work investigating
effects ofMTX on the levels of type 1 collagen has been performed at the protein
rather than the molecular level. Several in-vivo studies investigating effects of
chemotherapy on bone turnover and growth in children with acute lymphoblastic
leukaemia have reported effects on type 1 collagen synthesis. One study reported
that during high dose MTX treatment, children had reduced C-terminal propeptide of
type 1 collagen (PICP) levels and alkaline phosphatase levels and increased C-
terminal telopeptide of type 1 collagen (ICTP), compared to those not so treated
(Crofton et al, 1998). PICP quantitatively reflects type 1 collagen synthesis and is a
marker of the osteoblast in its early proliferative and undifferentiated state. Alkaline
phosphatase (AP) is a marker of the differentiated osteoblast whereas ICTP reflects
the breakdown of type 1 collagen largely, although not exclusively from bone. These
results suggest that during high dose MTX therapy there is reduced bone formation
and increased bone resorption.
A subsequent study carried out in a later non-intensive period of chemotherapy
reported that AP levels remained depressed throughout this period but that linear
growth and PICP levels had returned to normal (Crofton et al, 2000). The authors
therefore conclude that chemotherapy has an adverse effect of osteoblast maturation
and speculate that the component of chemotherapy most likely to be responsible for
this is weekly oral MTX administration. It has been shown in many animal models
and also in many in-vitro studies that MTX treatment suppresses osteoblast activity
and bone formation (May et al, 1996; Uehara et al, 2000; Davies et al; 2002), whilst
enhancing osteoclast activity and bone resorption, resulting in reduced bone mass
and trabecular bone volume (May et al, 1994; Moell et al, 1995; Wheeler et al,
1995). Therefore it would appear that the smaller oral doses administered during
continuing, less intensive chemotherapy may be sufficient to affect osteoblast
differentiation (AP) but not it ability to synthesise collagen (PICP) nor the activity
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of osteoclasts in degrading collagen (ICTP). The authors speculate that the
consequence of this is likely to be either ineffective collagen synthesis, in which
newly synthesised collagen is degraded without being incorporated into the bone
matrix or that normal amounts of collagen are laid down in growing bone followed
by suboptimal mineralisation. Either scenario may account for the fractures and pain
or the low BMD observed throughout chemotherapy.
5.8.5 MTX Effects on Relative Bone Morphogenetic Protein-4
(BMP-4) mRNA Levels Following Mechanical Stimulation
BMP-4 mRNA levels decrease in HBC following 20 minutes 0.33 Hz mechanical
stimulation. In the presence of 50 nM MTX BMP-4, mRNA expression decreases
following mechanical stimulation and there is no significant difference in relative
levels ofBMP-4 when comparing the control (no MTX) and MTX treated cells.
These results suggest that BMP-4 gene expression is regulated by a
mechanotransduction pathway that is not reliant on IL-1 (3 and is unaffected by MTX.
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CHAPTER 6.
ADENOSINE AFFECTS NORMAL HBC
RESPONSES TO CYCLICAL MECHANICAL
STIMULATION.
It is widely acknowledged that adenosine production is increased in response to
MTX treatment and that increases in adenosine may account, at least in part, for the
anti-inflammatory effects ofMTX in rheumatoid arthritis although the exact
mechanisms behind this are unclear (Cronstein et al, 1992; Cronstein et al, 1993;
Montesinos et al, 2000; Cronstein et al, 2001). The present study has shown that
MTX inhibits the response ofHBC in culture to 20 minutes of 0.33 Hz mechanical
stimulation and that MTX mediates this effect by inhibiting a component of the
mechanical stimulation pathway, which lies upstream of the release of the
transferable factor IL-ip. Although the exact mechanisms involved in MTX
mediated inhibition ofHBC responses to mechanical stimulation are unclear, results
ofmethylene blue cell adhesion assays indicate that integrin function may be
affected by MTX. There is also some evidence to suggest that the anti-inflammatory
effects ofMTX in rheumatoid arthritis maybe due to decreased neutrophil adhesion
at sites of inflammation, and that this decreased neutrophil adhesion arises as a
consequence of inhibitory effects of adenosine on integrin conformation (Cronstein
et al, 1992). Therefore it is possible that adenosine signalling may play a role in
MTX inhibition ofHBC responses to cyclical mechanical stimulation, and
experiments have been performed to investigate this.
6.1 Adenosine inhibits HBC Electrophysiological
Responses to Mechanical Stimulation
The full numerical results of individual experiments from which the values given in
the Tables in this chapter are derived are given in Appendix I. Results shown in this
chapter are from a single representative experiment. Experiments were repeated
from HBC derived from at least 3 adult or juvenile donors and were reproducible
between donors.
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Experiments were performed to investigate the effects of adenosine (100 pM) on
HBC responses to 20 minutes of 0.33 Hz cyclical mechanical stimulation (Shimegi et
al, 1998).
The resting membrane potential of 5 HBC was assessed prior to the addition of 100
pM adenosine. HBC were incubated with adenosine for 20 minutes at 37°C,
following which time the membrane potential of a further 5 HBC was assessed. The
HBC were then mechanically stimulated for 20 minutes at 0.33 Hz. Following
stimulation, the membrane potentials of another 5 HBC were measured.
Adenosine itselfwas found to have no effect on the membrane potential of resting
cells, but it inhibited cell membrane hyperpolarisation following 20 minutes of 0.33
Hz cyclical mechanical stimulation (Table 6.1).
Table 6.1 - Adenosine inhibits HBC responses to cyclic mechanical stimulation.
Membrane Potential (-mV)
(mean +SEM)
Reagent n Resting + Aden Post MS % Change
(Resting - Post MS)
Nil 5 26.8 ±1.2 n/a 39.4 ±0.8 +47%*
Aden (100 pM) 5 27.2 ± 1.6 33.0±2.4 28.2 ±1.46 +3.6%ns
Results shown are from a single experiment and are consistent between experiments
and between cells from 3 different donors (Appendix I).
*
p < 0.001; ns = non-significant.
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6.2 Adenosine D eaminase (ADA) Restores N ormal H BC
Responses to MTX Treated Cells.
The results in Table 6.1 show that 100 pM adenosine inhibits HBC responses to
mechanical stimulation. To test the hypothesis that adenosine signalling is involved
in MTX mediated inhibition ofHBC mechanotransduction, electrophysiological
experiments were performed which incorporated both MTX and adenosine
deaminase (ADA), an enzyme responsible for the breakdown of adenosine to inosine.
Initially, the effect of ADA on HBC was examined in resting HBC and in HBC
subjected to 20 minutes of 0.33 Hz mechanical stimulation. The resting membrane
potential of 5 HBC was assessed prior to incubation with ADA (0.125 U/ml) for 10
minutes at 37°C. Following the incubation period, the membrane potential of a
further 5 HBC were assessed and the cells were then mechanically stimulated at 0.33
Hz for 20 minutes. Following stimulation, the membrane potentials of another 5
HBC were assessed. ADA itselfwas found to have no effect on HBC resting
membrane potential and HBC mechanically stimulated in the presence of ADA
hyperpolarised as normal (Table 6.2).
The effect ofADA on MTX mediated inhibition ofHBC responses to mechanical
stimulation was then assessed. The resting membrane potential of 5 HBC was
assessed prior to the addition of ADA. Following the 10 minute incubation period,
the membrane potential of a further 5 HBC was assessed. The cells were then
incubated with 50 nM MTX for 30 minutes at 37°C. Following this incubation
period, the membrane potentials of another 5 HBC were assessed and the cells were
then subjected to 20 minutes of 0.33 Hz mechanical stimulation. Following this
time, post stimulation membrane potentials of another 5 HBC were recorded
HBC hyperpolarised following mechanical stimulation in the presence ofADA and
MTX (Table 6.2).
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*p<0.01,ns=on-significant.
6.3 Adenosine Decreases HBC Adhesion to Fibronectin
and Type 1 Collagen Coated Surfaces.
The present study has previously been shown that 1 pM, 50 nM and 1 nM MTX
decrease HBC adhesion to FN and type 1 collagen surfaces, and it has been proposed
that integrin function (in particular the Pi integrin subunit) maybe affected by MTX.
To investigate whether the decrease in HBC adhesion to FN and type 1 collagen
observed following MTX addition is mediated via mechanisms involving adenosine,
methylene blue cell adhesion assays were performed to investigate the effect of 100
pM adenosine on HBC adhesion to FN and type 1 collagen.
HBC were incubated with 100 pM adenosine for 90 minutes before being allowed to
adhere to either fibronectin or type 1 collagen coated surfaces. After 3 hours, non¬
adherent cells were removed by pouring off the supernatant and gently washing the
adherent cells with PBS. HBC were stained using methylene blue. The amount of
staining is proportional to the number ofbound cells (see Figure 2.11).
The results show that HBC adhesion to both fibronectin (Figure 6.1) and type 1
collagen (Figure 6.2) coated surfaces is significantly decreased by incubation with
100 pM adenosine. The decrease in cell adhesion observed is of similar magnitude
to that seen following incubation with 50 nM MTX. Experiments were performed in









Figure 6.1 - The effect of adenosine on the adhesion of HBC to fibronectin (FN).
The adhesion ofHBC to FN was compared to the adhesion of cells treated with 50 nM
MTX or 100 pM adenosine for 90 minutes at 37°C. The values shown represent the
mean of 3 experiments carried out in triplicate +1 SEM. Both MTX and adenosine
decrease the adhesion ofHBC to FN when compared to adhesion in the absence of either
adenosine or MTX.
*

















Figure 6.2 - The effect of adenosine on the adhesion ofHBC to type 1 collagen (coll 1).
The adhesion ofHBC to Type 1 collagen was compared to the adhesion of cells treated
with 50 nM MTX or 100 pM adenosine for 90 minutes at 37°C. The values shown
represent the mean of 3 experiments carried out in triplicate +1 SEM. Both MTX and
adenosine decrease the adhesion ofHBC to coll 1 when compared to adhesion in the
absence of either adenosine or MTX. Raw data can be found in Appendix I.
*
p < 0.05 (Mann Whitney U test).
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6.4 Al5 A2A and A3 but not A2B Receptor Antagonists
Reverse the Inhibitory Effects of MTX on HBC
Responses to Mechanical Stimulation.
To further test the hypothesis that adenosine signalling is involved in MTX mediated
inhibition ofHBC mechanotransduction, electropysiological experiments were
performed which incorporated both MTX and an adenosine receptor antagonist,
specific to one of the four adenosine receptors (Ai, A2a, A2B or A3).
The resting membrane potential of 5 HBC was assessed prior to incubation with each
of the specific adenosine receptor antagonists at the appropriate concentration for 10
minutes at 37°C. Following the incubation period, the membrane potential of a
further 5 HBC were assessed, and the cells were then mechanically stimulated at 0.33
Hz for 20 minutes. Following stimulation, the membrane potentials of another 5
HBC were assessed. The antagonists themselves were found to have no effect on the
resting membrane potential, and HBC mechanically stimulated in the presence of the
adenosine receptor antagonists hyperpolarised as normal (Table 6.3).
The effect of each of the adenosine receptor antagonists on MTX mediated inhibition
of HBC responses to mechanical stimulation was then assessed. The resting
membrane potential of 5 HBC was assessed prior to the addition of antagonists.
Following the 10 minute incubation period, the membrane potential of a further 5
HBC was assessed. The cells were then incubated with 50 nM MTX for 30 minutes
at 37°C. Following this incubation period, the membrane potentials of another 5
HBC were assessed and the cells were then subjected to 20 minutes of 0.33 Hz
mechanical stimulation. Following this time, post stimulation membrane potentials
of another 5 HBC were recorded
In the presence of the Ai receptor antagonist, 8-Cyclopentyl -1, 3-dipropylxanthine
(DPCPX), the A2a receptor antagonist 8-(3-chlorostyryl)-caffeine (CSC), and the A3
receptor antagonist MRS-1191, MTX treated cells hyperpolarised significantly
following mechanical stimulation, suggesting that adenosine signalling via these
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receptors is involved inMTX inhibition ofHBC responses to cyclical mechanical
stimulation. These results are shown in Table 6.3, Table 6.4 and Table 6.6.
In the presence of the A2b receptor antagonist, alloxazine, MTX treated cells do not
hyperpolarise following cyclical mechanical stimulation. These results would
suggest that MTX treatment does not induce signalling via A2b adenosine receptors,
or that signalling via A2b adenosine receptors is not a component ofMTX inhibition
ofHBC responses to cyclical mechanical stimulation (Table 6.5).
In summary, these results suggest that the inhibitory Gj-protein linked Ai and A3
receptors and also the stimulatory Gs-protein linked A2A, are involved in MTX
inhibition ofHBC signalling. The results suggest that A2B receptors do not play a
role in this response.
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Nil MRS-1191(100nM) MTX(50nM) MRS-1191(100nM)
+MTX(50nM).
5 5 5 5
30.0±1.92 31.612.29 35.211.98 35.811.85
n/a 33.012.07 n/a 24.411.21
n/a n^a 33.611.69 36.011.92
49.413.88 45.214.23 31.811.82 51.411.99
+65%* +43%**
-9%ns +44%*
Resultsshownarefromingleexperim ntandc nsistentbetwexp rimentsa dfr cell2diff r ntnors(A p dix
I). *p<0.005,*p.ns=non-significant.
6.5 Discussion.
6.5.1 Adenosine inhibits HBC Electrophysiological Responses to
Mechanical Stimulation.
Adenosine is found in all living cells and its concentration is regulated by a variety of
pathophysiological conditions. Under appropriate conditions adenosine is released
from the cell where it can interact with specific cell surface adenosine receptors to
modulate cell function in an autocrine or paracrine manner. These receptors were
originally classified as Pi or P2 purinergic receptors, based upon their preference for
adenosine or adenine nucleotides respectively (Burnstock, 1978). The relative
potencies for Pi sites are, adenosine > AMP > ADP > ATP, whereas the potencies for
the P2 sites are, ATP > ADP > AMP > adenosine (Olah et al, 1992). Activation ofPi
receptors by adenosine has been known to regulate a diverse set ofphysiological
functions including cardiac rate and contractility, smooth muscle tone, sedation,
neural activity, platelet function, lipolysis and renal function (Collis et al, 1993).
Although much evidence shows the ubiquity ofPi (adenosine) receptors, there is
limited data available regarding their expression in osteoblasts. Lerner et al, (1987)
reported that A2 like receptors are linked to cAMP stimulation in rat calvarial bone
and in isolated osteoblastic cells from the calvaria, but with no real relation to cell
function. Similarly Shimegi et al (1998), showed that Ai receptor stimulation by
adenosine induces proliferation ofMC3T3-E1 osteoblastic cells, but the signalling
pathways involved could not be determined.
Despite the widespread use ofMTX in the treatment ofRA, its action in the
treatment of inflammation is still unclear. A number of clinical observations suggest
that MTX does not suppress inflammation in rheumatoid arthritis by inhibition of
DHFR alone. Several clinical trials have demonstrated that neither folate
supplementation nor administration of reduced folate (folinic acid) reversed the
therapeutic effects ofMTX in the therapy ofRA, indirect evidence against inhibition
ofDHFR (Hanrahan et al, 1988, Morgan et al, 1990). Also, several side effects of
MTX commonly associated with DHFR inhibition are not observed following low
172
dose MTX administration. Indeed, bone marrow toxicity and leukopenia, common
due to inhibition ofDNA synthesis, do not occur, a finding which is consistent with
the hypothesis that the anti-inflammatory effects ofMTX are not primarily due to
DHFR inhibition.
Several studies have provided evidence to suggest that the therapeutic effects of
MTX may be linked to the capacity ofMTX to increase adenosine concentrations
(Baggott et al, 1986; Cronstein et al, 1991; Cronstein et al, 1993; Montesinos et al,
2000). Studies have shown that MTX accumulates within cells and inhibits the
enzyme AICAR transformylase, resulting in increased AICAR concentrations.
Increased AICAR concentrations promote, by a complex mechanism, the increased
release of adenosine (Figure 1.9) (Gruber et al 1989, Barankiewicz et al, 1990),
which is believed to act in an anti-inflammatory manner.
The experiments in the current study, were performed to investigate if adenosine
signalling is involved in the inhibitory effects ofMTX on HBC responses to cyclical
mechanical stimulation.
The results presented in Table 6.1 demonstrate that adenosine, inhibits HBC
membrane hyperpolarisation in response to 0.33 Hz cyclic mechanical stimulation.
These results are similar to those seen following the same regime of cyclical
mechanical stimulation in the presence ofMTX, which may indicate that adenosine
is involved in the inhibitory effects ofMTX on HBC. Further evidence is provided
by the observation that normal hyperpolarising activity can be restored to MTX
treated cells by the addition of ADA, an enzyme involved in the breakdown of
adenosine to inosine.
6.5.2 A1? A2a and A3 but not A2b Receptor Antagonists Reverse the
Inhibitory Effects ofMTX on HBC Responses to Mechanical
Stimulation.
Limited evidence exists regarding the expression of adenosine receptors in bone
cells. It is known that Aj and A2 receptors are espressed in osteoblasts but not in
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osteoclasts Experiments utilising adenosine receptor antagonists were undertaken to
investigate the specific adenosine receptor subtypes involved in MTX mediated
inhibition ofHBC responses to mechanical stimulation.
The results of the specific anagonist experiments performed in this study have
demonstrated that the inhibitory effects ofMTX can be reversed by an Ai, A2A or A3
receptor antagonist but not by an A2B receptor antagonist. These results are
somewhat unexpected as Aj and A3 receptors are negatively linked to adenylate
cyclase via inhibitory G; proteins while the A2A receptor is positively linked to
adenylate cyclase via a stimulatory Gs protein. Therefore, one would expect that
differing signalling cascades are activated following receptor binding.
There are several possible explanations for the results obtained. It is possible that the
signalling pathways activated are distinct from the classical positive / negative
coupling to adenylate cyclase. For example, there is much evidence to indicate that
the participation of actvation of adenosine receptors may promote the activation of
the mitogen-activated-protein kinases (MAPK), which are known to play are
essential role in processes such as cell differentiation, survival, proliferation (van
Corven et al, 1993; Shimegi et al, 1998) and death. MAPK are typically activated
via receptor tyrosine kinases, but can also be activated by G protein coupled
receptors including adenosine recptors.
A lack of antagonist specificity could also account for the unexpected results
obtained in this study. For example DPCPX, the 'specific' Aj recptor antagonist
may have actions on more than one type of adeosine receptor. This Ai antagonist is
extremely selective for the rat A] adenosine receptor versus the rat A2 receptor (1000
fold), but its potency is decreased at the human A] recptor versus the human A2A
receptor (30 fold) (Klotz et al, 1998). Moreover, it has also been demonstrated that
this antagonist has some affinity for the A2b receptor (Linden et al, 1999). Similarily,
CSC is a functionally specific antagonist at A2a receptors versus Ai receptors (500
fold), although the selectivity of CSC for A2A receptors via A2B receptors is yet to be
established.
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6.5.3 Adenosine Decreases HBC Cell Adhesion to Type 1 Collagen
and FN - Possible Effects on Integrin receptors?
Gruber et al, (1989) have demonstrated that administration of acadesine, the non-
phosphorylated precursor ofAICAR, prevents accumulation of neutrophils in
ischemic myocardial tissue in a canine reperfusion injury model. Parallel with the
diminished neutrophil accumulation was the observation of diminished infarct size
and increased adenosine release from the ischemic myocardium. Similarly,
Cronstein et al, have demonstrated that, at pharmacologically relevant
concentrations, MTX, like acadesine, promotes adenosine release from cultured
fibroblasts and endothelial cells (Cronstein et al, 1991). This study also
demonstrated that the adenosine released from MTX treated cells, in turn, inhibits
neutrophil adherence to connective tissue cells, a critical step for infiltration or injury
by neutrophils. Neutrophils are known to express both Ai and A2 adenosine
receptors and using specific Ai and A2 receptor agonists, Cronstein et al, (1992),
have provided evidence to suggest that adenosine, binding to the A2 receptor inhibits
adherence of stimulated neutrophils to the endothelium. Neutrophils adhere to the
endothelium via a variety of adhesion molecules and receptors and can alter their
adhesiveness in response to agents such as IL-1 (Harlan et al, 1985). Intact
CD1 lb/CD 18 (|32-integrin) molecules on the surface of the neutrophils are known to
be critical for the adherence of FMLP-stimulated neutrophils to endothelial cells,
gelatin and fibrinogen because an antibody directed against the P2-integrin inhibited
neutrophil adhesion to all of these surfaces (Cronstein et al, 1992).
Although it is unlikely that P2-integrin expression is decreased by adenosine, there is
evidence to suggest that adenosine may inhibit upregulation of P2-integrin expression
on stimulated neutrophils (Wollner et al, 1993), or that occupancy ofA2 receptors
inhibits conformational changes in the P2-integrin subunit, which are necessary for
neutrophil adhesion to endothelial cells. At present, there is no data describing
similar effects of adenosine on other integrin receptor subunits including the Pi
integrin, although it is possible that adenosine may affect other integrin receptors by
a similar mechanism, and this may explain the decreases in HBC adhesion to
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fibronectin and type 1 collagen observed following adenosine (and MTX) treatment.
Signalling pathways involved remain to be elucidated.
Cell surface expression of an integrin alone is not sufficient to guarantee adhesion. It
is now known, for many cell types, that integrin mediated cell binding to
extracellular ligands can be enhanced dramatically by certain stimuli, which activate
intracellular signal transduction cascades. Activation of these signalling transduction
cascades can 'activate' integrins from the cytoplasmic face of the membrane in order
to bind to their ligands, a phenomenon known as 'inside-out integrin signalling'. For
example, for P2 integrins to mediate cell-cell interactions (Dustin et al, 1989), and for
lymphocyte pi integrins to mediate adhesion efficiently, leukocytes must be
activated. Soluble agonists such as thrombin or adenine nucleotides activate platelet
and leukocyte integrins. These agonists probably do not act directly on the integrins,
but bind to cellular receptors leading to engagement of'classical' signal transduction
systems. Cellular receptors that couple to non-receptor tyrosine kinases are known to
activate integrin dependant adhesion pathways in leukocytes whereas seven
transmembrane proteins such as thrombin (or adenosine) receptors, couple to
downstream elements through the activation ofheterotrimeric G-proteins. Both
types of receptors stimulate pathways which involve the activation of
phospholipases, phosphatidylinositol lipid breakdown and activation of cellular
protein kinases (Hynes et al, 1992, Lub et al; 1995). It is still unclear exactly how
intracellular signal transduction events alter the affinity of ligand binding to
integrins, although cytoskeletal interactions are believed to be important (Otey et al,
1990; Lewis et al, 1995; Dedhar et al, 1996). The cytoplasmic portions of both the
a-integrin (Kassner et al, 1993; Kassner et al, 1994) and P-integrin chains (Chen et
al, 1992, Pasqualini et al, 1994) are believed to participate in the inside-out integrin
signalling process. Certain motifs present on the cytoplasmic tails of both a and p
subunits are believed to be targets for inside-out signalling and are thought to be
responsible for regulating integrin affinity states. One of these motifs is the highly
conserved NPxY (Asn-Pro-x-Tyr; where x represents any amino acid) (O'Toole et al,
1995) found in the cytoplasmic domain of the integrins Pi - P7, with the exception of
p4. Point mutations in this motif can abolish integrin activation (O'Toole et al,
176
1995). Anothermotif is the conserved membrane-proximal sequence KLLxxxD
(Lys-Leu-Leu-xxx-Asp) of the p cytoplasmic domains, which is also involved in
regulation of integrin affinity state as deletion ofpart of this sequence results in a
constitutively active integrin (Tozer et al, 1996).
As HBC adhesion is altered following MTX treatment and the results obtained are
consistent with a role for adenosine in this response, it may be possible that the a5Pi
integrin is modulated by inside-out signalling mechanisms which are activated as a
result of adenosine binding to G-protein coupled adenosine receptors. The proposed
mechanisms are summarised in Figure 6,3.
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Figure 6.3 - Proposed pathway by which the adhesiveness of the Pi integrin is
moduated by MTX. AICAR = 5-aminoimidazole-4-carboxamide ribonucleotide,
FA1CAR = formyl-AICAR, ATP = adenosine triphosphate, ADP = adenosine
diphosphate, AMP = adenosine monophosphate, AMPDA = adenosine
monophosphate deaminase, ADA = adenosine deaminase.
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CHAPTER 7.
SUMMARY AND GENERAL DISCUSSION.
> Cyclical mechanical stimulation at a frequency of 0.33 Hz results in a
hyperpolarisation ofHBC, via activation of small conductance Ca++ activated
K+ (SK) channels. The mechanotransduction pathway involves the as|3i
integrin receptor, stretch-activated ion channels, the actin cytoskeleton and
tyrosine kinases with subsequent release of IL-1(3. PLC, DAG, IP3 and PKC
are known to be involved in the downstream signalling events initiated by IL-
1P.
> This study has demonstrated that, following a single 20 minute period of 0.33
Hz mechanical stimulation, collagen type 1 mRNA levels increase and
remain elevated for up to 24 hours post stimulation. It is known that bone
mass increases in response to mechanical stimulation (Rubin et al, 1984,
Frost, 1987, Sessions 1989), and therefore it is expected that type 1 collagen
mRNA levels would increase in response to mechanical stimulation as type 1
collagen comprises 95% of the organic part ofbone. BMP-4 mRNA levels
are decreased following a single 20 minute period of 0.33 Hz mechanical
stimulation and remain depressed for up to 24 hours post stimulation. The
fact that mechanical stimulation causes a decrease in relative BMP-4 mRNA
levels which is accompanied by an increase in relative type 1 collagen levels
may indicate that the mechanical stimulus that is being provided in the
current model is inducing a differentiation / anabolic response, driving the
cells towards a more mature active bone cell phenotype.
> MTX dose dependently inhibits HBC responses to 0.33 Hz cyclical
mechanical stimulation. The results obtained suggest that the mechanisms
responsible forMTX mediated inhibition of hyperpolarisation are involved
early in the mechanotransduction pathway; upstream of IL-(3, or that the
secretion of IL-ip from the cell is affected. Investigation of components of
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the signalling pathway which lie upstream of IL-P secretion, indicate that
MTX does not affect the conformation of the actin cytoskeleton. There is a
significant decrease in HBC adhesion to the ECM proteins fibronectin and
type 1 collagen following MTX treatment, which may indicate that Pi
integrin function is affected by MTX.
> The responses of type 1 collagen and BMP-4 to 0.33 Hz cyclical mechanical
stimulation are unaffected by MTX, suggesting that the mechanotransduction
pathways controlling the expression of type 1 collagen and BMP-4 are
distinct from the CC5P1 integrin mediated pathway and are not reliant on IL-ip.
> It has been demonstrated that adenosine inhibits HBC hyperpolarisation
following 0.33 Hz cyclical mechanical stimulation, and that the inhibitory
effects ofMTX on HBC responses to mechanical stimulation can be
prevented by ADA. Cell adhesion to fibronectin and type 1 collagen is
decreased in the presence of adenosine, suggesting that pi integrin function is
affected by adenosine. Although these results suggest that adenosine
signalling may be involved in MTX mediated inhibition ofHBC responses to
cyclical mechanical stimulation, further work is required to determine the
exact mechanisms involved.
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This study has allowed the investigation ofMTX on the responses of a
heterogeneous culture ofHBC to mechanical stimulation. The results presented in
Chapter 3, clearly show that the cultures obtained consist of cells which posses an
'osteoblast-like phenotype' although the heterogeneity of the culture means that care
must be taken when interpreting the results as one cannot be certain which cell types
in the culture are responsible for the responses observed. While other extraction
methods, such as enzymatic digestion, may yield a purer population of'osteoblastic'
cells, such protocols also have limitations. For example, enzymatic digestion
typically produces few cells, which may result in lengthy periods in culture and
increased possibility of cell dedifferentiation.
The results of this study have clearly shown that primary HBC from both juvenile
and adult donors respond to 0.33 Hz cyclical mechanical stimulation with cell
membrane hyperpolarisation. Statistical analyses have shown that the
hyperpolarisation observed is significant but that there is no significant difference in
magnitude of hyperpolarisation when comparing HBC from juvenile and adult
donors. Although membrane hyperpolarisation is used throughout these studies as an
indicator ofmechanically induced cell signalling, the actual significance of the
membrane hyperpolarisation response is still unclear, nor is it known ifmembrane
hyperpolarisation is the 'end-point' of this mechanotransduction pathway or simply
an intermediate step leading to further signalling pathways which are yet to be
determined. At the present time, is also unknown ifmechanically induced membrane
hyperpolarisation has any functional role in the cell, or if the cell derives any benefit
from potassium efflux and a more negatively charged environment. As the
membrane hyperpolarisation response following stimulation is transient (only lasting
10-15 minutes), it is also unclear which mechanisms are involved in restoring the
membrane potential to its 'normal' resting state. Although these studies concentrate
on the study and manipulation of the asPi mediated pathway; it is not assumed that
this is the only pathway which is activated by 0.33 Hz mechanical stimulation.
Indeed, these studies have shown that both collagen 1 and BMP-4 gene expression
can be mechanically regulated by 0.33 Hz mechanical stimulation but that the
signalling pathways involved are distinct from the asPi mediated pathway. At
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present the mechanotransduction pathways responsible for alterations in type 1
collagen and BMP-4 gene expression following 0.33 Hz are unknown and would
benefit from further investigation.
These studies have shown that MTX dose dependently inhibits the hyperpolarisation
response to mechanical stimulation. It was extremely important to perform several
toxicity assays on the MTX treated cells as it was necessary to ensure that inhibition
of stimulation induced hyperpolarisation is not a result of cell toxicity. This is
extremely important, as the therapeutic benefits ofMTX in malignancy rely on the
ability of this drug to inhibit DNA replication and kill cells. Three kinds of toxicity
assay which investigate both necrosis and apoptosis were performed which provided
conclusive evidence that, at the concentrations utilised, MTX did not have a toxic
effect on HBC.
This study has also shown that the inhibitory effects ofMTX lie in the upstream part
of the mechanotransduction pathway prior to IL-1P release. Experiments have
shown that the conformation of the actin cytoskeleton is not affected by MTX, but
that cell adhesion is decreased following MTX administration, and that this is likely
a result ofMTX effects on the Pi-integrin subunit. It is not known whether
decreased cell adhesion to the substrate results in inadequate propagation of the
signal form the substrate to the integrin receptor or whether effects on the Pi-integrin
subunit may affect integrin clustering, focal adhesion formation, recruitment of
proteins and / or tyrosine kinase mediated events. It would have been useful to
investigate focal adhesion formation using immunofluorescence and to investigate
focal adhesion proteins such as FAK, which are known to be tyrosine phosphorylated
following mechanical stimulation.
It is interesting that MTX affected levels of collagen 1 following mechanical
stimulation (although not significantly). Although it is widely recognised that MTX
has effects on type 1 collagen levels, these effects are normally only seen in patients
subjected to long term high dose MTX therapy. Therefore, it is of interest that MTX
causes a decrease in type 1 collagen mRNA levels after an incubation period ofonly
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30 minutes. From these results, it is not possible to ascertain what effect (if any)
MTX has on type 1 collagen protein levels in HBC and therefore it may have been
interesting to investigate type 1 collagen protein levels following mechanical
stimulation. Caution must also be taken when comparing these results to those
obtained from in-vivo studies. Although studies estimate that following
intramuscular MTX administration the concentrations observed in serum, synovium
and bone are 0.6 pM, 0.28 nM and 0.29 nM respectively (Kremer et al, 1986; Preston
et al, 1993), it is extremely difficult to accurately assess what concentration ofMTX,
individual bone cells are exposed to. It is also likely that HBC in monolayer may be
more susceptible to both strain and MTX that osteoblasts in-vivo, owing to the fact
that they are 'less protected' than osteoblasts in-vivo which are surrounded by a rich
ECM and strong framework and which have contact with other bone cell types such
as osteocytes.
Although MTX has been used for many decades in the treatment of rheumatoid
arthritis, the exact mechanism of action ofMTX remains unclear. A great deal of
evidence however, points toward a mechanism of action which is distinct from
DHFR inhibition, as the concentrations required to attain clinical efficacy are much
lower than those used to treat malignancy and cell toxicity is not commonly
observed. Many studies have proposed a role for adenosine as an anti-inflammatory
mediator, whose concentration is increased by MTX administration. Although it is
known that adenosine (and adenosine receptors) are found in all living cells, there is
limited data about adenosine receptor expression in osteoblasts. The present studies
have indicated that adenosine may have a role in MTX inhibition of stimulation
induced hyperpolarisation in HBC. Previous studies have suggested an interaction
between MTX and adenosine signalling in inflammatory cells, but this study is the
first time that MTX and adenosine signalling has been studied in bone cells. The
studies have shown that adenosine inhibits stimulation induced hyperpolarisation to a
similar magnitude to MTX and that the effects ofMTX are reversed by adenosine
deaminase, suggesting that the effects ofMTX on HBC may be mediated via
adenosine. In addition, adenosine decreases HBC adhesion to both fibronectin and
collagen type 1 suggesting that adenosine may also have inhibitory effects on the (3i-
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integrin subunit. It is not known whetherMTX and adenosine exclusively affect the
Pi-integrin subunit, or whether several integrin subunits may be affected. The
present studies failed to determine which adenosine subunits are involved in MTX
induced adenosine signalling. As mentioned previously, this may be due to a lack of
specificity of the adenosine receptor antagonists used or it may be that the signalling
pathways activated are distinct from the common positive / negative coupling to
adenylate cyclase. Experiments which measure levels of cAMP before and after
mechanical stimulation would perhaps provide information as to which adenosine
receptors are involved. Similarly, inhibition of adenylate cyclase with a selective
inhibitor would determine if adenylate cycalse has a role in this pathway or whether
an atypical or novel adenosine signalling pathway is responsible. Once this has been
established experiments can be performed to elucidate the exact signalling
mechanisms involved. At the present time, it is unclear how such signalling
pathways might lead to alterations in integrin conformation and / or expression.
There is limited evidence to suggest that adenosine can reduce the adhesion of
stimulated neutrophils to endothelial cells by inhibiting upregulation of P2-integrin
subunits or by preventing conformational changes which are necessary for adhesion.
It is most likely that adenosine exerts its effects on the integrin subunits via an
'inside-out' signalling mechanism. It is thought that 'inside-out' integrin signalling
is as crucial as 'outside-in' integrin signalling, and that 'inside-out' signalling is
responsible for ensuring that the integrin subunits are in an 'appropriate'
conformation to be activated by 'outside-in' signalling. At present, the exact
mechanisms involved in 'inside-out' signalling are poorly defined but it is believed
that various intracellular signalling pathways including phosphatidylinositol lipid
breakdown, protein kinase C and small G-proteins may be involved in activation (or
repression) of integrins via certain highly conserved motifs which are located on the
cytoplasmic domains of the integrin subunits. Further investigation of these
signalling pathways may involve transfection ofbone cells with integrin subunits
with point mutations or deletions of the cytosolic consensus sequences. The
usefulness ofperforming such experiments on transfected human bone cell lines are
limited by the fact that human bone cell lines examined in the preliminary stages of
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Original data from which the results given in the Tables of Chapters 4, 5 and 6 are
calculated. The Table number corresponds to that in the Results chapters.
A = HBC grown from trabecular bone fragment obtained from adult donors.
C = HBC grown from trabecular bone fragment obtained from juvenile donors.
Table 4.1 - Raw data from which parameters in generalised linear model were
estimated.
(a) Raw data collected from juvenile HBC.






























































































(b) Raw data collected from adult HBC.


























































































Table4.2-EffectofCMfr mHBCmechanicallystimulatedfor20min t s,thmembr np tentialprev slyunsti ulated HBC. Membranepotential(- V) DonornRestingPostMSResting
With-CM
12542A534,27,27,25,25 12485C530,26,21,21,30 12507A539,31,29,38,29 12779C519,19,22,26,18
40,41,40,56,38 66,55872 58,248,51,68 68,524437
23,752 22,3304 24,3960 32,29,28,31,33
38,36,39,41,35 55,67,0 60,594872 51,48,38,42,6
Table 4.3 - Effect of recombinant IL-lp on HBC membrane potential.
Membrane Potential (-mV)
Donor n Resting + IL-lp
12485 C 5 34,32,25,27,29 62,44,50,52,49
12551 C 5 40,38,41,39,41 66,50,61,50,51

















31,29,35,36,2 46,25 ,9 38,45,42,48,3 37,31,48,2,4
n/a
55,36428,4 63,34540 35,45,32,39,4







28,736, 40,41,33,34,31 34,33,36,32,3 34,44,38,35,36
n/a
38,38,36,40,30 35,32,43,35,49 39,4845,3
38,405,44,7 38,402, 42,3697,50 50,643,8









28,43,28,1 35,37,42,2 1 35,36,36,33,38 39,24028
n/a 39,36,40,31,30 33,50644 31,46,38,41,32
39,4743 40,0,38,6 38,645 40,26397


























































































Table5.3-EffectofMTXnthm mbranehyperpolaris tionrespo sefHBCtIL p.
MembranePotential(- V)
DonorReagentRestingC lls+MTXIL1-P 12485CNil534,32,25,27,29n/a62,44, 0,5 ,49 50nMMTX35,24,29,30,3825,42,25,24,3146,5 ,61,56,42 12485CNil537,39,44,42,36n/a64,5 ,4 ,59,55 50nMMTX37,37,48,41,3845,40,38,40,490,43,5 ,51,63 12251CNil540,38,41,39,41n/a66,50,6 ,50,51 50nMMTX33,33,37,39,308,34,47,36,3352,61,5 ,5 ,46
Figure 5.4 - The effect ofMTX on the adhesion ofHBC to fibronectin (FN).
Results are expressed as % of control (No MTX)
12443 C 12592 C 13929 A Mean
No MTX
100.0 100.0 100.0 100.0
1 p.M MTX
53.0 72.0 68.0 64.3
50 nM MTX
63.0 65.0 68.0 65.3
1 nM MTX
52.0 68.0 76.0 65.3
Figure 5.5 - The effect ofMTX on the adhesion ofHBC to type 1 collagen (coll 1).
Results are expressed as % of control (no MTX).
12648 C 12779 C 13929 A Mean
No MTX
100.0 100.0 100.0 100.0
1 pM MTX
54.0 48.0 64.0 55.3
50 nM MTX
60.0 70.0 66.0 65.3
1 nM MTX
64.0 47.0 75.0 62.0
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13897CNil5 ADA5 MTX5 ADA+MTX5
40,41,35,33,34 40,37 36,02528 22,7364
n/a
24,4053 n/a 26,31,42,9,34
n/a n/a 30,35,37,33,35 28,625
62,5445 44,867 23,26,37,31,27 52,40667
13880ANil529,27,3 ,34,35n/a/58,4 ,44,50, 4 ADA530,24657,n/a52,439 MTX526,24,36,36,24n/a34, 1,33,40, 643,3 ,29,38,44 ADA+MTX532,40,27,32,286,42,29,29,299,29,28, 9,3640,54,54,57,64
Figure 6.1 - The effect of adenosine on the adhesion ofHBC to fibronectin (FN).
Results are expressed as % of control (no reagent).
12648 C 13800 A 13920 A Mean
No Reagent
100.0 100.0 100.0 100.0
100 pM
Adenosine
58.0 78.0 58.0 64.7
50 nM MTX
62.0 76.0 65.0 67.7
Figure 6.2 - The effect of adenosine on the adhesion ofHBC to type 1 collagen (coll
1). Results are expressed as % of control (no reagent).
12648 C 13821 A 13920 A Mean
No Reagent
100.0 100.0 100.0 100.0
100 pM
Adenosine
68.0 79.0 78.0 75.0
50 nM MTX
72.0 76.0 78.0 75.3
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Table6.3-hAjrec ptor,8-Cyclopentyl-13-dipropylxanthine(DPCPX),res r snormalHBCrespon estmech nical stimulationtoMTXtrea edcells. MembranePotential(-mV) +DPCPX
+MTX
PostMS
n/an/a 27,41,23,29,30n/a n/a31,32,23,27,25 29,20,29,22,3227,20,21, 8,32








521,29,26,24,28 541,30,26,24,26 528,35,39,39,34 524,41,28,29,20
13900ANil5 DPCPX5 MTX5 DPCPX+MT5
33,30,39,29,38 40,53346 32,36,38,38,29 25,31,29,28,40
n/an/a50,64,53,70,63 44,31,36,35,31n/a53 51,49,59,49 n/a30,38,38,39,3438,42,45,34, 0 29,39,40,36,383 ,27,24,34,3365,39,68, 7,58
Table6.3(continued)-hAjrec ptor,8-Cyclopen yl-13-dipropylxa hine(DPCPX),restor sormalHBCr sp ses mechanicalstimulationtoMTXr atedcells. MembranePotential(- V) DonorReagentResting+DPCPX+MTstMS 13883ANil540,34,42, 6,31n/a/65,48,57,53,67 DPCPX534,45,31,30,333,38,33,33, 5n/a66,5 ,61,59,52 MTX530,38,41,39,42n/a32,48,45,37,324 36 26 29,28 DPCPX+MT529,26,28,24,3436,31,36,32, 229,35,35,48,3847, 1,47 46,56
Table6.4-hA2Areceptor,8-(3-chlorostyryl)aff ine(CSC)storesnormalHBr p n stMTXr at dell .
MembranePotential(- V)
DonorReagentesting+CSCMTXPosMS 13883ANil528, 3,35,24,27n/a44,59,41,58 48 CSC530,32,30,29,384 1 4 30 2n/a66 5 6 5 9 MTX530,40,41,31,37n/a36,28,39,40 48 36 28,37,38 CSC+MTX522,30,32,29,306 27 0 233 ,41,4 ,37, 153 9 51 40 5 13956CNil529, 2,28,41,33n/a60,59 55 64 58 CSC+MTX531,37,34,42,348 0,40,39,3029,35 39 4060 62 51 46









13921ANil5 Alloxazine5 MTX5 Alloxazine+MTX5
33,41,31,32,37 34,27,31,34,38 38,7?543 40,2437
n/a
32,33,5 62 n/a 44,3260
n/a n/a
33,41,40,40, 34,73
59,2,41,42,47 43,7505 30,924 40,2832
13909ANil542,30,30,35,38n/a65,50,55,59,61 Allozazine+MTX532,37,38,36,3743,37,38,45,353,40,42,41,467,38,45, 8 39






36,3928n/a n/a30,459 21,26,27,26,2234 42 32,33,39





13891CNil5 MRS-11915 MTX5 MRS-1191+MTX5
27,53026 29,40833 32,38,41,30,35 36,0544
13909ANil541,38,47,39,47n/a6,58,51,64,47 MRS-1191+MTX537,43,46,37,3838, 0,35 45 444, 4, 357,66,56
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